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ABSTRACT 
Biomimetic engineering opens unprecedented possibilities of combining biomolecules (i.e. 
proteins, DNA, polysaccharides) with synthetic materials (i.e. synthetic polymers). This 
combination results in unique hybrid systems with functionalities that mimic processes in 
living organisms. While the translational value of functional biomimetically engineered 
structures is of exceptional importance in fields such as technology, engineering, chemistry, 
biology and medicine, due to the properties the structures inherit from both the synthetic and 
bio-materials, the understanding of how biomimetically engineered systems self-assemble and 
function is equally important, as it gives insight in how non-living systems progressed to living 
organisms. Some of the most prominent examples of functional biomimics include 
polymersome based catalytic nanocompartments, multicompartment systems that mimic 
cellular organization and artificial organelles. In this thesis, the focus lies on understanding and 
applying the fundamental principles of biomimetic engineering by equipping colloidal 
nanoarchitectures (soft polymer nanoparticles and hollow sphere polymersomes) with 
functional biomolecules (transmembrane proteins and enzymes).  
First, the most important questions are addressed – why do polymer nanoarchitectures present 
ideal building blocks for creating novel biomimics, how do biomimics self-assemble in 
solution, which methods are most frequently used for their characterization, and where the 
applications of biomimics are in technology and medicine. Both colloidal and 2D 
supported/free standing polymeric nanoarchitectures structures are discussed in order to 
familiarize the reader with the wide range of nanoarchitectures that can be formed by polymers, 
however the focus primarily rests on biomimetic design of colloidal nanoarchitectures, as their 
colloidal nature favours them as therapeutic agents that can act on the cellular level.  
To develop a pH responsive protein delivery agent, a biomimetic approach is applied in 
equipping self-assembled poly(ethylene glycol)-b-poly(methylcaprolactone)-b-poly(2-
(N,Ndiethylamino)ethyl methacrylate) (PEG-b-PMCL-b-PDMAEMA) polymer nanoparticles 
with a therapeutic enzyme, acid sphingomyelinase. Due to the electrostatic interactions 
between the negatively charged enzyme and the positively charged PDMAEMA groups present 
in the nanoparticle corona, the biomimetically engineered nanoparticles display a distinct 
protein localization on their corona and a pH dependent release behavior of the attached 
protein. The application of the self-assembled system as a very efficient delivery agent for 
catalytically active biomolecules is demonstrated in human epithelial HeLa cells.  
ABSTRACT 
 6 
Next, a more complex nanoscale biomimic - a pH triggered catalytic nanocompartment - is 
built by biomimetically engineering the nanoarchitecture of poly(2-methyl-2-oxazoline)-
block-polydimethylsiloxane-block-poly(2-methyl-2-oxazoline) (PMOXA-b-PDMS-b-
PMOXA) polymersomes. Aqueous cavities of polymersomes are loaded with horseradish 
peroxidase while a chemically modified Outer membrane protein F (OmpF) is reconstituted in 
polymersome membranes. The chemical modification of OmpF transforms the otherwise 
unspecific pore into a selective and pH responsive pore, through which molecules can only 
diffuse once the attached molecular cap blocking the pore is cleaved.  Hence, once the modified 
OmpF is functionally reconstituted in polymersome membranes it allows the developed 
biomimic to present an on demand catalytic activity. As a first proof of concept of a pH 
responsive catalytic nanocompartment the system demonstrates that a spatial control of a 
reaction inside a nanocompartment can be achieved and supports the further development of 
complex reaction spaces that can act in an analogous manner to cellular compartments, where 
in situ reactions are modulated by a plethora of responsive proteins.  
Finally, biomimetically engineered polymersomes are designed for an in vitro and in vivo 
application as artificial organelles. In order to mimic processes taking place in lipid membranes 
of cellular organelles, polymersome membranes are equipped with a genetically and 
chemically modified OmpF. The structural modifications done at the rim of the OmpF pore, 
limit the OmpF permeability to small molecular weight molecules, but make it capable of 
responding to the presence of small signaling molecules. When the modified OmpF is 
reconstituted in membranes of enzyme loaded polymersomes it prevents the enzyme to access 
enzymatic substrates. However, the presence of of glutathione, which for example is found in 
abundant concentrations in the cytoplasm, readily cleaves the chemical modification of OmpF 
and opens the pore, thereby allowing the encapsulated enzyme to catalyze a reaction. The 
responsiveness of the self-assembled system to glutathione, abundantly present in the 
cytoplasm, makes the developed biomimic a suitable candidate for intracellular functionality 
as an artificial organelle. To demonstrate this, we not only show that the system is functional 
in the cellular microenvironment of human epithelial HeLa cells but also that it is robust enough 
to function in vivo in Zebrafish embryos.   
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Chapter 1. 
FUNCTIONAL BIOMIMETIC DESIGN OF POLYMER 
NANOARCHITECTURES⊥  
 
The first chapter serves to introduce the fundamental principles of biomimetical engineering 
of polymer nanoarchitectures and their applications. The reader is familiarized to amphiphilic 
block-copolymers - central building blocks of supramolecular polymer nanoarchitectures. 
Next, the thermodynamically driven self-assembly and characterization of both colloidal 
polymer nanoarchitectures (micelles, soft nanoparticles and polymersomes) and 2D polymer 
nanoarchitectures (films and membranes) is discussed. Both colloidal and 2D polymer 
nanoarchitectures equally serve as suitable platforms to which biomimetic engineering can be 
applied, however the focus here is primarily on the biomimetic engineering and application of 
colloids, due to their high translational value in biomedicine. Together the size, colloidal 
nature and fundamental architecture of colloid based biomimics support a wide range of 
applications, such as that of drug delivery agents, defined catalytic compartments, nanoscale 
systems that can imitate functions of cellular organelles or even micro scale cell mimics in the 
form of polymer based multicompartments.  
 
 
 
 
 
 
 
 
 
 
⊥⊥This chapter is partially reprinted and has been published: T. Einfalt, G. Gunkel-Grabole, A. Najer, M. Spulber, C.G. Palivan, Supramolecular 
Architectures: Supramolecular Architectures from Self-Assembled Copolymers, CRC Conciese Encyclopedia of Nanotechnology, 2015, 1055-
1072 
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1.1 INTRODUCTION 
 
Inspired by nature, biomimetical engineering represents a scientific approach where 
fundamental principles acquired in engineering, chemistry and biology are applied to combine 
synthetic and bio- materials for the design of hybrid systems with functions that mimic 
biological processes. Motivated by structures and processes present in nature, such as the 
cellular plasma membrane, nanoscale biomimics represent hybrid materials that function with 
a high degree of precision and efficiency, for example when in the role of artificial organelles. 
The concept is especially important in the field of nanotechnology, as the unique combination 
of synthetic supramolecular nanoarchitectures and biomolecules gives rise to novel materials 
that inherit both the robust nature of the synthetic nanoarchitecture and the well-defined and 
efficient function of biomolecules. In order to favor an interaction with biomolecules the 
synthetic backbone of nanoscale biomimics needs to possess highly defined structural 
properties (i.e a well-defined membrane fluidity and thickness), which makes only a few 
synthetic systems eligible for this role1.  The role of biomimetically engineered systems ranges 
from that of versatile agents in drug delivery to catalytic nanocompartments and functional cell 
mimics1,2.  
 
Thermodynamically driven self-assembly of molecules in solution represents a key process in 
nature and serves as inspiration to build a variety of biomimetical supramolecular 
nanoarchitectures, by starting with the corresponding building blocks. In nature, the result of 
self-assembly appears in examples like the tertiary structure of proteins, the helical structure 
of DNA, or the bilayer morphology of cellular membranes1,2. Driving forces behind molecular 
self-assembly involve various molecular interactions such as van der Walls interactions, 
hydrogen bonds and hydrophobic/hydrophilic balance.  Biomimetic engineering of novel 
hybrid materials relies on the functional incorporation of biomacromolecules (DNA, proteins, 
polyssacharides) into the synthetic supramolecular nanoarchitectures, either during the self-
assembly or after the synthetic backbone of the nanoarchitectures has already been formed. 
When combined, robust synthetic materials and highly functional biomacromolecules 
complement each other in stability and functionality. The synergistic effect between them gives 
rise to a high mechanical and chemical stability along with a highly defined, modulated and 
efficient functionality. When designing biomimetic nanoarchitectures the high degree of 
stability of the synthetic material along with the preservation of biomolecule functionality has 
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to be taken into account. In this respect polymers and copolymers are synthetic macromolecules 
that represent prominent materials for biomimetic systems, as they can be chemically 
engineered to possess a specifically tailored composition in addition to possessing a very robust 
structure that allows complex interplay with a variety of biomolecules3. Depending on their 
chemical nature, and conditions in which the self-assembly process takes place, synthetic 
polymers alone or in combination with biomolecules generate a plethora of different 
supramolecular architectures, which range in size from a few nanometers in diameter up to 
several micrometers. This versatility has been explored extensively in the past, giving access 
to wide range of hybrid structures including biomimetically engineered micelles, soft 
nanoparticles, worms, or vesicles in solution, as well as planar membranes and polymer films1,4 
(Scheme 1.).  
 
 
 
Scheme 1. Biomimetically engineered artificial nanoarchitectures. Principles of 
biomimetic engineering are applied to merge the gap between synthetic and biological systems, 
leading to the design of new hybrid systems that inherit the properties of both synthetic and 
biological systems. Adapted from Ref2 with permission. 
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1.2 AIM OF THE THESIS 
The aim of this thesis is to advance the state of the art in development of biomimetically 
engineered polymer nanoarchitectures, with the focus on designing novel hybrid colloidal 
structures with enhanced functionalities. The colloidal nature, shape and size makes 
polymersomes, micelles and soft nanoparticles some of the most prominent materials in 
modern day drug delivery applications. However, in order to design systems that go beyond 
established drug delivery methods, very important properties like the ability of molecular 
recognition, an enhanced catalytic activity or triggered functionality all have to be taken into 
account. Biomimetic engineering offers a way to introduce these properties to the otherwise 
inert nature of synthetic nanoarchitectures in a way where they are combined with 
biomolecules that present some kind of intrinsic functionality. Previously this methodology 
has been applied to colloidal nanoarchitectures for the development of systems like the first 
artificial peroxisome5, organelle like polymersome DNA clusters6, targeted antigen 
functionalised polymersomes7 and heparin decorated polymersome8 based nanomimics. Here 
we begin by designing a protein carrier based on PEG-b-PMCL-b-PDMAEMA polymer 
nanoparticles9, that can attach and release therapeutic proteins on demand.  This mimics a 
fundamental phenomena of carrier nanostructures found in nature, where for example nano 
sized globular proteins and lipoproteins, such as high density lipoproteins, low density 
lipoproteins 10, transferrin and ferritin11 have their architectures specifically tailored to carry 
molecules, such as cholesterol and iron, from one organ to the other in the human body. Further, 
we investigate how the hollow-sphere nature of PMOXA-b-PDMS-b-PMOXA polymerosmes 
can be engineered to design a synthetic compartment system with on demand catalytic 
functionality12. Such as spatial control of compartmentalised reactions is vital for the advance 
of novel therapeutics, as it mimics the natural function of cellular organelles and provides a 
mean to design artificial organelles. Finally, the aim of the thesis is to advance the state of the 
art design of polymersome based artificial organelles, by testing the functionality and stability 
of responsive catalytic nanocompartments in vitro and in vivo.  
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1.3 SYNTHETIC POLYMER NANOARCHITECTURES AND 
THEIR SELF-ASSEMBLY 
 
Synthetic polymers represent essential building units for the self-assembly of colloidal and 2D 
(supported or free standing) nanoarchitectures, such as micelles, soft nanoparticles, disks, 
worm like structures, polymeric vesicles, polymer films, polymer membranes1,13.  
 
The diversity of assemblies generated by polymers is a consequence of the wide variety of 
compositions, functionalities and shapes in which polymers occur. Synthetic polymers - 
classified in homopolymers, copolymers-  are obtained by a variety of synthetic polymerization 
procedures 1,14. Homopolymers consist of identical repeating units of monomers connected by 
covalent bonds, whereas block-copolymers are polymers made of two or three or more different 
blocks of covalently linked homopolymers. In most frequent methods of synthetizing block-
copolymers, monomers are first polymerized to longer homopolymeric blocks. Once these are 
complete, two, three or more homopolymeric blocks are linked together in a final step that 
yields the desired block-copolymer. However alternative means of synthesis, such as one pot 
reactions where all the monomers are reacted together, also exist and should be considered15.  
In this way, amphiphilic properties of the final product are the result of different hydrophyilic 
and hydrophobic properties of induvidual homopolymer blocks. The amphiphilic properties of 
the along with the respective lengths of polymer chains and the method used in preparation of 
nanoarchitectures predominantly determine shape of the self-assembled nanoarchitectures13. 
An exception are polyelectrolytes, which represent a special group of polymers that display 
characteristic charged functional groups along the polymer chains, which lead to the assembly 
of nanoarchitectures based on the opposite charges of the polyelectrolyte multilayers16.  
 
To synthetize the desired product, the polymerization reaction is selected depending on the 
nature of the monomers and the desired products. During synthesis, key parameters (i.e solvent, 
temperature and time) have to be controlled in order to obtain a molecular weight and narrow 
dispersity of the polymer17. Several methods of synthesis exist to synthetize polymers, each 
with advantages, such as a narrow polydispersity of the product, and disadvantages, such as 
the need of organic solvents or toxic catalysts. Some of the most prominent synthesis routes 
are: (a) living anionic and cationic polymerization18,19, (b) controlled ring-opening 
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polymerization20, and (c) controlled radical polymerization (CRP), which includes: (i) atom 
transfer radical polymerization (ATRP)21, (ii) reversible addition-fragmentation chain transfer 
polymerization (RAFT)22 and (iii) nitroxide mediated radical polymerization (NMP)23.  
The  poly(2-methyl-2-oxazoline)-block-polydimethylsiloxane-block-poly(2-methyl-2-
oxazoline) PMOXA-b-PDMS-b-PMOXA and PEG-b-PMCL-b-PDMAEMA copolymers, 
discussed later on in Chapter two, three and four are obtained by controlled ring opening 
polymerization. The PEG-b-PMCL-b-PDMAEMA copolymers require an additional step of 
ATRP polymerization. Ring opening polymerization techniques (ROPT) are widely used for 
the synthesis of well-defined polymers, since by controlling the catalyst, monomer type and 
nature of the initiator tailor made polymers can be synthetised18,20,21. 
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1.4 COLLOIDAL NANOARCHITECTURES 
Micelles, soft nanoparticles and polymersomes are colloidal assemblies generated by the self-
assembly of amphiphilic block-copolymers in aqueous or organic media. They are the most 
frequently mentioned colloidal nanostructures, due to their popularity in a large variety of 
medicinal applications as biosensors, drug/contrast agent carriers, mimics of biomembranes, 
catalytic nanocompartments, and very recently, as model nanocompartment spaces for the 
design of artificial cell organelles (Figure 1.)17,24,25. 
 
 
 
 
 
Figure 1. Schematic representations and respective cryo-TEM images of colloidal 
nanoarchitectures. Panel A. Schematic drawing of colloidal nano-scaled self assemblies, 
micelles, cylindrical micelles – „worm like“ structures, and polymersomes. Adapted from Ref17 
with permission. Panel B. Cryo-TEM pictures of micelles, vesicles, and worm-like micelles. 
Adapted from Ref26 with permission.  
 
 
 
 
 
A
B
Spherical	micelles
“Worm”	like	
micelles
Polymersomes
100	nm
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1.4.1 MICELLES 
 
Micelles are colloidal nanoarchitectures generated, and thermodynamically stabilized, when 
the polymer concentration in a given solvent is higher than the critical micellar concentration 
(CMC), and disassemble upon dilution of the polymer concentration below the CMC. Primarily 
the process is governed by the reduction of Gibbs free energy. The rate of the assembly and 
disassembly is dependent on the structure of the amphiphilic polymers, such as the chain 
length, hydrophobicity, hydrophylicity. These properties determine the interactions between 
the polymer chains in solution, such as hydrogen bonds and van der Walls interactions27. The 
critical micellization temperature (CMT) represents the temperature above which amphiphilic 
molecules can be found as aggregates. Below the CMT they remain as unimers28. The critical 
micellar temperature is a point of phase change below which the surfactant remains in 
crystalline form, even in aqueous solution. Micelles have a broad size distribution. Their 
architecture consists of an inner core, generated by the hydrophobic domain, and hydrophilic 
corona, which shields the core29. 
Micelles are generated by a variety of amphiphilic copolymers: diblocks, triblocks, or grafted 
copolymers30,31. Depending on the copolymer chemical composition, solvent, and preparation 
method micelles have different shapes, ranging from spheres to cylinders and lamellar 
bilayers32. For example, coil-coil block copolymers can lead to either spherical star-like 
micelles or “crew-cut” micelles, depending on the length of the corona chains (Figure 2.)33,34.  
Rod-coil block copolymers can form either disk-like micelles or rod structures depending on 
the lengths of the corona chains35,36. 
 
Figure 2. Schematic illustration of micellar nanoarchitecture. A crew-cut micelle (left) and 
a starlike micelle (right). Adapted from Ref 34 with permission.  
The terms “nano-rods”, “nanotubes”, “worm like” “disk” micelles refers to cylindrical 
structures with a tubular core diameters ranging from a few 5 nm to 100 nm37. Their length, 
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however, can exceed 1µm, as the thermodynamic favored state of longer structures is favored 
over short ones. ”Worm-like” micelles have two distinct architectures: linear and branched. 
The predominant topological effect determines the morphology: linear morphology in the case 
of end-caps, and branched in the case of Y-junctions (Figure 3).  There are situations where 
both types of architectures can coexist in different proportions38.  
 
Figure 3. Cylindrical micelles. Topological defects in cylindrical micelles: end caps and y-
branch junctions adapted from Ref38 with permission.  
 
Spherical micelles are the most frequently used micellar structures, with sizes ranging from 
10-100 nm39. Their popularity is a consequence of their size, spherical shape and the 
hydrophobic core that can serve to entrap hydrophobic molecules. The latter is beneficial for 
various applications - the most prominent being as drug delivery systems or solubilization 
agents. One of the most frequently used hydrophilic domains is poly(ethyleneglycol) (PEG) 
due its biocompatibility, and low toxicity39. As hydrophobic blocks, polyamino acids, 
polyethers, and polyesters, such as poly(propylene oxide) (PPO), poly(D,L-lactic acid) 
(PDLLA), poly(ε-capro- lactone) (PCL), poly(L-aspartate) and poloxamers are typically 
employed30,31.  
 
Commonly applied methods for micelle formation and entrapment of molecules in micelle 
cores are: i. direct dissolution, ii. solvent exchange, and iii. film rehydration. More elaborate 
techniques, in terms of equipment, are evaporative spin coating and corona cross-linking 
strategies or the combination of direct dissolution / solvent exchange with microfluidics40. An 
amphiphilic block copolymer in aqueous medium around the CMC of the copolymer represents 
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the most straight forward approach of generating micelles. The dissolution is followed by 
heating and the addition of hydrophobic molecules in order to promote encapsulation. Once 
the temperature drops below the CMT the hydrophobic molecules are encapsulated in the inner 
core of micelles. The solvent exchange method is based on dissolution of copolymers and 
molecules to be entrapped in an organic solvent, and subsequent addition of water, which will 
favor micelle formation. The inverse method is used as well, depending on the copolymer 
solubility: the addition of an organic solution to an aqueous solution of copolymers and 
hydrophobic molecules intended to be entrapped. Lack of miscibility of the organic solvent in 
the aqueous medium can lead to oil in water (O/W) emulsion, which requires subsequent 
removal of the organic phase. The rate by which the organic solvent is removed not only 
determines the number of micelles, but also their size and the possible creation of aggregates. 
Film rehydration method is based on dissolution of the block-copolymer in a suitable organic 
solvent, which is then evaporated under reduced pressure resulting in a thin polymer film41. 
The film is then rehydrated by addition of aqueous solution under stirring, and 3D assemblies 
are formed. Spin coating method is based on a deposition of copolymers as uniform thin films 
on flat surfaces, which favors the formation of micelles due to preferential interactions between 
one of the copolymer blocks and the solid surface. Corona cross-linking strategies employ 
chemical cross-linking of the polymer chains, which form the micellar corona of preformed 
micelles42,43. 
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1.4.2 SOFT NANOPARTICLES 
 
Amphiphilic block copolymers can form spherical colloidal structures named soft-
nanoparticles. Despite the similarity of soft nanoparticles to micelles in size and composition, 
the equilibrium dynamics of soft-nanoparticles are different and are not driven by the self-
assembly of block-copolymer around the CMC.  Soft-nanoparticle self-assembly relies highly 
on the hydrophobic interactions and molecular entanglement of polymer chains within the 
nanoparticle core and is in general irreversible. In this respect the hydrophobic unit of the 
polymer chains should be long enough to assure a consequent “frozen” state of molecular 
entanglement (Figure 4.)44. Interestingly, soft nanoparticles can be formed by folding a single 
chain of polymer, if the chain is sufficiently long45. This demonstrates that the self-assembly is 
driven by the same forces as the self-assembly of protein molecules, which are folded from a 
single chain of amino acids. Typically, the size of soft-nanoparticles ranges between 50 to 
200nm. Once self-assembled, the colloidal stability of the nanoparticles is assured by steric or 
electrostatic repulsions between individual nanoparticles, which prevents fusion from 
Brownian collision 44. Preparation techniques for nanoparticles include direct dissolution and 
nanoprecipitation followed by solvent removal, which influence the size or aggregation number 
of particles depending on the rate and magnitude of the solvent dilution or removal46,47.  
 
 
Figure 4. Soft-nanoparticle formation via self-assembly. Pathways of polymer chain self-
assembly and the products. Micelles are formed by the CMC driven self-assembly of 
amphiphilic block copolymers. Nanparticles are formed by the rapid and non-equilibrium self 
assembly of amphiphilic block-copolymers. Adapted from Ref44 with permission.  
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1.4.3 POLYMERSOMES 
 
Polymer vesicles, named polymersomes48 ,are structural analogues to lipid vesicles (liposomes) 
built from amphiphilic block copolymers instead of lipids (Figure 5). During self assembly of 
polymersomes either spherical mono- (ABA-type polymer) or bilayer membranes (AB-type) 
enclosing a watery core are formed. The hydrophilic to total mass ratio (f-value), the packing 
parameter (p = v/a0lc), and the polydispersity index are key parameters, which govern the self-
assembly process (v = volume of hydrophobic part, a0 = contact area of head group, lc = length 
of hydrophobic part) 3,49. f-ratios in a range of 25 - 45% and p parameters between 0.5 and 1 
and a polydispersity index around 1 favour formation of polymersomes. The polymerization 
routes used to obtain well-defined amphiphilic copolymers have been described above18-21,50,51.  
 
 
 
Figure 5. Membrane composition of polymersomes. The polymeric membrane is formed by 
either diblock (AB), triblock (ABA or BAB), or multiblock polymers (ABABA, ABC or 
ABCA), where A, B and C are chemically different polymer blocks. Adapted from Ref52. 
 
While lipid membranes are typically 3 – 5 nm thick; the membrane thickness of polymersomes 
can be fine-tuned in the range of about 5 to 30 nm, depending on the length of the blocks53. In 
contrast to micelles and soft nanoparticles, polymersomes can also be found in sizes from 1µm-
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20µm. The larger giant unilamellar vesicles (GUVs) are especially appealing due to their 
potential as cell mimics. Polymersomes offer a wide variety of advantages compared to 
liposomes, especially higher mechanic stability, and greater chemical versatility48,54,55. The 
driving force for polymersome formation is mostly the hydrophobic effect. A special group are 
polymersomes with a polyion complex membrane (PICsomes), formed by ionic interactions of 
oppositely charged polymers (Polyelectrolytes) 16. The composition of the amphiphilic block-
copolymer used for polymersome formation can be either purely synthetic 3, biohybrid16,56, or 
purely biological 57,58. Specific functions, such as targeting properties, can be implemented by 
including biological entities directly into the block copolymer before vesicle formation56 or by 
functionalizing of preformed vesicles with targeting ligands59,60.  
 
 
Figure 6. Membrane functionalisation of vesicles. Left: Unmodified polymersome 
membranes, Right: Polymersome membranes modified with targeting ligands. Adapted from 
Ref61 with permission.  
 
Another critical step is to choose the appropriate polymersome formation technique. The latter 
is usually specific for each polymer - a technique that works for one polymer cannot necessarily 
be applied to other polymers. The most suitable technique might even change depending on 
the nature of the desired molecules to be encapsulated. Currently used polymersome formation 
methods are similar to those used for micelle formation: direct dissolution of dry polymer 
powder, film rehydration, solvent exchange method in addition to double emulsion technique, 
electroformation and microfluidics60,62,63.  Polymersome size is highly dependent on the 
preparation method. For example, film rehydration yields small multilamellar vesicles, 
whereas electroformation was specifically developed to produce micrometer-sized 
polymersomes60. After formation of the polymersomes, extrusion – separating a polymersome 
solution through a filter with defined pore sizes – is often applied to obtain smaller 
polymersomes with a narrower size distribution.  Interestingly polymersomes made from 
diblock, but not triblock, copolymers can be transformed from unilamellar to bilamelar 
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“double” polymersomes under hypertonic shock, demonstrating the close relation, and the 
intrinsic differences of polymersomes and liposomes (Figure 7)64. 
 
 
 
 
 
 
 
 
 
 
Figure 7. Osmotic transformation of polymersome vesicles. Cryo-TEM images of shape 
transformation from unilamellar vesicles to bilamellar vesicles due to hypertonic shock. Small-
angle neutron scattering performed on polymersomes. Adapted from Ref64, with permission. 
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1.5 SUPPORTED AND FREE STANDING 2D POLYMER 
NANOARCHITECTURES 
 
Polymer-films, self-assembled monolayers, polymer membranes, polymer brushes and 
polymer layers represent supported and/or free standing 2D polymer nanoarchitectures that can 
equally serve as platforms for the design of nano-scale biomimics. However, as biomimetic 
engineering of 2D polymer structures is beyond the scope of this thesis, the following 
paragraphs serve to briefly introduce the reader to the variety of 2D nanoarchitectures formed 
by synthetic polymers.  
 
1.5.1 POLYMER FILMS 
Polymer films are thin layers of polymers that are typically attached to a solid substrate, but 
they can be also found as entirely free-standing between air-water interfaces. They represent 
one of the simplest models of biological self-assemblies and are important as they provide 
information about the fundamental thermodynamics behind self-assembly 1.Their size ranges 
from a few nm up to several micrometers in thickness, and largely depends on the type of film 
and the preparation method. Owing to the wide range of polymer synthesis techniques and 
polymer film types available, the characteristics and film properties can be effectively tuned to 
specific needs. Their permeability, wettability, mechanical, optical or adhesive properties can 
be controlled 65 making them ideal candidates for a plethora of different applications in 
biomedical coatings,  sensors, photovoltaics, lubrication, and filtration.  
 
 
1.5.2 SELF-ASSEMBLED MONOLAYERS 
 
Self-assembled monolayers (SAMs) are the thinnest polymer films on solid support, having a 
thickness up to a few nanometers (Figure 7.)66. The monolayers are formed spontaneously 
through chemisorption of functional molecules at the interface of solid surfaces with liquids or 
gases67,68. The most commonly used systems include thiol-functionalized molecules on gold 
surfaces (Figure 9) and alkylsilanes on silicon or glass69. The resulting polymer films are 
thermodynamically stable, highly ordered, and nearly defect-free surface coatings66,68. A range 
of solid substrates is available for functionalization through this method, particularly 
hydroxylated surface of different materials can for example react with alkylsilanes68. This 
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method of surface modification is not limited to attachment of polymers. In fact, small 
molecules are frequently immobilized via this method.  
 
Figure 8. Self-assembled polymer monolayer. Different steps take place during the self-
assembly of self-assembled moolayer on a gold surface. In order to allow chemical binding of 
the polymer molecules (red) to the gold surface (yellow) thiol groups are presented at the end 
of polymer chains (black). The different phases are presented: a.) physiosorption, b.) lying 
phase formation for molecules, c.) nucleation of the standing up phase and finally the 
completion of the standing up hase of the self-assembled monolayer. Adapted from Ref67 with 
permission. 
 
1.5.3 POLYMER MEMBRANES 
 
A polymeric membrane can be formed from amphiphilic di- or triblock copolymers, thereby 
resembling the structure of naturally occurring lipid-based cellular membranes 70,71 These 
membranes are very soft and flexible and do not require covalent attachment to an underlying 
substrate. The membranes can be formed directly on the surface through synthesis of block 
copolymer brushes from surface-immobilized initiator moieties or through grafting of 
polymer chains to the surface. Alternatively, the membrane can be pre-formed and 
subsequently deposited on a solid support using the Langmuir-Blodgett method72,73. A third 
synthetic route is to first assemble polymeric vesicles (as discussed above), which are then 
ruptured on the solid support to yield a planar membrane (Figure 9.)74. 
a
b
c
d
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Figure 9. From polymersomes to planar membranes. Preformed polymersomes are ruptured 
on solid support to yield planar membranes. Adapted from Ref1 with permission. 
 
1.5.4 POLYMER BRUSHES  
 
Polymer brushes are another well-studied class of polymers on solid support. However, unlike 
polymer membranes they are not directly self-assembled in solution but require covalent 
attachment on a surface. They obtained their name “brushes” because the polymer chains are 
stretched away from the substrate, resembling a brush (Figure 10.)75. Depending on external 
stimuli (i.e pH), the polymer chains forming the brush can be extended or coiled. Polymer 
brushes can be synthesized in solution and subsequently grafted to a surface, or they can be 
grown directly on the surface from previously immobilized initiator molecules76. The different 
types of living/controlled radical polymerization techniques77,78 are established to synthesize 
polymer brushes;, however, metathesis polymerization79 and supramolecular polymerization80 
methods have also been employed successfully. The accessible thickness, which relates to the 
degree of polymerization in free polymers81, depends on the parameters of the polymerization 
reactions such as time, catalytic system, or solvent, but typically thicknesses around or 
exceeding 100 nm are generated. Different nanomorphologies of the polymer film can be 
generated depending on the lengths of the polymer blocks and the exposed solvent77. 
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Figure 10. Polymer brushes and polymer film formation. Schematic illustration of a 
polymer brush, where the polymer chains are stretched away from the surface giving a dense 
polymer film . Adapted from Ref78 with permission.  
 
1.5.5 POLYMER CARPETS  
 
More recently, polymer brushes have also been synthesized on soft and thin initiator layers to 
yield entirely free standing polymer films termed  “polymer carpets”82,83. Other free-standing 
films are pore-spanning membranes,74 or polyelectrolyte layers bridging pores as large as 
100 µm2,84. Polymer sheets of only a few nanometers in thickness have been obtained by using 
specifically designed monomers 85 and by cross-linking of aromatic self-assembled monolayers 
86. These different types of free-standing polymeric films have their general synthetic route in 
common; typically, the film is first generated on a solid support and subsequently lifted off 
82,83,86 (Figure 11).  
 
 
Figure 11. Freestanding Polymer carpet. Dimensions of an exemplary polymer carpet 
composed of a crosslinked substrate and a polymer brush. Adapted from Ref82 with permission. 
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1.5.6 POLYMER LAYERS  
 
Thicker and thus more robust polymer layers can be obtained by deposition of polymers on 
solid support. Typical methods include spin-coating87 and layer-by-layer (LbL) assembly of 
polyelectrolytes  (Figure 12.)88. In both techniques, the thickness of the polymer film can be 
easily controlled by the preparation parameters, and thicknesses in the micrometer range are 
accessible. The ease of film formation using the LbL method and the solubility of 
polyelectrolytes in aqueous systems set important prerequisites for biomedical applicatons89, 
but the method is also used to deposit polymerization initiators83,90. A more laborious method 
of preparation presents spin coating spin-coating, on the other hand, that can be used for the 
formation of polymer layers used in various applications91. 
 
Figure 12. Polymer films formed with layer-by-layer method. Model of a polymer film 
formed with the layer-by-layer method, in blue a charged polymer and in red an oppositely 
charged polymer, adapted from Ref89 with permission. 
 
 
 
 
 
 
 
 
 
 
 
 
 
FUNCTIONAL BIOMIMETIC DESIGN OF POLYMER NANOARCHITECTURES 
 26 
1.6 CHARACTERIZATION OF POLYMER 
NANOARCHITECTURES 
 
 1.6.1 CHARACTERIZATION METHODS FOR COLLOIDAL 
NANOACHITECTURES 
 
For proper characterization of the assembled colloidal nanoarchitectures various properties, 
such as assembly size, homogeneity, shape, and surface charge must be analyzed. The 
characterization techniques are roughly divided in:  
i. scattering methods (light and neutrons scattering) 
ii. microscopy techniques 
 
SCATTERING METHODS  
 
Light scattering methods such as static and dynamic light scattering (SLS and DLS 
respectively) and flow cytometry are commonly used as non-destructive methods that assess 
various colloidal nanoarchitecture parameters such as the size, concentration, architecture 
(solid sphere, vesicular structure, cylindrical micelles, etc), and presence of various populations 
of assemblies (for example micelles and vesicles). In addition, the vesicular zeta potential can 
be determined by measuring the electrophoretic mobility of assemblies in a capillary cell, 
where they are exposed to an alternating current92,93,94 (Figure 14).  
 
 
 
Figure 13. Prinicples of light scattering analysis. The intensity correlation function is 
correlated to a size distribution by intensity.  
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Small angle neutron scattering (SANS) is a technique in which a neutron beam passes through 
a sample and the resulting scattered neutrons are counted as a function of angle and wavelength 
providing information about the morphology, size, and interactions of 3D assemblies present 
in the sample95. 
 
 
MICROSCOPY TECHNIQUES  
 
Electron microscopy techniques such as scanning electron microscopy (SEM), transmission 
electron microscopy (TEM), and cryogenic TEM (Cryo –TEM) are frequently used when high 
resolution is required, for example when examining the architecture and membranes of 
colloidal nanoarchitectures (Figure 14.). These techniques are based on focusing a beam of 
electrons on the specimen: the acquired images are the result of the interactions of electrons 
through the sample26,53.  
 
 
Figure 14. Cryo-TEM of PMOXA-b-PDMS-b-PMOXA. Application of cryo-TEM for the 
determination of the thickness of PMOXA-b-PDMS-b-PMOXA polymersome membranes. 
Adapted from Ref53 with permission.  
 
Conventional microscopy is normally used in the case of colloidal structures that present a 
relatively big size (>1µm) or when investigating the intracellular localization and function of 
colloidal nanostructures. It is of exceptional value, when it is necessary to obtain information 
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on the behavior of specific structural domains. The latter can be labelled with fluorophores, 
which serve to distinguish the labelled domain from the rest of the nano/micro architecture 
(Figure 15) 96,53. In this respect, fluorescence microscopy is most frequently applied as confocal 
laser scanning microscopy (CLSM). CLSM is an optical imaging technique, which leverages 
on a spatial pinhole placed at the confocal plane of the lens. This eliminates out of focus light 
and enables reconstruction of 3D structures from images that are acquired with optical 
sectioning. Until recently the intrinsic resolution of CLSM was limited by the diffraction limit 
of light, meaning that objects smaller than 200-300nm could not be distinguished. However 
recent advances in techniques such as the stimulated emission and depletion allow a lateral 
resolution of down to 60nm97.  
 
Figure 15. Fluorescence microscopy images of polymeric giants. Fluorescence images of 
giant unilamellar polymersomes, acquired by CLSM. Red fluorescence: m-Cherry, Cyan 
fluorescence coumarin fluorophore. Adapted from Ref96 with permission. 
.  
Data collected by fluorescence microscopy or computer-enhanced video microscopy can be 
applied to single particle tracking (SPT). By using SPT the relative position of an object is 
directly monitored in time and recorded. This provides information about the movement of the 
observed objects and their paths, which can be analyzed independent of theoretical fitting 
models. The typical size resolutions of this technique are in the range between 20 – 100 nm, 
while time resolutions range from 25µs to 100ms and heavily depend on the type of camera 
that is used in the measuring device. The camera can for example, capture a video file of the 
particles moving under Brownian motion. By using nanoparticle tracking analysis (NTA) many 
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individual particles can be followed simultaneously individually and their hydrodynamic 
diameters determined using the Stokes Einstein equation (Figure 16.)98. 
 
 
 
Figure 16. Nanoparticle tracking analysis.  Principle of using microscopy for single particle 
analysis. Adapted from Malvern.com. 
 
 
A particular useful technique to study both the sizes of nanoarchitectures and their interactions 
with specific molecules is fluorescence correlation spectroscopy (FCS). FCS makes use of a 
very small observation volume (~ 1 fl), named confocal volume, and follows the diffusion of 
fluorescent molecules through it. Much information relevant to analyzing the behavior of 
nanoarchitectures can be extracted from the autocorrelation curve of the signal, which is related 
to the diffusion of fluorophores in and out of the focal volume. The half-value decay time gives 
an estimate of the mean diffusion time. Information about particle concentration can also be 
determined, as the inverse amplitude of the correlation curve equals the average particle 
number within the focal volume. In the case when there are multiple molecules in the confocal 
volume, there is a higher average fluorescence but a smaller relative fluctuation from each 
molecule. Hence, the effect of a single molecule is diminished, giving smaller fluctuations and 
a lower correlation amplitude55,99 (Figure 17.).  The significant  advantage of FCS is that it is 
capable of detecting single molecules at high spatial and temporal resolutions, while the 
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concentrations can be kept in the nanomolar range. A drawback however is, that the observed 
molecules have to be fluorescent and that the appropriate dye has to be selected for each 
purpose.  It is a technique that is of tremendous importance in biomimetic engineering of 
nanoarchitectures as it allows to determine diffusion coefficients, correlated to possible 
interactions of fluorescent molecules with supramolecular assemblies, such as polymersomes, 
liposomes and nanoparticles in the pico- to nanomolar concentration region 8,100-103. 
 
 
 
 
Figure 17. General principles of fluorescence correlation spectroscopy. Application of a 
focused laser beam, FCS can be used to determine fluctuations of fluorophores diffusing either 
freely in solution or when they are bound to larger objects. This is done by observing their 
diffusion through a very small, optically defined volume, referred to as the confocal volume, 
that is illuminated by a focused laser beam. The autocorrelation function of the recorded signals 
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describes the normalized variance of the fluorescence fluctuations and tells how self-similar 
the recorded signal is after a certain time delay. The shape of the autocorrelation curve G(t) 
provides the characteristic times for molecular residence in the focal volume (τd). In the case 
of a short time delay relative to the τd, the normalized integral of the overlapping region is close 
to 1, and the autocorrelation function has a maximal amplitude. However, with longer time 
delays, the overlapping region gradually decreases until the autocorrelation function has fallen 
to zero. Conversely, a few molecules in the observation volume result in a low average 
fluorescence with larger fluorescence fluctuations detected from a single molecule and a higher 
correlation amplitude. Adapted from Ref104 with permission.  
 
1.6.2 CHARACTERIZATION METHODS FOR 2D POLYMER 
NANOARCHITECTURES 
 
CHARACTERIZATION METHODS FOR POLYMER FILMS AND MEMBRANES 
 
The formation of polymer films on solid support, or as free-standing films, requires specialized 
characterization methods78. The central parameters of interest are the polymer film and 
membrane thickness, the homogeneity, and the morphology. Different methods are available 
to determine these parameters; for example, the thickness can be determined by spectroscopic 
ellipsometry or by atomic force microscopy, which also images the morphology and the 
homogeneity. Insights into the mass of immobilized polymer on a surface as well as 
interactions of the polymer film (e.g. with biomolecules) can be studied in detail by quartz 
crystal microbalance 105 and surface plasmon resonance 106. The composition of polymer films 
can be probed by infrared spectroscopy, x-ray photoelectron spectroscopy, and mass 
spectrometry107,  while surface characteristics such as the wettability are accessible through 
contact angle measurements. Particular applications of polymer films require more specialized 
techniques like the determination of adhesion phenomena,108  charges in the polymer film,109 or 
the insertion of proteins into the film71. 
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1.7 BIOMIMETIC ENGINEERING OF COLLOIDAL 
POLYMER NANOARCHITECTURES 
 
Mimicking biological processes, by engineering biomimetic nanostructures, named biomimics, 
is an elegant strategy that is relevant to various scientific fields such as materials science, 
chemistry, electronics and medicine1,110,111. The biomimetic design is realized by applying a 
bottom-up approach – arranging of synthetic and biological molecules at the nanoscale via self-
assembly. In this way it is possible to combine individual biological units, known for their 
sophisticated structure and activity (e.g. proteins, lipids, DNA), with robust synthetic materials 
(e.g. polymers, porous silica surfaces, nanoparticles) 2,8,112-115. The combination results in new 
hybrid materials that present emergent properties and functionalities. Biomimics contribute to 
the basic understanding of engineered materials at the nanoscale and are already being used in 
a wide range of applications, such as sensitive diagnostic surfaces116, efficient systems for 
precise local therapy,117,118 patient orientated tailored medicine 8,102,119,120, and highly efficient 
detoxification of environmental pollutants121. In addition to their translational potential, 
biomimics contribute to our present understanding of synthetic biology and evolution, and 
provide a deep insight in the progression from non-living materials to living systems by 
imitating the molecular organisation found in prokaryotic and eukaryotic cells103,121-125.  
Nanoscale biomimics must cope with a complex scenario of requirements to preserve the 
structure and functionality of the biomolecules that are included in the hybrid assembly and 
finally serve the desired applications. For example, extreme temperatures, organic solvents and 
denaturizing reactants, normally used in catalysis or for the preparation of colloidal assemblies, 
need to be avoided because they lead to loss of biomolecule functionality126. Here the most 
common methods of biometical engineering of colloidal nanostructures (micelles, soft 
nanoparticles and polymersomes) will be presented. 2D supported and free standing polymer 
architectures can eaqually serve as platforms for biomimetic engineering, however that topic 
is beyond the scope of this thesis. 
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1.7.1 BIOMIMETIC ENGINEERING OF MICELLES AND SOFT 
NANOPARTICLES 
 
Micelles and soft nanoparticles offer possibilities of modifying their synthetic nanoarchitecture 
in a biomimetic fashion by either encapsulation of biomolecules inside their hydrophobic core, 
entrapment of biomolecules between the polymeric chains of the corona or by anchoring of 
biomolecules on the surface of their corona. 
 
ENTRAPMENT OF BIOMOLECULES  
 
Entrapment has previously been used to carry therapeutic biomolecules127 or catalytically 
active biomolecules 128. The nature of micellar / soft particle self-assembly offers a straight 
forward approach to entrap molecules, readily protecting the encapsulated biomolecules from 
degradation. Once buried between the hydrophobic polymer chains biomacromolecules 
preserve their structure and functionality but cease to be active as the  crowded molecular 
environment prevents them to access binding sites or substrates. Hence, the entrapped 
biomolecules remain protected, but inactive until the nanoarchitetures are disassembled127.  
 
ANCHORING OF BIOMOLECULES 
 
In this respect to entrapment of biomolecules in micelles / soft nanoparticles, anchoring of 
biomolecules (proteins, sugars, DNA) on the micellar / soft nanoparticle corona by either 
covalent bonds or ionic interactions provides the possibility of using micelles and nanoparticles 
as carriers, that allow the attached biomacromolecules to interact with their environment, 
especially important when molecular recognition when used as a targeted delivery approach31. 
An example of biomimetic decoration of soft polymer based nanoparticles with therapeutic 
enzymes is presented in this thesis and will be discussed in Chapter 2. 
 
1.7.2 BIOMIMETIC ENGINEERING OF POLYMERSOMES 
 
Unlike micelles and soft-nanoparticles, that temporary inactivate entrapped biomolecules, by 
steric effects of polymer chains, polymersomes can preserve the functionality of biomolecules, 
while keeping the polymersome nanoarchitecture intact. The robust membrane of 
polymersomes serves as a border for a confined inner aqueous compartment where 
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biomolecules move and function freely. This mimics the natural organization of lipid based 
compartments, but offers improved mechanical stability (Figure 18)129.  
 
 
 
Figure 18. Schematic representation of biomimetic modifications done on polymersomes. 
Topological regions of interest: Aqueous cavity of polymersomes where hydrophilic molecules 
can be encapsulated, hydrophobic region of the polymersome membrane and membrane 
surface.  Adapted from Ref130 with permission. 
 
ENCAPSULATION OF BIOMOLECULES  
 
Entrapment of biomolecules in the hydrophilic compartment of polymersomes protects them 
from their environment and represents a key approach for the design of functional biomimetics 
that are closer to natural cellular or subcellular compartments1.  
Catalytically functional biomolecules, such as enzymes and their mimics are of particular 
interest as encapsulation introduces a specific functionality and converts the polymersome into 
a catalytic nanocompartment (nanoreactor). Examples of previously encapsulated 
biomolecules include enzymes (i.e β-lactamase, horseradish peroxidase, nucleoside hydrolase 
or acid phosphatase, superoxide dismutase), photosensitizers (Rose Bengal bovine serum 
albumin conjugate), oxygen carriers (haemoglobin) and others99,131-134. Systems that are more 
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complex rely on the simultaneous encapsulation of a set of enzymes that work in tandem and 
mimic the crowded molecular environment of cellular compartment spaces5. 
 
MEMBRANE FUNCTIONALIZATION  
 
A key requirement for the function of biomolecules encapsulated inside polymersomes is that 
the polymersome membrane is permeable for a molecular exchange of substrates/products 
between the polymersome inner cavity and the polymersome environment49,135.   
 
Various methods have been developed to induce permeability to polymersome membranes, 
such as using polymers, which spontaneously form porous membranes, inducing membrane 
permeability with organic solvents, or incorporation of stimuli responsive polymer chains into 
the membrane136,137. However, a drawback of these methods is that they do not allow a defined 
control of the membrane permeability, essential in preventing the escape of encapsulated 
biomolecules from the polymersomes cavity.  
 
An elegant method to overcome the issue of membrane permeability is a bioinspired approach 
that renders the membrane permeable by the incorporation of biopores and membrane proteins 
138,139. In this way selective membrane permeability of polymer membranes towards protons 
and ions has been achieved by insertion of small pore forming peptides like gramicidin and 
ionophores like ionomycin139,140. Membrane permeabilization by the latter is straight forward 
as they are usually added directly to pre-formed polymersomes using trace amounts of organic 
solvents, such as EtOH. In contrast, a more complex scenario of membrane functionalization 
is presented by the functional reconstitution of larger membrane associated proteins, which 
have to remain functional despite the large hydrophobic mismatch between synthetic block-
copolymer membranes (9-13 nm) and the size of the proteins (3.3-7.1 nm)141. Functional 
reconstitution is possible only if the type of polymer chains forming the polymersomes present 
a high flexibility and and adapt to the hydrophobic parts of membrane proteins by coiling4. In 
addition, harsh conditions such as extreme temperatures and organic solvents have to be 
avoided, since they readily lead to protein denaturation. Functional protein reconstitution is 
achieved by either addition of the desired membrane protein during the polymersome formation 
or by the post-hoc insertion of membrane proteins in destabilised polymersome membranes 4. 
In both cases, the removal of the detergent (i.e. OG, Triton X, SDS), used in the membrane 
protein isolation from cellular membranes, plays a vital role as it is not only allows the 
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membrane protein to be inserted in polymersome membrane but can also influence on 
polymersome stability142. Previously functional reconstitutions of bacterial membrane porines 
such as, Outer membrane protein F (OmpF), FhuA and LamB induced a size-dependent cut-
off permeability of polymersome membranes: only molecules smaller than the respective pore 
diameter (i.e 600 Da in the case of OmpF) can diffuse across the membrane139,138,143-145. 
Similarly, insertion of selective membrane proteins, such as GlpF or Aquaporin Z allowed a 
step further in controlling membrane permeability by allowing the diffusion of specific 
molecules, such as water and ribitol, through the polymersome membrane121,116. Significant 
efforts have been made in obtaining stimulus-responsive polymersomes by the reconstitution 
of chemically and/or genetically modified membrane proteins that act as “gates”, however up 
to date only few examples remain. In this way histidine residues, which induced a pH 
dependent permeability to OmpF, were introduced to the OmpF pore by point mutations of 
native amino acids146, whilst chemical modifications of key amino acid residues of 
FhuA{Onaca:2008tt} and  MscL147 resulted in reduction or pH responsive behaviour of porins. 
Once reconstituted in polymersome membranes, these modified membrane proteins allowed a 
pH or redox potential triggered permeability of polymersome membranes.  
 
In addition to inducing passive membrane permeability, biomimetic modification of the 
polymersome membrane opens possibilities of utilizing membrane proteins that do not act as 
passive pores but have membrane associated catalytic activity. As for example, 
NADH:ubiquinone reductase (complex I) a mitochondrial membrane associated protein was 
reconstituted in PMOXA-b-PDMS-b-PMOXA polymersomes, in order to mediate electron 
transfer from NADH to ubiquinone142 (Figure 19.). Further such examples include alpha-helical 
model proteins bacteriorhodopsin (BR) / proteorhodopsin that acted as light mediated proton 
pumps and the F0F1-ATP synthase photon pump148,149.  
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Figure 19. Biomimetic engineering of polymersome membranes.  A. Functional 
reconstitution of channel proteins that allow enhanced membrane permeability. B. Functional 
reconstitution of catalytically active membrane proteins. Adapted from Ref1 with permission. 
 
Another approach lies in modifying the polymersomes by attaching molecules at their external 
interface. This imitates the plethora of proteins, glycoproteins that act as catalysts, receptors or 
ligands on the surface of natural cell membranes6,8. In this way polymersomes can be 
engineered to allow molecular recognition, which is of great importance in biomedical 
applications. Furthermore, molecular networks can be formed by connecting multiple 
polymersomes through DNA recognition6. Attachment is achieved by covalent attachment of 
biomolecules, such as heparin chains, antibodies and DNA to functional end groups of polymer 
chains 6,7 but could also be achieved by electrostatic attachment of biomolecules to charged 
polymer endgroups.  
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1.8 APPLICATION OF BIOMIMETICALLY ENGINEERED 
COLLOIDAL NANOARCHITECTURES 
 
 
1.8.1 APPLICATION OF MICELLES AND SOFT NANOPARTICLES 
 
One of the main applications of micelles and soft nanoparticles is as carriers for therapeutic 
molecules or contrast agents. Entrapment of active compounds within their nanoarchitecture 
ensures they are protected from degradation and loss of activity through enzymatic attack150. If 
the hydrophilic corona is appropriately selected, micelles injected in the circulation of 
mammals avoid protein absorption, and thus systemic elimination151. Due to their size, micelles 
accumulate in solid tumor tissues via an enhanced permeability and retention effect152 (Figure 
20). In addition functionalization of the micelle corona with specific ligands allows targeted 
delivery of active compounds to desired tissues or cell types31. Once micelles reach the 
intracellular environment, the molecular cargo is released either by diffusion from the carrier, 
or by change of micelle morphology in the presence of different stimuli such as temperature, 
acidic pH, or light153.  For example, poly(ethylene oxide)-b-poly(eta-caprolactone) (PEO-PCL) 
was used for filomicelle formation, providing a biodegradable and compatible system for 
paclitaxel delivery154. Polymeric micelles can entrap contrast agents, for magnetic resonance 
imaging (MRI), and x-ray computed tomography (CT)31. The applications of micelles as 
carriers for therapeutic agents have recently been supported by phase I clinical trials delivering 
anti-cancer drugs. 155,156.  
 
 
Figure 20. Polymer micelles as delivery agents. Schematic representation of a.) Polymeric 
micelles. b.) Micelle conjugated with a targeting moiety. c.) Micelle loaded with a contrast 
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agent or imaging moieties. d.) Micelle designed for triggered drug release. e) Stimuli 
responsive block-copolymer micelles for targeted delivery. Adapted from Ref31 with 
permission.  
 
1.8.2 APPLICATION OF POLYMERSOMES 
 
Polymersomes have the advantage of allowing the encapsulation/entrapment of both 
hydrophilic and hydrophobic molecules in the same vesicle due to their intrinsic architecture. 
This allows for the construction of complex systems beyond traditional drug delivery vehicles 
24,157, such as catalytic nanocompartments (nanoreactors), artificial organelles 24,150,157-161, active 
surfaces (e.g. biosensors)150, and multicompartment systems that mimic cellular functions and 
provide deeper understanding of biology162.  
 
 
DELIVERY AGENTS  
 
 The robustness large size of their hydrophilic compartment, and their chemical versatility are 
main advantages of polymersomes compared to other delivery carriers and diagnostic agents163. 
By an appropriate selection of the copolymers to contain stimuli-responsive blocks, it is 
possible to release cargo “on demand” 164. Common triggers used for stimuli-responsive release 
from polymersomes are pH, temperature, redox-potential, and concentration gradients of 
certain molecules (e.g. glucose) 54,55,165. Another advantage of polymersomes for drug delivery 
is their long in vivo circulation time, 47.3h half-life compared to 10.6h for PEGylated 
liposomes in mice 55. The long circulation time was achieved by using the hydrophilic domain 
PEG, known to reduce adsorption of proteins and subsequent opsonisation by cells166. Other 
factors that support the use of  polymersomes for biomedical applications are the 
biocompatibility/biodegradability of the polymers, their size, shape and surface properties24. 
Especially surface modificiation of polymersomes with targeting ligands offers unprecedented 
possibilities of achieving disease targeted drug delivery. Two prominent examples include 
antibody-polymersome conjugates that were applied to target and overcome the blood-brain 
barrier, which is an essential obstacle for successful delivery of drugs into the human brain and 
nanomimics – polymersomes presenting receptors required for parasite attachment to host 
cells, that served to interrupt the parasite life cycle of P. falciparum7,8.  
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CATALYTIC NANOCOMPARTMENTS 
 
Catalytic nanocompartments, commonly referred to as nanoreactors, are engineered by 
encapsulation of active compounds (proteins, enzymes, mimics, or combinations thereof) that 
perform chemical/biochemical reactions inside the cavity of polymersomes. The membrane 
permeability allows an exchange of substrates/products with the environment and can be 
specifically tuned by the chemical nature of copolymers by chemical modifications167,168 or by 
incorporation of natural channel proteins, as discussed above158,159. Catalytic 
nanocompartments evolved from one-step reactions inside the polymersome cavity134,169, to 
two-step ATP synthesis149  or more complex reactions such as three-enzyme cascade reactions 
170,171. Another example of such a complex system includes the transcription of DNA to mRNA 
and the subsequent translation to yield fluorescent proteins172. Immobilized catalytic 
nanocompartments were also used as precise biosensors or to synthesize antibiotics on demand 
and on site. For example bacterial growth was inhibited by antibiotics (cephalexin), locally 
produced by catalytic nanocompartments containing penicillin acylase, and having a permeable 
membrane due to the insertion of bacterial outer membrane protein F (OmpF) to allow substrate 
and product permeation. To mimic the crowded environment found in cell organelles, catalytic 
nanocompartments were generated that had channel proteins reconstituted in their membranes 
and encapsulated enzymes along with a crowding agents (Ficoll or polyethylene glycol) inside 
their cavity103 .  
 
ARTIFICIAL ORGANELLES  
 
The concept of artificial organelles was introduced by reports of catalytic nanocompartments 
performing their enzymatic reactions in situ inside cells (Figure 21)5,25,158. Different examples 
of systems that have the potential to act as artificial organelles have been recently developed 
based on liposomes, porous silica nanoparticles, and polymer compartments in combination 
with biomacromolecules 5,173,174. One example of polymersome based artificial organelles is the 
detoxification of reactive oxygen species (ROS) by artificial peroxisomes. Two enzymes 
(superoxide dismutase and catalase) acting in tandem inside the cavity of polymersomes 
equipped with channel proteins for membrane permeabilization, detoxified superoxide radicals 
and hydrogen peroxide in cells that were exposed to reactive oxygen species.  These artificial 
organelles protected cells from oxidative stress to the same extent as natural peroxisomes5.  
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Figure 21. Design of artificial cell organelles. Panel A.) Schematic representation of a cell 
including various organelles. Panel B.) Naturally occurring peroxisomes, which are nanometer-
sized organelles involved in ROS regulation. Panel C.) Artificial peroxisome containing 
antioxidant enzymes and membrane-bound channel proteins for detoxification of ROS. Panel 
D.) Cascade reaction of superoxide radicals and hydrogen peroxide that takes place inside 
artificial peroxisomes. Adapted from Ref5, with permission. 
 
MULTICOMPARTMENT SYSTEMS AND CELL MIMICS 
 
Another direction of polymersome research is to establish multicompartment systems that act 
as simple cell models. First attempts have been made by engineering polymersome cavities 
that mimicked the crowded molecular space of the cytosol122,162,172. Controlled production and 
loading of giant polymersomes was realized by microfluidic techniques172, filling the 
polymersomes with a whole transcription- and translation machinery in order to synthesize 
fluorescent proteins from DNA plasmids (Figure 8)172. Other attempts produced 
multicompartment polymersome systems that mimicked cytosol properties within giant 
polymersomes 162,175,176. In this manner small polymersomes (100-200nm) were encapsulated in 
big polymersomes (2-10µm) together with a crowding agent (alginate)175. Alginate completely 
arrested movement of the small polymersomes, whereas the addition of dextran only slowed 
down the polymersome diffusion. Cascade reactions were also implemented in a 
multicompartment polymersome systems171. Two kinds of catalytic nanocompartments 
(containing two different kinds of enzymes) were encapsulated in micrometer-sized 
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polymersomes together with a third enzyme (“cytosolic” enzyme), enabling cascade reactions 
in this compartmentalized structure with participation of all three enzymes.  
 
 
 
 
 
 
Figure 22. Polymersomes as Multicompartment models and nanofactories. Cell-free 
expression of fusion protein membrane-related bacterial protein-red fluorescent protein (MreB-
RFP) in polymersomes by DNA transcription and translation. Panel a.) Schematic 
representation of the expression system. Panels b-d.) Confocal microscope images showing 
production of MreB-RFP (red spots) in PEG-b-PLA polymersomes. Panel e.) Fluorescence 
intensity increase over time due to protein expression adapted from Ref122, with permission.  
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Chapter 2.  
 
PEG-b-PMCL-b-PDMAEMA NANOPARTICLES FOR 
CONTROLLED LOCALIZATION AND pH SENSITIVE 
RELEASE OF BIOMACROMOLECULES ⊥ 
 
In this chapter, PEG-b-PMCL-b-PDMAEMA copolymer nanoparticles are biomimetically 
engineered such as to act as carriers for therapeutic proteins. To do this, the positively charged 
nature of the PDMAEMA block, forming the corona of the nanoparticles, which allows 
controlled localization and release of negatively charged biomolecules is made use of. The 
chapter provides an insight into the synthesis and self assembly of PEG-b-PMCL-b-
PDMAEMA copolymers, the behavior of self-assembled PEG-b-PMCL-b-PDMAEMA 
nanoparticles in response to pH and particle interactions with small molecular weight and 
large biomacromolecules. Finally, the potential application of PEG-b-PMCL-b-PDMAEMA 
copolymer nanoparticles biomimetically engineered with a therapeutic protein, acid 
sphingomyelinase, is demonstrated in human epithelial HeLa cells. 
 
 
 
 
 
 
 
 
 
 
 
⊥This study has been published: D.Vasquez*, T. Einfalt*, W. Meier, C. G Palivan PEG-b-PMCL-b-PDMAEMA copolymer nanoparticles for 
controlled localization and  pH sensitive release of biomacromolecules, Langmuir, 32, 10235-10243 (2016) 
 
*Both authors contributed equally.   
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2.1 MOTIVATION AND PROBLEM DEFINITION 
 
Protein therapy, an essential part of treating several diseases, aims to increase the levels of 
deficient proteins, displace dysfunctional proteins or inhibit biological processes by delivering 
functional proteins into cells177. In this respect, therapy via direct administration of proteins is 
limited and ineffective because of low bioavailability, rapid degradation through enzymatic 
attack or immonogenity178. The need to develop novel solutions for protein administration has 
led to the design of colloidal carriers with sizes in nanometer range that serve as efficient 
transporters and enhance the protein bioavailability in specific spatial and time conditions. In 
particular these carriers include a variety of polymer nanoarchitectures (particles, capsules, 
micelles, or vesicles) in which specific proteins are entrapped, encapsulated or attached24. The 
nature of protein entrapment depends on the chemical nature of the copolymer, its molecular 
weight, the presence of functional end groups, and protein-polymer interactions179. Hence 
careful selection of components that build the supramolecular assembly is vital for protein 
localization,180 and controlled protein release180,181. In this respect, copolymer assemblies based 
on PCL-PEG-PCL182,183, PEO-PCL-PAA184 and PEG-PCL-PAA185 have been used to study 
their interactions with model proteins, such as bovine serum albumin (BSA) and therapeutic 
proteins, such as insulin (REF). Of particular interest are nanoarchitectures that present 
responsiveness to various stimuli, such as pH, temperature or the presence of chemical or 
biological compounds186. Responsive behavior is important as it allows the release of proteins 
in the presence of a stimulus, either by degradation of the assembly or by detachment of the 
biomolecules induced by a change in protein-polymer interactions186. For example, pH 
responsive assemblies have high potential for medical applications because pH is an essential 
signaling factor that accompanies pathological conditions (e.g. inflammation, cancerous tissue) 
187. Various pH responsive polymer assemblies such as polyionic complex micelles188, 
nanocapsules189, or aldehyde displaying silica nanoparticles190 have been used to deliver 
therapeutic drugs. In particular, PEG-b-PCL-b-PDMAEMA assemblies have been reported as 
delivery carriers for RNA191, DNA192 and siRNA184, but not yet for proteins.  
The motivation behind chapter two of this thesis is to demonstrate that biomimetically 
engineered PEG-b-PMCL-b-PDMAEMA asymmetric copolymer nanoparticles can allow 
controlled localization and subsequent pH dependent release of therapeutic proteins.  The 
protein binding efficiency of PEG-b-PMCL-b-PDMAEMA is evaluated both with a model 
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protein, BSA fluorescein isothiocyanate conjugate (BSA-FITC) and the therapeutic protein 
acid sphingomyelinase (ASM), known for its role in catalyzing the breakdown of 
sphingomyelin to ceramide in the treatment of Niemann-Pick disease193. Asymmetric tri-block 
copolymers PEG-b-PMCL-b-PDMAEMA were selected to self-assemble into biocompatible 
and biodegradable nanoparticles that can support a specific localization of biomacromolecules 
on their surface194. The presence of the positively charged PDMAEMA block induces pH 
responsiveness, whilst poly(methylcaprolactone) (PMCL) favors the formation of more stable 
colloidal assemblies, because it is fluid at room temperature, and more hydrophobic than poly 
caprolactone 195 .Formation and stability of PEG-b-PMCL-b-PDMAEMA nanoparticles in 
PBS, as relevant environment for attachment of proteins, have been characterized by a 
combination of light scattering, transmission electron microscopy (TEM and cryo-TEM), and 
fluorescence correlation spectroscopy (FCS). The effect of the ratio between the hydrophobic 
block and the pH-sensitive block on the entrapment/release of ASM allowed improvements in 
the system efficiency for protein delivery. Enzyme activity assays were performed to establish 
whether protein entrapment affected its activity once released from the nanoparticles, whilst 
up-take and toxicity in HeLa cells were evaluated by a combination of [3-(4,5-dimethylthiazol-
2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay and 
fluorescence activated cell sorting (FACS). Stimuli-responsive nanoparticles with controlled 
localization of proteins represent a smart solution for protein therapy, serving to improve the 
release as a key parameter for efficient therapeutic solutions.  
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Scheme 2. Schematic illustration of the self-assembly of PEG-b-PMCL-b-PDMAEMA 
copolymers before and after interaction with a charged protein at pH 7.2.  The BSA or 
ASM are attached to the positively charged particles through electrostatic interactions. Adapted 
from Ref9 with permission. 
2.2 PEG-b-PMCL-b-PDMAEMA COPOLYMER SYNTHESIS 
 
PEG-b-PMCL-b-PDMAEMA tri-block copolymers were obtained by a three step synthesis: (i) 
ring-opening polymerization of γ-methyl-ε-caprolactone (MCL), (ii) functionalization of PEG-
PMCL with an ATRP-initiating group, and (iii) ATRP of DMAEMA with mPEG-b-PMCL-Br 
as macronitiator194. Tri-block copolymers were assigned as A45BmCn where m and n represent 
the chain length of PMCL and PDMAEMA groups respectively determined from the 1H NMR 
spectra (Figure S1, SI).  
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2.3 SELF-ASSEMBLY OF PEG-b-PMCL-b-PDMAEMA 
SUPRAMOLECULAR NANOSTRUCTURES 
 
Self-assembly of PEG-b-PMCL-b-PDMAEMA (PEG45-b-PMCL110-b-PDMAEMA37 and 
PEG45-b-PMCL101-b-PDMAEMA27) copolymers was performed at various pH values in the 
range 3.5 - 10 in order to analyze both the 3D assemblies generated in dilute solutions, and 
their pH responsiveness. Nanoarchitectures formed by copolymers were characterized by a 
combination of light scattering (dynamic and static), and TEM. TEM micrographs of self-
assembled nanostructures of copolymers show the coexistence of two populations of spherical 
objects with different sizes (Figure 21 A, B).  
 
Figure 23. TEM micrographs nanoarchitectures generated by PEG-b-PMCL-b-
PDMAEMA copolymers at physiological pH. A. A45B110C37 copolymer, B. A45B101C27 
copolymer. Scale bars: 200nm.  C. Cryo-TEM micrograph of 3D supramolecular assemblies 
of A45B110C37 copolymer after 2 months. Scale bar: 200 nm. Adapted from Ref9 with permission. 
 
In this particular case, the size distribution of the spherical objects was measured by DLS to 
analyze the predominance of populations. According to the CONTIN algorithm, there are two 
populations of spherical objects: a population of particles with RH∼ 100 nm, and a second one 
with smaller particles of RH∼ 50 nm (Figure S2, SI). However, the existence of two separated 
populations allows us to analyze the data by taking into account only the population of particles 
with larger size. The ratio (ρ) between the radius of gyration (Rg), obtained from SLS, and the 
hydrodynamic radius (RH), from DLS experiments (ρ = Rg/RH) was calculated, because it is 
known to be a specific parameter for identification of the morphology of spherical nano-objects 
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(Table 1).  ρ values of the copolymer assemblies were 1.19 - 1.23, which characterize an 
architecture of soft spherical nanoparticles with a hydrophilic corona, in agreement with 
previous reports196. A value for RH larger than that obtained from TEM was expected, because 
the RH from DLS experiments is the sum of the particle size and its surrounding hydration 
sphere. 
 
 
Table 1. Physico-chemical parameters of PEG-b-PMCL-b-PDMAEMA copolymers in 
physiological conditions (PBS, pH 7.2 at 25 °C). 
Copolymer Mw 
(g/mol)a 
ζ 
potential 
(mV)* 
RH 
(nm) 
Rg 
(nm) 
Rg/RH PDI 
A45B110C37 22100 20.2 ± 0.3 88 ± 10 112 ± 8 1.27 1.50 
A45B101C27 18167 12.9 ± 0.2 50 ± 12 66 ± 6 1.32 1.30 
RH: hydrodynamic radius; Rg: radius of gyration; *a. MW, weight-average molar mass 
At pH = 7.2, the radius of nanoparticles increased from 50 nm up to 88 nm as the length of 
the B and C blocks was increased (from 101 to 110 units for the B block and from 27 to 37 
units for the C block). Under physiological pH, nanoparticles were stable for more than two 
months, as indicated by cryo-TEM and TEM micrographs (Fig. 1 C, S3, SI). In addition, cryo-
TEM micrographs indicate a soft-core particle morphology for these assemblies, in the self-
assembly conditions used here, specifically selected for attachment of proteins relevant for bio-
applications. 
Particle architecture and size are influenced by various factors such as: chemical nature of the 
blocks, chain length of each block and the ratio between them, the domain of the polymer 
exposed to the environment, pH and temperature. Therefore, the changes in the architecture 
and size of nanopoarticles were analysed at different pH values. By varying the pH, the particle 
size for each copolymer changed, indicating a pH sensitive behavior (Figure 24, Figure S3). 
The hydrodynamic radius, RH, was affected both by the pH ( 3.5 – 12.0), and the molecular 
properties of the copolymers: DH increased from 50±8 to 150±22 nm for A45B101C27, and from 
72±11 to 174±26 nm for A45B110C37 nanoparticles. While the size of A45B101C27 nanoparticles 
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did not change for pH values 6.0 - 7.4, A45B110C37 nanoparticles increased their size in this pH 
range. The increase of the hydrodynamic radius upon increase of the pH is associated with the 
decrease of the electrostatic repulsions, which initiates an aggregation process of the small 
nanoparticles197,198. The aggregation process can lead to a probable sedimentation of large 
aggregates as indicated by the SLS experiments (Figure S4). The equilibrium between the two 
fractions of nanoparticles is shifted towards the smaller nanoparticles (Figure S2, SI). With 
increasing pH, the particles lose their charge and the equilibrium shifts to larger nanoparticles, 
due to the start of a particle-particle aggregation process. 
The pH sensitive behavior of PEG-b-PMCL-b-PDMAEMA soft nanoparticles indicates that 
the polymer domain exposed at the interface with the environment is predominantly 
PDMAEMA with possible PEG chains as well. Whereas there is no power to separate PEG 
and PDMAEMA, by taking into account the molecular characteristics of PEG and PDMAEMA 
monomers, PEG is not likely to be located at the external surface of the corona because of the 
bulky conformation of PDMAEMA for both copolymers. The resulting nanoparticle 
morphology is therefore based on PEG mainly embedded in the hydrophilic domain, and the 
branched PDMAEMA exposed at the particle surface. This privileged orientation of the 
PDMAEMA domain is exactly the one necessary to support attachment of biomolecules based 
on electrostatic interactions. In addition, note that only a small number of PEG chains can be 
located at the exterior domain with the environment to not obstruct protein attachment because 
of the repellent property of PEG199,200 . 
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Figure 24. Hydrodynamic diameter (DH) of PEG-b-PMCL-b-PDMAEMA NP. A45B110C37 
nanoparticles (circles), and A45B101C27 nanoparticles (squares) at different pH values. Dashed 
lines represent a transition domain where both small and large nanoparticles co-exist. Adapted 
from Ref9 with permission. 
 
The effect of temperature on the hydrodynamic diameter of nanoparticles was assessed 
between 25°C and 40°C, a range relevant for medical applications. There was only a small 
change in nanoparticle diameter between 25°C and 40ºC, which would not affect the possible 
medical application of the nanoparticles (Figure S5, SI).  
 
2.4 INTERACTION OF PEG-b-PMCL-b-PDMAEMA 
NANOPARTICLES WITH SMALL MOLECULAR WEIGHT 
MOLECULES 
 
Sodium fluorescein (Mw = 376.27 Da) was used as a model molecule to establish whether 
small molecular mass molecules can be attached to the surface of nanoparticles. In this respect 
fluorescence correlation spectroscopy (FCS) was used to examine the interaction of sodium 
fluorescein with the soft nanoparticles, by measuring the diffusion time of free sodium 
fluorescein, and sodium fluorescein-nanoparticles, respectively. By using FCS, as discussed in 
depth in the introduction, the laser-induced fluorescence of the excited fluorescent molecules 
that pass through a very small probe volume is auto-correlated in time to give information 
about the diffusion times of the molecules. These provide information about interactions of the 
fluorescent molecules with larger target molecules, including encapsulation/attachment of 
proteins in/to nanoparticles due to their proportionality to the RH of the fluorescent object 
(according to the Stokes-Einstein equation). The change of the diffusion time for the free dye 
of τD =38 µs to 5.5 ms (for A45B101C27 nanoparticles), and 5.9 ms (for A45B110C37 nanoparticles) 
indicates that the dye interacts with both types of nanoparticle. Electrostatic interactions 
represent the driving force for the attachment of sodium fluorescein, and attachment 
efficiencies (A.E) of 40% and 67%, respectively were obtained when the 
hydrophobic/hydrophilic ratio between the C and B blocks was increased (SI, Table S1). As 
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expected, nanoparticles with a longer positively charged C block are able to attach more 
molecules (67%) than those with a shorter positively charged C block (40%). 
 
2.5 INTERACTION OF PEG-b-PMCL-b-PDMAEMA 
NANOPARTICLES WITH BIOMACROMOLECULES 
 
A further step was to select model proteins and analyze whether they bind to PEG-b-PMCL-
b-PDMAEMA soft nanoparticles. Water soluble BSA was selected due to its negatively 
charged protein backbone for pH > PI (isoelectric point PI = 4.7 at 25°), which favours its 
binding to the positively charged nanoparticles. The isoelectric point of the copolymers was 
determined by titration (Figure S6, SI), and attachment of BSA labelled with fluorescein 
isothiocyanate (FITC) to the nanoparticles was studied by FCS. The diffusion time (τd) for the 
free BSA-FITC at room temperature was τD = 82 µs (Figure S7 A-a and B-a, SI), and the 
autocorrelation curve for BSA-FITC-nanoparticles (Figure S7 A-b and B-b, SI) indicates the 
presence of slowly diffusing particles for both copolymers. This population with a reduced 
diffusion time, τD = 5.71 ms (for A45B110C37), and τD = 5.53 ms (for A45B101C27) represents more 
than 73 % of the total number of fluorescent particles that passed through the confocal volume 
during the measurement time, and corresponds to BSA-FITC-nanoparticles. The remaining 
diffusing fluorescent particles correspond to free BSA-FITC molecules, which were not 
attached to nanoparticles, and were detected due to their high quantum yield, and the high 
sensitivity of FCS. Upon interaction with BSA-FITC, the hydrodynamic radius of protein-
nanoparticles changed compared to the values obtained from light scattering data (Table 2). 
However, it is known that there are differences between the hydrodynamic radius determined 
by FCS and DLS201, and therefore this difference is not considered as relevant. Light scattering 
of labelled protein-loaded nanoparticles was excluded because of the interference of the 
fluorophore with the laser used in light scattering experiments.   
The attachment efficiency was calculated as the number of fluorescent labeled proteins per 
nanoparticle in comparison with the theoretical maximum number of fluorescent labeled 
proteins per nanoparticle (SI). The maximum number is calculated by dividing the volume of 
the vesicle with the volume of the fluorescent protein. Due to the preparation method of the 
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particles (co-solvent method), the radius used for calculations for A.E. were the RH. The 
attachment efficiency of the nanoparticles indicates that the proteins are present in the outer 
corona of the nanoparticles because of the PDMAEMA domain predominantly exposed at their 
external surface. Nanoparticles morphology, which combines the molecular specificity of PEG 
and PDMAEMA with the results of the proteins attachment, is indeed based on PEG mainly 
forming the outer part of the nanoparticle core of PMCL, which is embedded into the domain 
of the branched PDMAEMA as the particle surface. The presence of the PDMAEMA domain 
at the interface of the nanoparticles with the environment favored both a controlled localization 
of charged biomolecules, and their pH-sensitive release. 
Note that the protein-ABC fraction represents the overall bound protein-nanoparticle 
population in a two-populations FCS fit (free protein fraction and bound-protein fraction), 
without distinguishing between different numbers of nanoparticles or different number of 
proteins/nanoparticle in various samples. A.E. values are the key parameters used to analyze 
the differences between the protein binding to different copolymers nanoparticles.  
 
 
 
 
 
 
 
Table 2. Attachment efficiency of BSA-FITC to PEG-b-PMCL-b-PDMAEMA 
nanoparticles.  
           IEP: Isoelectric point; DH: hydrodynamic radius (*) by FCS (**) by DLS; A.E: attachment efficiency; τD: diffusion 
time 
The A.E. of BSA-FITC increased from 13 to 22 % when the size of the hydrophilic block 
PDMAEMA increased (Table 2). This effect is attributed to electrostatic interactions between 
the positively charged hydrophilic block and the negatively charged protein at pH 7.2, in 
agreement with reports indicating that positively charged nanoparticles entrap proteins with 
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isoelectric points lower than pH 5.5202. The release of BSA-FITC protein as a function of time 
was evaluated by FCS (Figure S8, SI). At pH = 5.8, PEG-b-PMCL-b-PDMAEMA 
nanoparticles released up to 70 % of BSA-FITC independent of the hydrophobic/hydrophilic 
ratio of the copolymers. 
A step further towards the development of a product for therapeutic applications was to 
produce sphingomyelinase-bound nanoparticles, and the fraction of sphingomyelinase labeled 
with OregonGreen 488 succinimidyl ester (o-ASM) bound to polymer nanoparticles was 
evaluated in a similar manner to that described in the preceding paragraph. The autocorrelation 
curve for the free labeled enzyme resulted in a diffusion time of τD = 126 µs, whereas a 
significant increase was observed when the enzyme was added to nanoparticles: τD = 4.15 ms 
for A45B110C37, and τD = 3.33 ms for A45B101C27 nanoparticles, respectively (Figure 25 A and B). 
Similar to the BSA attachment, this significant increase in diffusion time is attributed to 
interaction of the enzyme with the nanoparticles. The hydrodynamic diameter of protein-
nanoparticles increased compared to that of BSA-nanoparticles as a result of both the 
differences in molecular masses of the biomolecules, and higher attachment efficiency for 
ASM (Table 2 and 3). The stronger interaction of the enzyme molecules with both types of 
nanoparticle is indicated by the fraction of enzyme-nanoparticles of > 89%. 
 
Figure 25. FCS analysis of PEG-b-PMCL-b-PDMAEMA NP interaction with ASM. FCS 
autocorrelation curves (continuous lines) and their fits (dotted lines) Panel A.) free o-ASM (a) 
and o-ASM-nanoparticles of A45B110C37 (b). Panel B.) free o-ASM (a), and o-ASM-
nanoparticles ofA45B101C27 (b). Curves are normalized to 1 to facilitate comparison. Adapted 
from Ref9 with permission. 
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Table 3. Attachment efficiency of o-ASM to PEG-b-PMCL-b-PDMAEMA (ABC) 
nanoparticles 
 
The A.E. of molecules to polymer nanoparticles can be affected by several factors, such as 
method of preparation, size of the nanoparticles, hydrophilic/hydrophobic ratio, or 
concentration of molecules to be attached203. In the case of PEG-b-PMCL-b-PDMAEMA 
nanoparticles, the particle size and the hydrophilic/hydrophobic ratio play an important role in 
the A.E., and results in an increase of > 50% when the sizes of the B and C blocks are increased. 
TEM micrographs (Figure S9, SI) show that attachment of proteins to PEG-b-PMCL-b-
PDMAEMA nanoparticles does not affect the architecture of nanoparticles compared to those 
without attached proteins (Figure 1). 
Localization of proteins upon interaction with polymer nanoparticles is a key factor affecting 
the release profile. In the case of BSA-FITC attached to the outer interface of nanoparticles of 
PEO-PCL-PDMAEMA copolymers, protein localization at the external interface has been 
reported to improve the release behavior185. In order to get more insight into the localization of 
ASM upon interaction with the copolymer nanoparticles, a combination of zeta potential 
characterization and FCS was used. Zeta potential was measured for PEG-b-PMCL-b-
PDMAEMA nanoparticles with and without enzyme (Figure S10, SI). Nanoparticles without 
ASM were positively charged (+15 mV), but upon ASM addition, the charge of biomolecule-
nanoparticles decreased dramatically (to -2 mV). This significant charge difference indicates 
that ASM molecules interact with the outer shell of the nanoparticles, in agreement with the 
morphology of the nanoparticles with the PDMAEMA domain exposed towards the 
environment. Localization of ASM molecules at the external hydrophobic domain of the soft 
nanoparticles was assessed by comparing the fraction of o-ASM-nanoparticles with the fraction 
of o-ASM molecules interacting with nanoparticles already attached to non-labeled ASM. 
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First, copolymer nanoparticles (A45B101C27 or A45B101C37) without protein are prepared, then 
mixed with a solution of o-ASM during 50 minutes and measured by FCS (Figure S11, SI). 
The change in the autocorrelation function of the mixture of o-ASM with nanoparticle 
compared with that of the free o-ASM indicated that the proteins interacted with the outer 
corona of nanoparticles for both copolymers (Figure S11, SI), and an A.E of around 13 % was 
calculated for A45B101C27. Second, nanoparticles were prepared in the presence of unlabeled 
ASM and measured by FCS both before and after addition of a solution of o-ASM for 50 
minutes (Figure S11, SI). A significant decrease of the A.E to < 3% indicates that unlabeled-
ASM molecules are already attached to the nanoparticles and hinder supplementary interaction 
of o-ASM with the nanoparticles. Therefore, ASM is mainly localized in the outer hydrophilic 
domain of nanoparticles, a location which favors protein release under appropriate environment 
conditions. 
	
	
2.6 STIMULI RESPONSIVE BEHAVIOUR OF PEG-b-PMCL-
b-PDMAEMA NANOPARTICLES 
 
A key parameter for potential medical applications is the activity of ASM upon interaction 
with the nanoparticles. Since ASM is stable in acidic conditions193 ,its activity was measured 
at pH 7.2 both for ASM-A45B110C37 nanoparticles kept at this pH value, and for those previously 
exposed to acidic conditions for 60 min (pH = 5.5) (Figure 26). The activity of ASM-A45B110C37 
kept at pH 7.2 was lower than that of ASM-particles previously exposed to acidic conditions 
due to the lower accessibility of ASM molecules at pH 7.2, being protected in the hydrophilic 
corona of the nanoparticles. The location of the proteins at the external hydrophilic domain of 
the nanoparticles is clearly supported by the residual enzymatic activity of the protein-loaded 
nanoparticles at pH 7.2. If the proteins would have been located in the inner domain of the 
nanoparticles, their accessibility would have been completely inhibited and they should have 
no activity. The residual activity proves that the ASM proteins are located in the external 
hydrophilic domain and are still able to convert the substrate into product. In the case of ASM-
nanoparticles exposed to acidic pH, the more positively charged environment favors ASM 
release, which results in a significantly increase of the ASM activity.  
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Figure 26: Enzymatic activity of ASM modified NP. ASM-A45B110C37 nanoparticles kept at 
pH 7.2 (Red), and ASM-A45B110C37 nanoparticles exposed at pH 5.5 for 60 min (Blue); 
A45B110C37 nanoparticles (Yellow). Adapted from Ref9 with permission. 
 
Release of o-ASM was monitored by FCS for A45B110C37 (Figure 27A) and A45B101C27 (Figure 
27B) as a function of time and pH. At pH 5.5, the release profile of ASM- A45B110C37 
nanoparticles shows a fast ASM release within 240 min (70 %), followed by a plateau (around 
85 % release). The fast release profile is due to favored diffusion of ASM from the corona of 
the nanoparticles, because of the combined effect of the decreased charge of the protein 
molecules (pH < I.P) and the increased positive change of the environment. The fast release 
can be correlated with the increased activity of ASM-nanoparticles in acidic pH conditions (see 
above). At pH 7.2, as the proteins are negatively charged, electrostatic interactions favor their 
attachment to the nanoparticles, which results in a significantly slower release (30 % release in 
240 min). A similar release of ASM molecules was observed at pH = 7.2 for nanoparticles 
based on copolymers with a shorter C block. However, a slower release profile was observed 
at pH = 5.5 in the case of A45B101C27 nanoparticles compared to that resulting from A45B110C37 
nanoparticles: the decreased fraction of the released protein molecules from nanoparticles 
based on a shorter C block is due to a different balance in the electrostatic interactions, because 
of the different amount of attached proteins (Table 3).  
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Figure 27. Release behavior of o-ASM from ABC nanoparticles as a function of time. 
Panel A.) A45B110C37 nanoparticles at pH 7.2 (triangles), and at pH 5.5 (squares). Panel B.) 
A45B101C27 nanoparticles at pH 7.2 (squares) and at pH 5.5 (circles). Adapted from Ref9 with 
permission. 
	
2.7 APPLICATION OF BIOMIMETICALLY ENGINEERED 
NANOPARTICLES AS DELIVERY AGENTS 
The toxicity of nanoparticles was assessed in human epithelial HeLa cell line using the MTS 
assay by incubating for 24 hours with nanoparticles, BSA- or ASM-nanoparticles 
(concentrations up to 50 µg/ml). The nanoparticles and both protein-loaded nanoparticles all 
showed >70% cell viability (Figure 28).  
 
 
Figure 28. HeLa cell viability after 24 h incubation with protein modified nanoparticles. 
Panel A.) A45B110C37 nanoparticles (empty), A45B110C37 nanoparticles with BSA-FITC (stripes), 
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A45B110C37 nanoparticles with o-ASM (dense stripes). (B) A45B101C27 nanoparticles (empty), 
A45B101C27 nanoparticles with BSA-FITC (stripes), and A45B101C27 nanoparticles with o-ASM 
(dense stripes).  Adapted from Ref9 with permission. 
 
At the highest concentration A45B101C27 nanoparticles present a slightly lower cell viability 
(73%) than A45B110C37 nanoparticles (78%), due to a lower overall positive charge (ESI), in 
agreement with previous reports on cationic polymer nanoparticles204. However, upon 
attachment of protein molecules, both A45B101C27 and A45B110C37 nanoparticles at the highest 
concentration have a lower cytotoxicity (the effect is, due to the decrease in the overall positive 
charge, as indicated by zeta-potential measurements (Fig. S8, SI). The effect is seen for both 
copolymers, but it is more pronounced for A45B110C37-based nanoparticles. BSA-FITC loaded 
A45B110C37 nanoparticles presented a viability > 100%, due to the stimulatory effect of BSA on 
cell proliferation205 .Overall, the low cytotoxicity of protein-nanoparticles supports their further 
development for therapeutic applications. 
To be applied as a therapeutic agent, cellular uptake of ASM-nanoparticles is critical and 
therefore was investigated in HeLa cells using confocal laser scanning microscopy (CLSM). 
In HeLa cells incubated with the o-ASM/ABC nanoparticles for 24 h, the presence of a 
fluorescent signal for o-ASM/A45B110C37 nanoparticles, and o-ASM/A45B101C27 nanoparticles 
clearly indicated uptake of o-ASM loaded nanoparticles (Figure 29). 
 
Figure 29. Confocal laser scanning micrographs of HeLa cells incubated with ASM 
modified NP. The cellular membrane was visualized by Cell Mask Deep Red (green), nuclei 
with Hoechst 33342 (violet), and o-ASM (red).  Panel A.) Untreated cells, Panel B.) Cells 
treated with 50µg/ml o-ASM-A45B110C37 nanoparticles, Panel C.) cells treated with 50µg/ml o-
ASM-A45B101C27 nanoparticles. Insets: zoomed regions of HeLa cells treated with 50µg/ml o-
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ASM-A45B110C37 and 50µg/ml o-ASM-A45B101C27 nanoparticles. Scale bar: 50 µm. Adapted 
from Ref9 with permission. 
 
In addition, up-take by HeLa cells after incubation for 24h of nanoparticles containing 
fluorescently labeled BSA-FITC (1:12 labeling efficiency) and o-ASM (1:3 labeling 
efficiency) respectively, was measured by fluorescence-activated cell sorting (FACS).  A 
significant shift of the peaks corresponding to the cells incubated with nanoparticles compared 
to normal cells confirms uptake (Figure 30). The difference in fluorescence shift between 
nanoparticles loaded with BSA-FITC and o-ASM is attributed to the lower labeling efficiency 
of o-ASM. The stimulating effect of BSA is considered only as a minor factor, because the 
coating of nanoparticles with BSA has been reported to have little or no influence on the 
cellular uptake of nanoparticles206. 
 
Figure 30. Flow cytometry analysis of cellular uptake of HeLa cells for labeled proteins in 
nanoparticles: Untreated HeLa cells (red); HeLa cells treated with 50µg/ml o-ASM-A45B101C27 
(blue); HeLa cells treated with 50µg/ml o-ASM-A45B110C37 (grey); HeLa cells treated with 
50µg/ml  BSA-FITC-A45B101C27 (yellow), and HeLa cells treated with 50µg/ml BSA-FITC-
A45B110C37 (green). Adapted from Ref9 with permission. 
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2.8 CONCLUSION 
This chapter focused on the self-assembly of poly(ethylenegycol)-b-poly(methyl 
caprolactone)-b-poly(2-(N,N-diethylamino) ethyl methacrylate) copolymers with two different 
ratios of the hydrophobic to hydrophilic blocks generated soft nanoparticles to which proteins 
could be attached at a desired location in order to develop an efficient protein delivery platform. 
The asymmetry of the block copolymers favored a specific location for proteins and small 
molecular mass molecules: the PDMAEMA block predominantly present at the external 
interface favored attachment of proteins and small molecular mass molecules with the opposite 
charge, while PEG was mainly embedded inside the hydrophilic domain. The combination of 
the methods used in this study (LS, TEM, cryo-TEM, FCS, activity assays of the proteins) 
allowed for a deeper understanding of the nanoparticles’ morphology and behavior in the 
presence of proteins as key factors for future translational applications. Attachment of 
biomolecules was favored by a triggered effect of electrostatic interactions between the 
PDMAEMA domain and negatively charged molecules. Both BSA and o-ASM were 
successfully attached, and subsequently released from the self-assembled nanoparticles 
(>80%) when the pH was decreased to acidic values. This is the first system based on 
electrostatic attachment and release of therapeutic proteins (ASM), whilst preserving their 
activity. The protein-polymer nanoparticles showed low toxicity at concentrations up to 
50µg/ml, and were up-taken by HeLa cells. PEG-b-PMCL-b-PDMAEMA nanoparticles can 
attach a variety of biomolecules with charge opposite to that of the PDMAEMA domain, and 
then release them in a pH-responsive manner, which supports their further optimization for 
potential therapeutic applications. This study is the first one showing that it is possible to 
deliver proteins in a pH responsive manner by their controlled localisation in the nanoparticle 
interface with the environment.  
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Chapter 3. 
 
BIOMIMETICALLY ENGINEERED PH TRIGGERED 
PMOXA-b-PDMS-b-PMOXA CATALYTIC 
NANOCOMPARTMENTS⊥ 
 
In this chapter, the concept of pH triggered catalytic nanocompartments designed by 
biomimetic engineering of PMOXA-b-PDMS-b-PMOXA polymersomes is introduced. pH 
responsive catalytic nanocompartments are developed by simultaneous equipment of 
polymersomes with both a responsive protein gate - a chemically modified version of Outer 
membrane protein F (OmpF) and a catalyst - horseradish peroxidase. Insight is given into how 
chemical modifications of key amino acid residues, located at the constriction site of the OmpF 
pore affect the function of OmpF, the self-assembly of PMOXA-b-PDMS-b-PMOXA 
polymersomes and the functional reconstitution of OmpF into polymersome membranes. 
Finally, we demonstrate how the chemically modified OmpF affects the functionality of the 
self-assembled biomimic by acting as a pH responsive gate, thereby allowing controlled access 
of enzymatic substrates to the enzyme encapsulated in PMOXA-b-PDMS-b-PMOXA 
polymersomes. 
 
 
 
 
 
 
 
⊥This study has been published: T. Einfalt, R. Goers, I. A. Dinu, A. Najer, M Spulber, O. Onaca-Fischer and C. G. Palivan Stimuli-
Triggered Activity of Nanoreactors by Biomimetic Engineering Polymer Membranes, Nano Letters 11, 7596 – 7603, (2015) 
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3. 1 MOTIVATION AND PROBLEM DEFINITION 
 
The need to introduce new systems that can provide reaction spaces at the nano-scale level 
with high space and time precision responses is present in various domains, such as 
biomedicine, environmental sciences and chemical engineering. As discussed in chapter one, 
emerging concepts of molecular factories, artificial organelles and artificial cell mimics are 
already opening new frontiers in medicine. Inspired by biosynthetic processes in nature, 
researchers have become increasingly interested in designing reaction spaces based on 
vesicular supramolecular assemblies (polymersomes, PICsomes, or LBL capsules), with sizes 
in the nanometer range and containing active compounds so that they can function as catalytic 
nanocompartments13. The advantage of polymersome based nanocompartments, in respect to 
soft polymer nanoparticles discussed in chapter two, is their unique ability to simultaneously 
protect encapsulated biomolecules from their environment, while preserving their activity 
inside the aqueous cavity of the supramolecular assembly 13,134.  
Of particular interest in the generation of catalytic nanocompartments are polymersomes, 
because of their greater stability compared to liposomes,48 and the ability to modulate their 
properties (size, permeability, polarity, stimuli responsiveness) by changing the chemic al 
nature of the copolymers or their functionalisation130,207. The unique nanoarchitecture of 
polymersomes offers three topologic regions: the inner cavity, the membrane, and their exterior 
surface. These regions can be used to support the simultaneous loading of both hydrophilic and 
hydrophobic molecules, which can range from small molecular weight molecules (i.e. drugs 
and fluorophores) to macromolecules (i.e proteins)130. An essential molecular parameter that 
needs to be controlled for an in situ reaction inside the cavity of a catalytic nanocompartment 
is a membrane permeability that allows transport of the substrates required for the reaction, 
and the products generated by the reaction. To maximize the effectiveness of catalytic 
nanocompartments, especially when they are intended to serve as artificial organelles or simple 
mimics of cells, an additional step in design should be triggered activity. Significant efforts 
have been made to obtain stimulus-responsive polymersomes for use as drug carriers with 
enhanced efficacy by providing a homogenous spatial distribution, and increasing the 
localization of drugs in desired regions through triggered release54. Polymersomes serving as 
drug delivery carriers were designed to respond to specific stimuli, such as pH208, 
temperature209, light210, enzyme211 or a combination of thereof212. The release from the carrier 
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has been mainly obtained by dissociation or degradation of polymersomes into polymer chains 
or small molecules. However, this strategy involving the dissociation of the polymer 
supramolecular assembly upon the presence of stimulus(i) is not compatible with the concept 
of a catalytic nanocompartment, in which the enzymatic reactions should take place in situ, 
inside their inner cavity. There are a few examples of stimuli responsive catalytic 
nanocompartments (to light117,131, to  pH changes167,213), but they are either permeable only to 
reactive oxygen species117,131, or lack controlled permeability167,213. Therefore alternative 
strategies are required to design stimuli-triggered catalytic in which polymersomes both 
preserve their integrity, and an in situ reaction is triggered by the presence of a stimulus.  
The aim here was to develop catalytic nanocompartments with triggered activity based on the 
encapsulation of enzymes inside polymersomes with a membrane that is rendered selectively 
permeable by inserting chemically engineered channel porins to act as “gates”. The protein 
“gates” reconstituted in the polymersome membrane are partially closed, and open at different 
pH values: thus pH-controlled enzymatic activity inside the catalytic nanocompartments is 
mediated by the blockage/free diffusion of molecules through the porin channel (Scheme 1). 
Our biomimetic approach is inspired by protein function that is commonly found in nature, as 
for example the pH-gated M2 protein found in the capsid of the Influenza B virus, which has 
very low conductance at physiological pH values, but increases 50 fold at lower pH214. Change 
in pH presents as a model stimulus for our triggered catalytic nanocompartments, because it is 
an essential signaling factor that accompanies pathological conditions187. In medicine 
differences in pH are exploited by specific diagnostics or therapeutic agents215,216. 
Catalytic nanocompartments were generated by encapsulating a model enzyme, horseradish 
peroxidase (HRP), inside the inner cavity of poly(2-methyloxazoline)-block-
poly(dimethylsiloxane)-block-poly(2-methyloxazoline) (PMOXA6–PDMS44–PMOXA6) 
polymersomes with a membrane in which modified Outer membrane protein F, OmpF served 
as a protein “gate”.  
In order to obtain a responsive protein gate, OmpF was chemically modified with a “molecular 
cap” to be partially blocked/blocked/open depending on the pH values of the surrounding 
environment of the catalytic nanocompartment. Differences in accessibility of the OmpF pore 
for molecules (substrates and products of the in situ enzymatic reaction) represent key factors 
for triggering the activity of catalytic nanocompartments. Use of the bottom-up approach of 
combining polymersome membranes with protein gates allows the optimization of catalytic 
nanocompartments with respect to: (i) membrane permeability, (ii) the mass of the molecules 
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transported, and (iii) overall catalytic nanocompartment functionality. In contrast to 
polymersomes with membranes containing genetically modified OmpF, which served for pH-
sensitive release of a payload146, our catalytic nanocompartments represent an additional step 
in terms of functionality, because of the controlled modulation of the in situ enzymatic reaction.   
Developments in the design of catalytic nanocompartments with triggered activity, such as our 
system, will support the production of complex reaction spaces at the nanoscale in which the 
functionality is modulated in an analogous manner to that in cell membranes, and ultimately in 
the creation of artificial cells (Scheme 3.). In addition, the strategy introduced here will provide 
solutions for personalized medicine by a simple change of combinations of active compounds 
(enzymes, proteins, mimics) encapsulated inside the catalytic nanocompartments.  
 
 
Scheme 3. Concept of a catalytic nanocompartment with triggered activity based on a 
chemically engineered protein “gate” inserted in a polymersome membrane.  A change in 
pH induces the release of the sensitive molecular cap (green dots) from the protein “gate” 
allowing the entrance of substrates (red dots), and the release of the products of the enzymatic 
reaction (yellow dots). Adapted from Ref12 with permission. 
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3.2 ENGINEERING OF THE OMPF WILD TYPE PORE TO 
DEVELOP A PH GATE 
 
OmpF has already been used in its wild type form (trimer with a pore diameter that allows 
transport of molecules < 600 Da217) to render permeable the membrane of PMOXA-PDMS-
PMOXA polymersomes, and to develop catalytic nanocompartments for various 
applications5,134,218. In order to design a pH responsive “gate” that triggers the in-situ activity of 
catalytic nanocompartments, the OmpF pore was chemically modified by attaching a molecular 
cap to reduce accessibility of the pore at pH = 7.4 (Figure 31). The cap is cleaved when the pH 
decreases to 5.5, and the “open gate” allows diffusion of molecules, and initiation or increase 
in activity of catalytic nanocompartments depending on the degree of pore blockage.  
 
 
Figure 31. Molecular representation of the pH responsive OmpF.  A. OmpF with a pH 
responsive cap (red molecular region) in the “closed state”, and B. OmpF after release of the 
pH responsive cap, in the “open state”. Image shown is a static representation. Adapted from 
Ref12 with permission. 
 
There are various methods to modify the pores of channel proteins in order to reduce transport, 
such as replacement of native amino acids with ones selected to allow chemical modification 
(e.g. cysteins), modification of the amino acid sequence via trans-splicing, or introduction of 
novel amino acids at the genetic level219. Here chemical modification of OmpF wildtype 
presented the most straightforward approach. 
OmpF contains a constriction site with two amino acid half rings, which creates an electrostatic 
field that modulates solute fluxes and pore properties217,220. Diffusion of molecules through the 
OmpF pore is determined by six amino acid residues located inside of the constriction zone of 
A B
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the pore221. Since accessibility of the K16 and K46 residues located inside the pore cavity 
favours interactions with small molecular weight molecules, a binding of the pH sensitive cap 
to the these residues was expected.  Such an approach for the design of a pH responsive OmpF, 
has the advantage of being able to bind different porin “caps” that can block the pore to 
different degrees depending on their properties.   
We decided to first couple the lysine residues with levulinic acid by a simple sulfo-NHS/EDC 
reaction (Scheme 4.), and removed unreacted levulinic acid was by filtration and dialysis. This 
step was necessary to introduce reactive carbonyl groups, which favour the binding of a pH 
responsive cap cyanine5-hydrazide (Cy5-Hydrazide). Acid-liable chemical bonds, such as 
acetal, orthoester, hydrazone, imine and cis-aconyl bonds are well known to introduce pH 
responsiveness, and their degradation or hydrolysis under acidic conditions leads to the release 
of attached molecules222. Cy5-hydrazide was selected as the second part of the pH responsive 
linker, because its molecular weight (569.6 g/mol) matches with the pore size at the constriction 
region (Figure 31). In addition, as the fluorescence intensity of Cy5 is not influenced by a 
change in pH, the Cy5 fluorophore could be used for an efficient assessment of the “gate” 
functionality by fluorescence correlation spectroscopy (FCS) (see below). 
 
Scheme 4. Chemical modification of wild type OmpF. EDC/Sulfo-NHS coupling is used to 
attach levolunic acid. Subsequently pH sensitive molecular cap Cy5 hydrazide is attached to 
carbonyl groups. Adapted from Ref12 with permission. 
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After coupling Cy5-hydrazide to the carbonyl groups (referred to in the manuscript as “CA”) 
and the formation of a pH responsive hydrazone bond, any unreacted Cy5-hydrazide was 
removed by centrifugal filtration. To avoid the possible formation of multimers, and 
sedimentation in a non-amphiphilic environment, OmpF was stored in 3% octyl-
glucopiranoside (OG). However, as the presence of OG interferes with the purification of Cy5-
hydrazide, further purification through dialysis was necessary to lower the OG concentration 
below the critical micellar concentration. In this way residual Cy5-hydrazide entrapped in OG 
micelles was removed in addition to avoiding any influence of OG on polymersome formation. 
In order to prove the introduction of CA, carbonylated OmpF (OmpF-CA) was compared with: 
wild type OmpF (OmpF-WT), wild type OmpF with added Cy5-hydrazide (OmpF-WT-Cy5) 
and carbonylated OmpF with added Cy5-hydrazide (OmpF-CA-Cy5). After completion of the 
purification procedure, all these subsets of OmpF were tested with 2,4-dinitrophenylhydrazine 
(DNPH), a specific reagent to assess the presence of carbonyl groups. Successful introduction 
of carbonyl groups was found for OmpF-CA and a value of 56.5+/-16.8 nmol carbonyl groups 
per mg of protein was obtained by UV-Vis spectroscopy (Figure 32a). In contrast, OmpF-WT, 
OmpF-WT-Cy5, and OmpF-CA-Cy5 did not react with DNPH either because of the lack of 
CA (OmpF-WT and OmpF-WT-Cy5), or successful binding of Cy5-hydrazide to CA groups, 
which blocked further reactivity in the case of OmpF-CA-Cy5.   
 
 
Figure 32. Characterisation of OmpF modification. a) carbonyl content determination of 
OmpF-CA, OmpF-WT, OmpF-CA+Cy5 and OmpF-WT+Cy5 protein pores. s determined by 
a DNPH protein carbonylation kit, and b.) Molecular brightness (CPM) of OG micelles with 
various OmpFs and/or free dye in 3% OG or PBS: (1) OmpF-CA+Cy5, 3% OG pH 7.2 (Dark 
blue), (2) OmpF-CA+Cy5, 3% OG pH 5.5 (Blue), (3) OmpF-WT+Cy5, 3% OG pH 7.2 (Dark 
BIOMIMETICALLY ENGINEERED PH TRIGGERED PMOXA-b-PDMS-b-PMOXA 
CATALYTIC NANOCOMPARTMENTS 
 
 68 
red), (4) OmpF-WT+Cy5, 3% OG pH 5.5 (Red), (5) Cy5, 3% OG pH 7.2 (Dark grey), (6) Cy5, 
3% OG pH 5.5 (Grey), and (7) Cy5 pH 7.4 in PBS (Black). Adapted from Ref12 with permission. 
 
The binding of Cy5-hydrazide to the carbonylated OmpF was investigated by native page 
(Figure S12, S13, SI). Lower electrophoretic migration of OmpF CA-Cy5 (35.9 ± 0.01 pixels) 
compared with OmpF-CA (37.7 ± 0.03 pixels) results from the trimer having a higher 
molecular weight when bound to Cy5-hydrazide. The modification did not affect the stability 
of the OmpF trimer, because no dissociation into mono or dimers was observed (Figure S12, 
SI). 
An important aspect of a functional pH-responsive protein gate is the release of its sensitive 
cap upon the pH change. To observe this FCS was used, because it is able to assess the binding 
of fluorescent molecules to molecules with significantly higher molecular weight (protein, 
DNA, antibody), or to supramolecular assemblies (polymersome, nanoparticles)8,223, and their 
encapsulation/entrapment in such supramolecular assemblies224. In addition, FCS has already 
been used to determine the release of small molecules through modified porins146.  
FCS allows analysis of the binding of fluorescent molecules to molecules/assemblies with 
significantly higher molecular weight by comparing their diffusion property and molecular 
brightness (counts per molecule, CPM) in the free and bound states.224 In order to follow the 
release of Cy5 from OmpF-CA-Cy5 the brightness of OmpF-CA-Cy5 was compared with that 
of OmpF-WT+Cy5, and Cy5-hydrazide at different pH values, and in 3% OG to avoid 
aggregation and precipitation of OmpF. The presence of OG micelles complicated data 
interpretation because of interactions of dye molecules with the detergent micelles. Once 
solubilized in OG micelles, OmpF-CA-Cy5 had a diffusion time of τD = 350 ± 27 µs; both Cy5 
in OG micelles with τD = 249 ± 34 µs, and OmpF-WT+Cy5 with τD = 266 ± 50 µs diffused 
similarly (Table S2, SI). Nevertheless, OmpF-CA+Cy5 micelles had a higher molecular 
brightness (CPM = 17 ± 1 kHz) compared to OmpF-WT+Cy5, (CPM = 4 ± 1 kHz) and 
therefore, on average, contained more dye molecules per micelle; this indicates additional 
interaction of the membrane protein with the dye, as expected for modified OmpF-CA (Figure 
S14, Table S2, SI).  A decrease of brightness from 17 ± 1 kHz to 12 ± 1 kHz was observed 
after keeping OmpF-CA-Cy5 at pH 5.5 for 1 h, which indicates cleavage of the pH-responsive 
hydrazone bond leading to the release of Cy5-hydrazide into the environment (Table S3, SI). 
Complete recovery of the free dye by FCS was not possible due to the aforementioned 
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interaction of the dye with the detergent micelles. No significant change in brightness was 
observed in OG micelles both for OmpF-WT-Cy5 and for Cy5-hydrazide at pH = 5.5 or pH = 
7.2 (Figure 2b, Table S2, SI). 
 
3.3 SELF-ASSEMBLY OF pH TRIGGERED BIOMIMETIC 
CATALYTIC NANOCOMPARTMENTS 
 
In order to generate catalytic nanocompartments with pH triggered activity, simultaneous 
encapsulation of HRP and reconstitution of OmpF-CA-Cy5 was achieved during the self-
assembly of PMOXA6–PDMS44–PMOXA6 copolymers by thin film rehydration method. This 
preparation method has the advantage of avoiding organic solvents, which are difficult to be 
remove completely, and can also affect the biomacromolecules or be problematic in a later 
application of this system in vivo150. In addition, the film rehydration method is known as a 
mild method of enzyme encapsulation, as already reported for catalytic nanocompartments 
based on encapsulation of HRP13. Reconstitution of OmpF-WT and encapsulation of HRP in 
supramolecular assemblies of PMOXA6–PDMS44–PMOXA6 copolymers served to create a 
non-pH responsive catalytic nanocompartment control. 
PMOXA6–PDMS44–PMOXA6 copolymers were selected here because they have an 
appropriate hydrophilic-to-hydrophobic ratio, and have been reported to self-assemble into 
polymersomes with sizes of 100-200 nm139,140. In order to establish whether the insertion of 
modified or non-modified OmpF, as well as the decrease in pH, affects polymersome 
morphology and stability, light scattering experiments were performed. The results indicated 
the formation of spherical nano-objects with a RH of 77 nm for assemblies containing OmpF-
WT and HRP, and 79 nm for those with-CA-Cy5 and HRP. At pH 7.2 the structural parameter 
ρ (ρ = RG/RH) has values of 0.90 – 0.96 for un-permeabilised HRP-loaded polymersomes, 
OmpF-CA-Cy5 permeabilised HRP-loaded polymersomes, and OmpF-WT permeabilised 
HRP-loaded polymersomes, whereas at pH 5.5 ρ values are 0.96 - 1.05. These values are all 
close to 1.0, which is typical for hollow spheres; therefore the polymersome self-assembly 
process was not affected by the presence of HRP and/or OmpF reconstitution (Table 4, Table 
S3, SI).  
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TEM and cryo-TEM micrographs indicate the formation of spherical structures, with radii 
around 70 nm at pH = 7.2, both after self-assembly of PMOXA6–PDMS44–PMOXA6 
copolymers, and upon insertion of OmpF and encapsulation of HRP in the polymer assemblies 
(Figure 33 and Figure S15b, SI). Therefore, insertion of OmpF-WT / OmpF-CA-Cy5 and 
simultaneous encapsulation of HRP did not affect the self-assembly process of PMOXA6–
PDMS44–PMOXA6 copolymers into polymersomes. A slight decrease in size compared to un-
permeabilised polymersomes was observed, as already reported for such copolymers139,140. The 
decrease of pH to 5.5 neither affected the architecture nor the size of OmpF-WT and OmpF-
CA-Cy5 equipped catalytic nanocompartments (Table S3, SI). After 14 days OmpF-WT- and 
OmpF-CA-Cy5-equiped catalytic nanocompartments still preserved their structures, and did 
not aggregate.  
 
 
Figure 33. Cryo-TEM micrographs of catalytic nanocompartments. Panel A.) catalytic 
nanocompartments without OmpF, Panel B.) catalytic nanocompartments with reconstituted 
OmpF-WT, and Panel C.) catalytic nanocompartments with reconstituted OmpF-CA-Cy5. 
Scale bar = 200 nm. Adapted from Ref12 with permission. 
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Table 4. Molecular characteristics of PMOXA6–PDMS44–PMOXA6 assemblies without and 
with reconstituted OmpF at pH 7.2. Mw = 4500 g/mol, PDI = 1.8 fhydrophilic = 25 %. 
 
Nano-assemblies 
DLS/SLS 
Rg 
[nm] 
Rh 
[nm] 
ρ = Rg/Rh 
HRP-loaded nano-assemblies 95 106 0.90 
HRP-loaded nano-assemblies with 
OmpF-CA-Cy5 
77 80 0.96 
HRP loaded nano-assemblies with 
OmpF-WT 
79 84 0.95 
 
FCS was used to evaluate the insertion and calculate the number of OmpF gates/polymersome 
(OmpF-CA-Cy5/vesicle). FCS autocorrelation curves show a significant difference in τd values 
between freely diffusing Cy5-hydrazide (τd = 67 µs), OmpF-CA-Cy5 in 3% OG micelles (τd = 
266 µs) and polymersomes with reconstituted OmpF-CA-Cy5 (τd = 2914 µs) (Figure 34). The 
large increase in τd of OmpF-CA-Cy5-equipped polymersomes indicates that the modified 
protein gate was inserted in the polymer membrane. Furthermore by means of FCS it was 
possible to calculate a mean value of 55 OmpF-CA-Cy5 pores per polymersome by comparing 
the molecular brightness (CPM) of OmpF-CA-Cy5 in OG micelles (CPM = 17+/-1 kHz) with 
the molecular brightness of OmpF-CA-Cy5 equipped polymersomes (CPM = 945 +/-33 kHz). 
 
Figure 34. FCS autocorrelation curves of Cy5, OmpF-CA-Cy5 and reconstituted OmpF-
CA-Cy5. 100 nM Cy5-hydrazide in PBS (Black), OmpF-CA-Cy5 in 3% OG (Red) and OmpF-
CA-Cy5 in the membrane of polymersomes (Blue). Experimental autocorrelation curves 
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(dotted line), and their fit (full line). Curves normalized to 1 to facilitate comparison. Adapted 
from Ref12 with permission. 
 
The hydrodynamic radius (RH) of the OmpF-CA-Cy5 catalytic nanocompartments at pH 7.2 
was calculated by Stokes-Einstein equation to be 47+/- 4 nm, in agreement with the values 
obtained from TEM, Cryo-TEM, and light scattering experiments.  
 
3.4 FUNCTION OF pH TRIGGERED BIOMIMETIC 
CATALYTIC NANOCOMPARTMENTS 
 
A crucial point in demonstrating that a catalytic nanocompartment has triggered activity is to 
evaluate its activity as function of pH. In this respect two different enzymatic assays were used, 
the TMB (3,3’,5,5’- tetramethylbenzidine) colorimetric assay and the Amplex Red® 
fluorimetric assay. Amplex Red and TMB were selected because they differ in their molecular 
properties, as for example the charge or geometrical arrangement, and therefore serve as 
models to asses pore closure towards different types of molecule. It has been already reported 
that the molecular influx inside OmpF pores strongly depends on the properties of the 
molecules passing through them, which support an interaction, especially with the constriction 
zone.47 Therefore pore closing of a modified OmpF is based on two factors, which have to be 
considered together: the closing of the pore due to modification with a specific molecular cap 
(for example in our case CA-Cy5), and interaction of the molecules penetrating the pore with 
the constriction region. 
First, free HRP was tested to establish whether exposure to pH 5.5 affects its activity. No 
significant change in HRP activity was observed between incubation at pH 5.5 and pH 7.4 
when TMB and Amplex Red were used as substrates (Figure S16, S17 SI);47 thus any change 
in HRP activity inside catalytic nanocompartments is due to a triggered diffusion of substrates 
through the modified OmpF pore. 
When TMB (predicted polar surface area = 52 A2, MW = 240 g mol-1, Log P = 3.40, neutral at 
pH 7.4) was the substrate used to penetrate the modified OmpF gate, a smaller enzymatic 
turnover (around 38%) was obtained in catalytic nanocompartments equipped with OmpF-CA-
Cy5 at pH = 7.4, compared with the OmpF-WT catalytic nanocompartments at the same pH 
value (Figure 35, Figure S19). This decrease in in situ enzymatic activity of HRP for catalytic 
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nanocompartments equipped with OmpF-CA-Cy5 indicates a partial closing of the pore, which 
decreases the molecular influx of TMB molecules. As TMB has Mw = 240g mol-1, it is expected 
that this partial closing of the OmpF pore serves as a barrier, and thus will block molecules 
with higher Mw. 
At pH = 5.5, the activity of catalytic nanocompartments equipped with OmpF-CA-Cy5 
increased by 23%, indicating successful hydrolysis of the hydrazone bond, and the release of 
the Cy5-hydrazide molecular cap. The increase in the influx of TMB through the pore resulted 
in an increase in in situ catalytic nanocompartment activity. This allowed a comparable 
transport through the pore to that with carbonylated OmpF, and therefore a similar value for 
the in situ enzymatic reaction rate.  
  
Figure 35. TMB conversion kinetics measured at pH = 7.4 of catalytic compartments 
prepared with different OmpF subsets. (1) unpermeabelised catalytic compartments 
incubated at pH = 5.5 (Orange), (2) unpermeabelised catalytic nanocompartments incubated at 
pH 7.4 (Green), (3) OmpF-CA-Cy5 catalytic nanocompartments incubated at pH 7.4 (Blue), 
(4) OmpF-CA-Cy5 catalytic nanocompartments incubated at pH 5.5 (Gray), (5) OmpF-CA 
catalytic nanocompartments incubated at pH 5.5 (Red), (6) OmpF-WT catalytic 
nanocompartments incubated at pH 5.5 (Black), (7) OmpF-WT catalytic nanocompartments 
incubated at pH 7.4 (dark Blue). Adapted from Ref12 with permission. 
 
 
The enzymatic turnover of the Amplex Red substrate (predicted polar surface area 72 A2, MW 
= 257 g mol-1, Log P = 0.89, charge = -0.1 at pH 7.4) was drastically reduced (down to 14%), 
compared to OmpF-WT catalytic nanocompartments acting in similar conditions at pH = 7.4. 
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The blockage of Amplex Red influx through the pore is considered to be due to a combination 
of effects: (i) closing of the pore by the molecular cap, and (ii) electrostatic interaction of 
Amplex Red with the molecular cap. Such interactions of charged molecules with the positively 
charged constriction region of OmpF have been already reported for ampicillin.48 After 
decreasing the pH to 5.5, the activity of nanoractors equipped with OmpF-CA-Cy5 increased 
to 74% in one hour. This indicates a successful pore opening, which allowed a significant 
increase in the influx of substrates through the pore (Figure 36, Figure S17). The slight increase 
in activity of the catalytic nanocompartments equipped with OmpF-CA with time is explained 
by the concentration gradient of the substrate at the beginning of the enzymatic reaction. 
  
Figure 36. Amplex red conversion kinetics of catalytic nanocompartments equipped with 
different OmpFs (1) unpermeabilised catalytic nanocompartments (orange), (2) OmpF-CA-
Cy5 (blue), (3) OmpF-CA (grey), and (4) Ompf-WT (black) at pH 5.5, at time 0 (a) and after 
1 hour (b). Adapted from Ref12 with permission. 
 
Catalytic nanocompartments without inserted OmpF had a very low enzymatic turnover for 
both substrates at pH = 5.5, probably due to the presence of traces of HRP not removed by 
dialysis. As expected, no increase in activity was observed in catalytic nanocompartments 
without reconstituted OmpF at pH 5.5. This indicates that the permeability of polymersomes 
was not affected by the change in pH (Figure 35 Figure 36, Table S3, SI), in agreement with 
previous reports on the stability of PMOXA-b-PDMS-b-PMOXA polymersomes at different 
pH values139 . 
The difference in the decrease of the in situ activity of catalytic nanocompartments equipped 
with OmpF-CA-Cy5 at pH = 7.4 as function of the molecular nature of the substrates results 
from a modulation of the influx through the pore due to the combined effect of pore closing 
and intermolecular interactions of the substrates in the “spatially reduced” constriction region. 
Whilst the influx of the neutral TMB is only reduced by the pore closing, that of the slightly 
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negatively charged Amplex red is blocked by intermolecular interactions with the positively 
charged Cy5 fluorophore.  Our results are in agreement with previously reported data, in which 
mutations of key OmpF residues (K16 and K46) substantially altered the diffusion of molecules 
through the pore47,48.  
Therefore, depending on the desired application, the “gate” can be partially or fully closed at 
pH = 7.4, and opened at pH = 5.5, resulting in a modulation of the enzymatic activity inside 
the cavity of catalytic nanocompartments. The decrease in the functional diameter of the OmpF 
pore defining the size exclusion limit for diffusion represents the driving force for a triggered 
in situ activity of these catalytic nanocompartments. Our stimuli-responsive switch is one-time 
stimulus responsive, especially designed to be released and open the pore upon a pH change. 
Reversible control of opening/closing the OmpF channel could be engineered by a gating 
moiety, near the constriction site of the protein, which should be covalently attached, stable in 
acidic pH, and present specific properties dependent on the pH of the environment. Ongoing 
experiments are dedicated to engineer this type of sensitive molecular cap, which could 
influence in a reversible manner the influx of substrates through the pore. 
 
3.5 CONCLUSION 
In cellular and subcellular environments, reaction catalysts (enzymes or small molecular 
weight compounds) are often protected in specific compartments where they act in situ when 
necessary, as for example in the presence of a stimulus.  Here a new biomimetic strategy for 
developing catalytic nanocompartments possessing triggered activity is presented. Modulation 
of enzyme activity inside catalytic nanocompartments was successfully implemented by 
inserting chemically-modified channel proteins to act as pH-controlled “gates” in the 
membrane of enzyme-loaded polymersomes. Together with a preserved architecture of the 
polymersomes, the decrease/blocking of the flow of substrates through the membrane at neutral 
pH, and its unblocking at a lower pH resulted in very efficient stimulus-driven active catalytic 
nanocompartments. This system produces pH-triggered enzymatic activity, and therefore 
represents an additional step in the design of active systems capable of responding “on 
demand”. In, addition, an example of chemical modification of OmpF that results in both 
tuning the pore cut-off size (from 600Da in the case of OmpF- WT to around 240Da for OMPF-
CA-Cy5) and molecular selectivity is presented. 
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The design of catalytic nanocompartments with triggered activity opens new possibilities for 
advanced control of reactions at the molecular level, and is expected to have a significant 
impact in domains such as medicine or controlled catalysis. 
 
 
 
BIOMIMETIC ENGINEERING OF RESPONSIVE ARTIFICIAL ORGANELLES WITH 
IN VITRO AND IN VIVO FUNCTIONALLITY 
 77 
Chapter 4.  
 
BIOMIMETIC ENGINEERING OF RESPONSIVE 
ARTIFICIAL ORGANELLES WITH IN VITRO AND IN VIVO 
FUNCTIONALLITY⊥ 
 
The final experimental chapter of this thesis builds on the knowledge of developing a 
responsive catalytic nanoarchitecture, acquired in the second and third chapter, in order to 
design an artificial organelle with in vitro and in vivo functionality. To develop an artificial 
organelle, a responsive catalytic PMOXA-b-PDMS-b-PMOXA nanocompartment, capable of 
interacting with the intracellular environment of living cells, is designed.  For this purpose, a 
cysteine double mutant of OmpF is chemically modified to act as a reduction responsive gate 
in polymersome membranes. Through the functional reconstitution of the modified OmpF, in 
horseradish peroxidase loaded PMOXA-b-PDMS-b-PMOXA polymersomes, a biomimetic 
system is created that is capable of acting in response to small intracellular signalling 
molecules, such as glutathione. The function of the designed biomimic as an artificial organelle 
is demonstrated by the “in vitro” application in human epithelial HeLa cells and “in vivo” in 
zebrafish embryos. Surisingly, even after being recognised by the zebrafish embryo early 
immune system, it remains responsive and functional, due to the robust nature of the 
polymersomes. 
 
 
 
 
 
 
 
 
⊥This study has been submitted to Nature Communications: T. Einfalt, D. Witzigmann, C. Edlinger, S. Sieber, R. Goers, A. Najer, M 
Spulber, O. Onaca-Fischer and J. Huwyler, C. G. Palivan, Biomimetic artificial organelles with in vitro and in vivo reduction triggered 
activity 
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4.1 MOTIVATION AND PROBLEM DEFINITION 
 
Nanoscale biomimics designed as artificial organelles (AOs) are particularly appealing in 
biomedicine because of their ability to act as cellular implants by providing a required 
compound/signal, detoxifying harmful compounds, or changing cellular conditions and 
reactions129. AOs are based on nanoscale compartmentalisation of active compounds (enzymes, 
proteins, catalysts, mimics) within an artificial compartment that can reach, survive and 
function in the intracellular environment, thereby acting as a simplified mimic of nature’s own 
organelles. AOs compartmentalisation permits the compartmentalised  compounds to perform 
a specific in situ reaction, whilst being protected from the environment in the synthetic 
compartment129. Different examples of systems that have the potential to act as AO have been 
recently developed. They are based on liposomes, porous silica nanoparticles, and polymer 
compartments (polymersomes) in combination with biomacromolecules5,173,174. In vitro and in 
vivo preserved integrity and activity of the system represent essential requirements for a 
functional AO. However, only very few of such systems with AO potential have been tested in 
vitro to assess their cellular functionality and none have been assessed in vivo5,113,173,174,225.  
Polymer-based compartments named polymersomes are ideal candidates for the creation of 
AOs, due to their hollow sphere architecture with a membrane serving as a border to the inner 
environment, combined with an improved mechanical stability compared with the lipid-based 
compartments i.e. liposomes49,226. The encapsulation of active compounds in polymersomes 
represents a key approach for the design of AOs if the synthetic membrane is permeable for a 
molecular exchange of substrates/products with the environment to support the in situ reaction  
49,135. Previous examples of AO  are exciting because they show the ability of AOs to emulate 
cellular pathways (e.g. ROS detoxification or glucose oxidation) as a potent strategy for the 
substitution of decreased or absent cellular activity5. Stability, biocompatibility and low 
toxicity of AOs represent real advantages favouring AOs when compared to existing solutions 
for enzyme replacement, such as direct enzyme delivery and transfection227. However, none of 
the first reported AOs were evaluated in vivo, to indicate their functionality in living organisms. 
Another essential factor to tune AOs functionality and applicability is a triggered response to 
environmental factors, as for example the redox state of the cell, which regulates various 
processes involved in cellular signalling pathways228,229. Mitochondria, for example, can act as 
critical mediators of cellular redox homeostasis230, since their membranes contain proteins 
responsive to changes in glutathione (GSH), reactive oxygen species (ROS) or reactive 
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nitrogen species (RNS) levels231,232,233. As biological systems are required to respond to constant 
changes in the cellular microenvironment, triggered permeability of AOs membrane is essential 
to assure precise control of the in-situ reactions, and resulting products.  
Here a strategy to design biomimetic AOs with an in-situ enzymatic reaction triggered by the 
presence of an external cellular stimulus is presented in vitro and in vivo. Polymersomes were 
equipped with genetically modified OmpF porines to induce redox responsiveness to the 
membrane while simultaneously encapsulating a model enzyme, HRP inside their cavity as 
core of the AO functionality. Amphiphilic block-copolymers poly(2-methyloxazoline)-block-
poly(dimethylsiloxane)-block-poly(2-methyloxazoline) (PMOXA6–PDMS44–PMOXA6) have 
been used to self-assemble into polymersomes because they have already been shown to form 
membranes in which biopores and membrane proteins were successfully inserted and they 
preserved their functionality4. Once inserted in the polymersome membrane, the modified 
OmpF porines act as protein “gates” and trigger the in situ HRP enzymatic reaction. The 
molecular flow through the membrane is controlled in an open/closed state of the protein gate, 
directly related to changes in the environment of the polymersomes. A previously developed 
double cysteine mutant of OmpF234 is used as it opens the possibility of attaching molecular 
caps to the genetically introduced cysteine residues. By attaching the molecular cap using 
disulphide bonds the OmpF pore is blocked/unblockunblocked depending on changes in redox 
potential, which occur when the system enters the intracellular microenvironment. In contrast 
to polymersomes with membranes containing genetically modified OmpF, which served for 
release of a payload in reductive conditions235, the system presented here has an increased 
functionality, because it serves to control an in situ enzymatic reaction, and therefore the 
overall functionality of the AOs.  Inspired by cellular membranes, this strategy provides 
stimuli-responsiveness to the polymersome membranes without affecting the membrane 
integrity, as is the case of stimuli-responsive synthetic membranes of compartments236, nor the 
size and architecture of the polymersomes. Therefore, encapsulated HRP can fulfil its activity 
when the protein gate allows the specific molecular diffusion of substrates/products through 
the membrane and is simultaneously protected from proteolytic attack. A combination of 
spectroscopic methods (fluorescence correlation spectroscopy, electron paramagnetic 
resonance), LC-MS-MS analysis, light scattering (static and dynamic LS), transmission 
electron microscopy (TEM and cryoTEM) and enzymatic assays served to characterise the 
system in solution, and evaluate its triggered functionality. Crucial steps were to evaluate AOs 
toxicity and functionality in human epithelial HeLa cells, and then in vivo tolerability, 
BIOMIMETIC ENGINEERING OF RESPONSIVE ARTIFICIAL ORGANELLES WITH 
IN VITRO AND IN VIVO FUNCTIONALLITY 
 80 
preservation of the AOs architecture, and in situ regulation of the encapsulated enzymes 
activity in a vertebrate model (Scheme 4).  
Developments in the design of AOs with triggered activity result in complex reaction spaces 
at the nanoscale with functionalities modulated in an analogous manner to that of cell 
membranes, and represent a necessary step towards the creation of artificial cells. In addition, 
the strategy of engineering AOs acting as cellular implants in living organisms will provide 
solutions for personalized medicine by a straightforward change of the encapsulated 
biomolecules to cope with the specificity of the pathologic conditions. 
 
 
 
Scheme 4. In vivo functionality of AO. Functionality of AO was tested by injection into 
zebrafish embryos. After being recognised by the early immune system of zebfarish embryos, 
the biomimetic systems remains highly active. 
 
4.2 ENGINEERING THE OMPF CYSTEINE MUTANT PORE 
 
The key factor in engineering AOs - with activity triggered by changes in environmental 
conditions – is the “on-demand” permeability of the compartment towards enzymatic 
substrates/products. In addition, the structural integrity of the polymersome architecture, which 
mimics the architecture of the organelle, is required for enzyme protection, and generation of 
a confined reaction space. In a biomimetic approach PMOXA6-PDMS44-PMOXA6 
polymersome membranes were equipped with protein “gates” responsive to changes in GSH 
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concentrations present in intracellular environments, while preserving the architecture of the 
nanocompartment (Scheme 5A, B). 
To construct the responsive “protein gate”, a cysteine double mutant of OmpF (OmpF-M)234 
was chosen, because cysteine residues, replacing the amino acids K89 and R270, are expected 
to form reduction-sensitive disulphide bonds with molecules selected to serve as “molecular 
caps”. As demonstrated in the previous chapter molecular caps block the OmpF pore under 
specific conditions, and unblock them when changes in the environment occur.  
The ability of cysteine residues of OmpF-M to form disulphide bonds with thiol groups of 
small molecular weight molecules was examined using a suitable spin probe (bis-(2,2,5,5-
Tetramethyl- 3-imidazoline-1-oxyl-4-yl)disulfide)237 and the fluorescent dye SAMSA 
fluorescein (SAMSA-CF) (Scheme 5C, B)238.  
 
   
Scheme 5. Engineering of stimuli stimuli-responsive OmpF A. Schematic representation of 
modified OmpF acting as a gate in catalytic nanocompartments. B. Molecular representation 
of the OmpF-M cysteine mutant234. C. Chemical modification of OmpF-M cysteine mutant 
with the spin probe bis-(2,2,5,5-Tetramethyl- 3-imidazoline-1-oxyl-4-yl)disulfide, D. 
Chemical modification of OmpF-M cysteine mutant with the fluorophore SAMSA-CF .  
 
Coupling reaction of the molecular caps with the cysteine residues of OmpF-M resulted in the 
formation of OmpF conjugates (OmpF-S-S-CF for OmpF conjugated with SAMSA-CF and 
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OmpF-S-S-NO. for OmpF conjugated with bis-(2,2,5,5-Tetramethyl- 3-imidazoline-1-oxyl-4-
yl)disulphide) respectively. Unreacted reagents were removed by centrifugal filtration and 
dialysis. Modified OmpF-M conjugates were purified by extensive centrifugal filtration and 
dialysis to remove all unbound reagents. 
Binding of the thiol-reactive spin probe was evaluated by LC-MS-MS, and electron 
paramagnetic resonance (EPR). Upon in-gel digestion of the porin239, LC-MS-MS analysis of 
the peptide fragments indicated a 96 ± 4% labelling efficiency of the spin probe to cysteine 
residues of the OmpF-M. EPR spectrum of the bis-(2,2,5,5-Tetramethyl- 3-imidazoline-1-oxyl-
4-yl)disulphide in PBS at 298K consists of an isotropic triplet pattern (Figure S20, SI), with a 
hyperfine coupling aN value of 15.8 G, similar to reported values for analogous nitroxide probes 
with no aggregation present (15.8 G for 5 DSA in 0.1 M NaOH and 15.9 G for 16 DSA in 0.1 
M NaOH 240,241. A very weak second component is present as well, because of spin-spin 
interaction  resulting in an additional broadening of the third line237. In case of OmpF-S-S-NO., 
a broad anisotropic EPR spectrum with no additional isotropic component was obtained. This 
is similar to that reported for 5-DSA in lipid bilayers or cholesterol aqueous solutions, with 
typical g and A values (g(x) = 2.009, g(y) = 2.0065, g(z) = 2.0039, and A(x) = 6.0 G, A (y) = 
6.0 G, A(z) = 34 G)242. This spectrum results from a hindered rotation of the nitroxide probe243 
upon binding to the OmpF mutant (OmpF-S-S-NO.), and indicates the successful binding of 
the bis-(2,2,5,5-Tetramethyl- 3-imidazoline-1-oxyl-4-yl)disulphide to modified OmpF mutant 
at the cysteine level (Figure 37a).   
When OmpF-S-S-NO. was exposed to 10 mM DTT (Figure 37b) an isotropic EPR spectrum 
with aN value of 15.7 G – characteristic for the spin probe free rotation in PBS pH 7.4 –  was 
obtained, demonstrating that the reaction is reversible. This is a clear indication that the 
nitroxide spin probe bound to thiol groups of the OmpF under oxidative conditions is cleaved 
from OmpF in a reductive environment. 
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Figure 37. Characterisation of stimuli-responsive OmpF Panel a.) EPR spectra of bis-
(2,2,5,5-Tetramethyl- 3-imidazoline-1-oxyl-4-yl)disulfide labelled OmpF-M experimental 
(black) and simulated (blue). Panel b.) 3-imidazoline-1-oxyl-4-yl)disulfide labelled OmpF-M 
in 1% OG incubated with 10 mM DTT  experimental (black) and simulated (blue). Panel c.) 
Normalized FCS autocorrelation curves for SAMSA-CF in PBS (black), SAMSA-CF in 1% 
OG (blue) and OmpF-S-S-CF in 1% OG (Red). Dotted line – experimental autocorrelation 
curves, full line – fit. Panel d.) SAMSA-CF release kinetics from OmpF-M in 30 mM GSH, 
1% OG, as measured by FCS and analyzed with a two-component fit. 
 
SAMSA-CF was selected as a molecular cap to block the pore, due to its molecular weight 
(521.49 Da) expected to block the OmpF-M pore, and ability to form cleavable disulphide 
bonds244. Attachment of SAMSA-CF to OmpF-M introduces a stimuli-responsiveness to the 
pore, and therefore to the polymersome membrane when OmpF-S-S-CF is inserted. In addition, 
the fluorescent properties of SAMSA-CF served to analyze pore modification by a combination 
of SDS-PAGE and fluorescence correlation spectroscopy (FCS). 
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LC-MS-MS analysis of the peptide fragments indicated a labelling degree of OmpF-M of 81 ± 
31%. Furthermore, a fluorescent band appeared in the SDS-PAGE gel when SAMSA-CF was 
conjugate to OmpF-M compared to the OmpF wild type, which did not interact with the 
fluorophore.  This fluorescent band in SDS-PAGE supports the formation of OmpF-S-S-CF 
(Figure S2, SI). To mimic the intracellular reductive environment, where the glutathione 
concentration is kept at a constantly high level (10mM GSH) by cytosolic enzymes245, such as 
glutathione reductase, the behaviour of the reduction responsive molecular caps in a similar 
environment was studied.  Due to lack of a steady state concentration, and constant 
regeneration of GSH, an excess concentration of 30mM GSH was used to mimic the 
intracellular steady state of glutathione. In SDS-PAGE the fluorescent band disappeared when 
the OmpF-S-S-CF was mixed with 30mM GSH, indicating a successful cleavage of the 
molecular cap in reductive conditions. (Figure 37c, 37d, Figure S21, SI).  
The binding of SAMSA-CF to OmpF-M cysteine residues was also evaluated by FCS. 
Molecular brightness and diffusion times of SAMSA-CF in PBS (pH 7.4), SAMSA-CF in 1% 
OG PBS (pH 7.4) and SAMSA-CF bound to OmpF (OmpF-S-S-CF) in 1% OG PBS (pH 7.4) 
were compared (Figure 37c). A labelling efficiency of an average of two SAMSA-CF 
molecules per monomer was calculated by comparing the molecular brightness (counts per 
molecule, CPM in kHz) of SAMSA-CF (2.2 ± 0.7 kHz) with that of protein bound to SAMSA-
CF (4.8 ± 0.6 kHz) (Figure 37c). On contrary, wild type OmpF treated similarly as the cysteine 
mutant OmpF-M did not present any fluorescence after purification, therefore there was no 
binding of SAMSA-CF to OmpF-WT. To determine the kinetics of OmpF pore opening, the 
cleavage of SAMSA-CF from labelled OmpF-M upon addition of 30mM GSH at pH 7.4 was 
evaluated by FCS and an analysis by a two component fit. Due to cleavage of the disulphide 
bonds between the dye and the OmpF-M, the percentage of the free dye increased over time to 
85 ± 9 %, plateauing after one hour (Figure 1D, Figure S22, SI).  
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4.3 SELF-ASSEMBLY OF REDUCTION TRIGGERED 
CATALYTIC NANOCOMPARTMENTS 
 
In order to obtain stimuli-responsive catalytic polymersomes simultaneously encapsulated 
HRP in the inner cavity, and had inserted OmpF-S-S-CF or OmpF-S-S-NO. into the membrane. 
PMOXA6-PDMS44-PMOXA6 copolymers formed vesicles (as shown below) and 
spontaneously self-assembled in the presence of HRP or of both biomolecules (HRP and 
OmpF-S-S-CF or OmpF-S-S-NO.). Spherical vesicles between 100 – 200 nm were identified 
by cryo-TEM for polymer assemblies formed in the presence of HRP, polymer assemblies 
formed in the presence of HRP and OmpF-S-S-CF, and polymer assemblies formed in the 
presence of HRP and OmpF-SH (Figure 38A, Figure S23). These spherical polymer assemblies 
were demonstrated by light scattering to be polymersomes with: RH of 99 ± 2 nm for HRP-
loaded polymersomes containing OmpF-S-S-CF, RH of 89 ± 4 nm for polymersomes loaded 
with HRP and equipped with OmpF-SH and RH 101 ± 1 nm for HRP loaded polymersomes 
(Table S4, Table S5, SI). In the presence of 30 mM glutathione the polymersome architecture 
was not affected, with structural parameters ρ (ρ=RG/RH) values of 0.90 - 0.96 (all close to 1) 
confirming a hollow sphere morphology93. (Table S4, Table S5 SI). After 2 weeks of storage 
at 4ºC in dark, HRP-loaded polymersomes, HRP-loaded polymersomes equipped with OmpF-
SH and HRP-loaded polymersomes equipped with OmpF-S-S-CF preserved their size and did 
not aggregate (Figure S24, Figure, S25, Figure S26, SI). 
The insertion of channel proteins into enzyme-loaded PMOXA6–PDMS44–PMOXA6. 
polymersomes is critical for the in situ functionality of the encapsulated enzyme because the 
channels allow substrates and products of the enzymatic reaction to pass through the 
membrane. OmpF-S-S-CF and OmpF-S-S-NO. insertion into the polymersome membrane 
using was evaluated by FCS and EPR. A diffusion time of τd = 2573 ± 960 µs, was obtained 
for polymersomes with reconstituted OmpF-S-S-CF, indicating that the modified protein gates 
were successfully inserted into the polymer membranes. Four OmpF-S-S-CF porins / vesicle 
were calculated by comparing the molecular brightness of free fluorophore (2.2 ± 0.7 kHz) and 
the OmpF-S-S-CF equipped polymersomes (18.9 ± 11.1 kHz) OmpF-S-S-CF porins / vesicle), 
similar to values reported previously for the wild type OmpF12  (Figure 38b).   
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HRP-loaded polymersomes equipped with OmpF-S-S-NO. have an EPR spectrum with a broad 
single peak (g value 2.0065 and linewidth of 10G) (Figure 38c). As no additional peaks 
characteristic for the parallel and perpendicular component of the spin labelled OmpF EPR 
spectrum were present, the nitroxide polar group has a low mobility due resulting from its 
insertion in the dense polymer membrane. A similar behaviour was reported for 5-DSA and 
16-DSA when inserted in the membrane of polymersomes246. When polymersomes equipped 
with the spin labelled OmpF-S-S-NO. were exposed to reductive conditions (10 mM DTT), an 
isotropic characteristic EPR spectrum (aN = 15.9 G) superposed on the broad peak was 
obtained. The isotropic spectrum indicates a successful cleavage of the nitroxide spin probe 
from the OmpF, whilst the broad EPR component resulted from a fraction of spin label cleaved 
and located in the polymersome membrane, with the nitroxide polar group pointing towards 
the environment (Figure 38c). 
 
 
4.4 FUNCTIONAL CHARACTERSIATION OF REDUCTION 
TRIGGERED BIOMIMETIC CATALYTIC 
NANOCOMPARTMENTS 
 
The functionality of the HRP-loaded polymersomes equipped with OmpF-S-S-CF in response 
to external stimuli was assessed before and after the addition of 30 mM GSH, by following the 
fluorescent signal associated with conversion of Amplex Ultra Red to theResorufin-like 
product (RLP) during the in situ enzymatic reaction of HRP247. Enzymatic turnover of the AR 
substrate was reduced for HRP-loaded polymersomes equipped with OmpF-S-S-CF - 36±4% 
relative activity compared to HRP-loaded polymersomes equipped with OmpF-SH. The very 
low activity of HRP-loaded polymersomes without OmpF was taken into account for a 
background correction. The reduced activity of HRP-loaded polymersomes equipped with 
OmpF-S-S-CF suggests that this molecular cap is sufficient to reduce the passage of small 
molecules through the pore. The addition of 30 mM GSH to the system increased the activity 
of HRP-loaded polymersomes equipped with OmpF-S-S-CF equal to that of HRP-loaded 
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polymersomes equipped with OmpF-SH. Therefore, in the presence of GSH the reduction of 
the disulphide bridge between the attached SAMSA-CF cap and cysteine residues of the 
OmpF-M successfully restored the OmpF-M pore permeability to the substrate of the enzyme 
by releasing the cap from the pore. (Figure 38D, Figure S27, SI).  
 
 
 
 
  
Figure 38. Characterisation of stimuli-responsive catalytic nanocompartments Panel a.) 
Cryo-TEM micrographs of: (1) Polymersomes loaded with HRP and equipped with OmpF-S-
S-CF, (2) polymersomes loaded with HRP and equipped with OmpF-SH, and (3) 
polymersomes loaded with HRP without OmpF. Scale bar = 100 nm. Panel b.)  Normalised 
FCS autocorrelation curves of SAMSA-CF in PBS (Black), and OmpF-S-S-CF in the 
membrane of polymersomes (Blue). Dotted line = experimental auto correlation curves, solid 
line = fitted curve. Curves normalized to 1 to facilitate comparison. Panel c.), left panel: EPR 
spectrum of bis-(2,2,5,5-Tetramethyl- 3-imidazoline-1-oxyl-4-yl)disulfide labelled OmpF 
reconstituted in PMOXA6–PDMS44–PMOXA6 polymersomes (black line). Panel C, right panel:  
3-imidazoline-1-oxyl-4-yl)disulfide labelled OmpF reconstituted in PMOXA6–PDMS44–
PMOXA6 polymersomes and incubated with 10mM DTT  experimental (black line) and 
simulated (blue line). Panel d.)  Enzymatic activity of HRP-loaded polymersomes: OmpF-S-
S-CF equipped polymersomes (green, left panel), OmpF-SH equipped polymersomes (blue, 
left panel), OmpF-S-S-CF equipped HRP-loaded polymersomes (green, right panel), OmpF-
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SH equipped HRP-loaded polymersomes (blue, right panel). Left panel: Directly after addition 
of 30mM GSH, Right panel: 1 hour after addition of 30 mM GSH.   
 
4.5 STIMULI-RESPONSIVE ARTIFICIAL ORGANELLES 
 
Previously designed catalytically active PMOXA12–PDMS56–PMOXA12 polymersomes as 
artificial peroxisomes by our group successfully overcame the first barrier of cell membranes 
and escaped from endosomes5. Here one step further is achieved by developing a triggered AO 
system, whose functionality is modulated by the responsive OmpF porins. Several PMOXA-
b-PDMS-b-PMOXA based polymersomes have already shown high cytocompatibility in 
various cell lines 5,7.  In order to study the intracellular activation and enzymatic activity of 
AOs, the cytocompatibility was evaluated, by testing their cellular toxicity using the 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) 
assay. Notably, the AO did not show any decrease in cell viability in HeLa cells even after 48h 
(i.e. polymer concentration ranging from 0.25-0.75 mg ml-1), confirming biocompatibility of 
these AOs at the cellular level (Figure S29, SI).  
In order to study cellular internalisation and intracellular localization of polymersomes, 
polymersomes equipped with OmpF-S-S-CF, and polymersomes equipped with OmpF-SH, 
HRP conjugated with Atto-488 (HRP-Atto488) was encapsulated inside the cavity (Figure S30, 
SI). Cellular uptake assays in HeLa cells indicated successful internalization resulting in a 
particulate intracellular staining pattern with increasing intensity in a time dependent manner 
from 8 up to 24h (Figure 9a, Figure S31, Figure S32). After 24 h AO did not colocalize with 
early endosomes (PCC=0.101 ± 0.028; M1=0.026 ± 0.008, M2=0.003 ± 0.001; Costes=0.047 
± 0.017) or lysosomes (PCC=0.214 ± 0.015; M1=0.029 ± 0.010, M2=0.010 ± 0.005; 
Costes=0.037 ± 0.008), confirming a successful intracellular endosomal escape (Figure S12, 
SI) (Figure S33, SI). Localized HRP-Atto488 signals confirmed the intracellular integrity of 
polymersomes. In sharp contrast, if cells were treated by with a membrane disrupting agent 
(i.e. 0.1 % saponin) (Figure S34, SI), polymersomes were destroyed resulting in an intracellular 
cytoplasmic distribution of HRP-Atto488. 
The capacity of the AOs to act within target cells in a stimuli-responsive manner was 
investigated by a combination of confocal laser scanning microscopy (CLSM) and flow 
cytometry. Thus, it was thus possible to evaluate the potential of AOs to respond to increased 
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intracellular GSH levels. HeLa cells were incubated with HRP-loaded polymersomes without 
OmpF or HRP-loaded polymersomes equipped with either OmpF-S-S-CF or OmpF-SH to 
promote cellular uptake. Extracellular polymersomes were removed by washing before 
imaging the intracellular activity of AO. Cells were incubated with a 1:1 substrate mixture of 
H2O2 and AR to allow the intracellular deposition and finally the conversion of AR into its RLP 
by AO. In contrast to control cells, or those incubated with HRP loaded polymersomes without 
OmpF, a significant increase of intracellular fluorescence was observed with AOs equipped 
with OmpF-S-S-CF or OmpF-SH (Figure 39b, Figure S35). The same trend was observed when 
AR turnover was quantified by flow cytometry (Figure S36). The strong fluorescent signal for 
OmpF-S-S-CF equipped, HRP loaded polymersomes confirmed successful intracellular 
cleavage of the molecular cap. Thus, AOs were successfully activated within the intracellular 
environment of the target cells through reductive opening of the OmpF pores. 
 
Figure 39. Cellular uptake, intracellular activation and in vivo activity of AOs.  
Panel a: Confocal fluorescence micrographs of Hela cells showing cellular uptake of AOs 
loaded with fluorescently labelled HRP. Scale bar: 10µm 
Panel b: Cellular uptake and intracellular activation of enzyme loaded AOs Blue signal: 
Hoechst 33342 nucleus stain. Grey signal: CellMask Deep Red-Plasma membrane stain. Green 
signal: Atto-488 HRP. Red signal: Resorufin like product (RLP). Scale bar 20µm  
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Panel c: In vivo ZFE biodistribution and activity of AOs – lateral view of the ZFE cross-section. 
Blue signal: ZFE melanocytes. Green signal: HRP-Atto488. Red signal: Resazurin like product 
(RZLP). Arrows show regions of enzymatic activity of AOs.  
 
As a step further, the AOs in the present study were evaluated in vivo in the zebrafish embryo 
(ZFE) model to assess their safety and tolerability and to get a first insight into their 
performance in vivo. ZFEs were selected due to their recognition as a complimentary vertebrate 
animal model for applications such as compound screening in drug discovery, toxicological 
studies and recombinant disease models 248 249 250.  Due to their optical transparency, ZFEs open 
the possibility of imaging fluorescently-tagged objects and fluorescent processes in vivo at a 
high resolution over time 251 (Figure S37, SI). In order to follow the biodistribution of AOs, 
HRP-Atto488 loaded polymersomes with membranes without or with either OmpF-S-S-CF or 
OmpF–SH were injected intravenously into ZFE via the duct of Cuvier. No acute toxicity such 
as change in behaviour i.e. mobility, seizures, heart failure or other toxic effects such as 
malformations, denaturation of tissue fluids or yolk mass was observed in ZFE injected with 
AOs after 24h. ZFE analysed two hours post intravenous injection of all types of AOs 
containing Atto-488 conjugated HRP, showed a distinct fluorescent staining pattern (Figure 
S38, SI) in the posterior cardinal vein region of ZFE. The recognition of polymersome based 
AOs by the ZFE immune system was confirmed by the colocalization of AOs loaded with 
Atto647 conjugated HRP (Atto647-HRP) injected into transgenic ZFE specifically expressing 
eGFP in macrophages252. (Figure S30,  S39, SI).  In strong contrast to AOs loaded with 
Atto647-HRP, the free Atto647-HRP enzyme did not show significant macrophage 
colocalisation after 24h, even when Atto647-HRP was injected at concentrations of 0.2 mg ml-
1.  In order to assess in vivo stability, integrity, and functionality of AOs when exposed to the 
conditions in the macrophage microenvironment, a second injection of AOs together with the 
enzyme substrate Amplex Ultra Red (AR) was performed. Injection of the co-substrate H2O2 
in combination with AR was not necessary, since macrophages have the ability of producing 
H2O2. In addition, coinjection of H2O2 resulted in a red colouring of the whole blood volume, 
presumably due to haemolysis and thus interaction of AR with erythrocyte enzymes or 
haemoglobin 253 (Figure S40, SI). In these experiments, distinct colocalization within 
macrophages of the converted AR oxidation product was found only for HRP-Atto488 loaded 
AOs equipped with either OmpF-SH or OmpF-S-S-CF. This showed that the molecular cap of 
OmpF-S-S-CF is cleaved in vivo leading to activation of the catalytic AOs. In sharp contrast, 
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HRP-Atto488 loaded polymersomes without OmpF remained inactive demonstrating that the 
polymersome membrane is robust enough to stay intact in ZFE macrophages (Figure 39C).   
 
4.6 CONCLUSION 
 
The bioinspired strategy of creating AO presented here is based on incorporation of stimuli-
responsive SAMSA-CF modified OmpF in the membranes of PMOXA-b-PDMS-b-PMOXA 
polymersomes. The stimuli-responsive modification of OmpF acts as an efficient strategy to 
include life-like responsiveness in the synthetic polymersome membranes and allows the 
biomolecules (HRP) encapsulated in the polymersome cavity to fulfil their catalytic role only 
when the protein gate is open. By micking the dynamic processes present in membranes of 
cellular organelles, such as the mitochondria, this shows that the developed system can act as 
an artificial organelle (AO) once it reaches the cellular microeinvironment. Using the 
vertebrate zebrafish embryo model in vivo tolerability was proven along with a successful 
preservation of the AOs architecture and in situ regulation of the encapsulated enzymes 
activity.  Developments in the design of AOs with triggered activity, such as the system 
presented here, results in nanoscale reaction spaces with functionality modulated in an 
analogous manner to that of cell membranes, and represent a necessary step towards the 
creation of artificial cells.  
  92 
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Chapter 5. 
 
5. CONCLUSIONS AND OUTLOOK 
5.1 CONCLUSION  
 
Bioinspired approaches of modifying properties of synthetic materials by their combination 
with biomolecules, such as the combination of polymeric supramolecular nanoarchitectures 
with proteins, DNA or polysaccharides, serve to design new hybrid materials that mimic 
structures and processes found in living organisms. Compared to entirely synthetic materials, 
biomimics possess new properties, like an enhanced catalytic activity or selective 
responsiveness to changes in their environment, while retaining the robustness of their 
synthetic backbone. 
 
This thesis focused on biomimetic engineering of colloidal polymer supramolecular 
nanoarchitectures, namely soft nanoparticles and polymersomes. In this regard different 
approaches of biomimetic engineering have been applied in order to demonstrate controlled 
enzyme localisation of proteins on PEG-PMCL-PDMAEMA soft nanoparticles for the design 
of a smart protein delivery agent, controlled transport of enzymatic substrates through the 
membranes of enzyme loaded PMOXA-b-PDMS-b-PMOXA polymersomes for the design of 
triggered catalytic compartment and finally in vitro and in vivo validation of controlled 
transport of enzymatic substrates through the membrane of enzyme loaded PMOXA-b-PDMS-
b-PMOXA polymersomes equipped with a chemically and genetically modified OmpF. 
 
In the following paragraphs the most important results of chapters 2, 3 and 4, along with the 
conceptual contribution of the individual chapters to nanosciences and the further development 
of biomimetic engineering of nanoarchitectures are concluded. 
 
Chapter 2 demonstrates how nanoparticles self-assembled from asymmetric PEG-b-PMCL-b-
PDMAEMA copolymers can be biomimetically engineered by controlled attachment of 
proteins on their polymeric corona. By applying characterization methods, the biomimetically 
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engineered nanoparticles are shown to possess a well-defined morphology, specific protein 
localization and a pH responsive protein release behavior. We demonstrate that the ability of 
nanoparticles to attach and release proteins is a direct result of electrostatic interactions 
between the positively charged PDMAEMA domain and negatively charged protein 
biomolecules. The process of protein attachment and release through electrostatic interactions 
does not appear to interact with functional properties of the immobilized protein biomolecules. 
Once self-assembled in solution, the hybrid system shows low toxicity at therapeutic 
concentrations and can be taken up by human epithelial HeLa cells. These findings implicate, 
that the nature of PEG-b-PMCL-b-PDMAEMA nanoparticles opens a new possibility of 
responsive biomimetic modification through electrostatic interactions. In the future, the 
approach of modifying PEG-b-PMCL-b-PDMAEMA nanoparticles with negatively charged 
proteins presented in this study could be extended to other therapeutic proteins, such as insulin, 
DNA/RNA/mRNA or negatively charged polysaccharides.  
In chapter 3, the concept of biomimetically engineering colloidal polymer 
nanoarchitectures was extended to PMOXA-b-PDMS-b-PMOXA polymersomes. In contrast 
to the electrostatic attachment of enzyme biomolecules on the corona of polymer nanoparticles 
described in Chapter 2, here a model enzyme horseradish peroxidase is encapsulated in the 
inner aqueous cavities of polymersome nanocompartments. Permeability of the polymersome 
membrane and thereby access of small molecular weight molecules to the the encapsulated 
enzyme is achieved by the functional reconstitution of OmpF in polymersome membranes. In 
order to develop a pH responsive catalytic nanocompartment, we investigated how a chemical 
modification, done on key amino acids located at the constriction site of OmpF, blocks the 
OmpF pore and introduces a selective pH triggered permeability. Once reconstituted in 
biomimetically engineered catalytic nanocompartments, this pH responsive behavior of OmpF 
affects the enzymatic activity of the encapsulated enzyme. This chapter demonstrates, how a 
combination of synthetic polymersomes, a catalyst and a modified membrane protein can be 
used to design biomimics that can provide desired catalytic activity that can act on demand.  
Chapter 4 builds on the knowledge of engineering biomimetic colloidal 
nanoarchitectures acquired in Chapters 2 and 3, with the purpose of designing a functional 
artificial organelle.  Since artificial organelles need to mimic the natural compartmentalization 
found in cells, we decided to build a polymersome based biomimetic system by advancing the 
one designed in Chapter 3. In order to allow the catalytic polymersome nanocompartments to 
interact with cytoplasmic signaling molecules, we equipped polymersome membranes with a 
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genetically and chemically modified OmpF. Two cysteine residues, replacing amino acids K89 
and R270, were introduced at the rim of the OmpF pore opening the possibility to limit the 
pore permeability by binding molecular caps through disulfide bonds. Functional reconstitution 
of the modified OmpF pore allowed us to build a catalytic nanocompartment with a 
functionality that can be modulated by the intracellular glutathione and redox potential. Once 
the system was fully characterized in terms of structure and function, we showed that our 
biomimetically designed AO can reach and function inside cells. Furthermore, we 
demonstrated their applicability and function in vivo in zebrafish embryos. This proof of 
concept demonstrates that life-like nanostructures with in vivo and in cellulo functionality can 
be designed by taking a biomimetic path in designing novel nanoscale architectures. These 
findings represent a new powerful approach for enzyme therapy, and the  design of artificial 
cells. 
 
5.2 OUTLOOK 
 
The bioinspired strategies applied to develop biomimeitc nanoarchitectures presented in this 
thesis have important implications for future development of nano-scale biomimetical 
engineering. First – the developed biomimics serve as proof of concepts, they demonstrate that 
biomimetically engineered nanoarchitectures have a tremendous translational value in fields 
such as medicine and technology. Novel systems could in the future be fine tuned to develop 
patient tailored therapeutic and diagnostic agents or to serve as the first artificial cell implants. 
Second – by studying the interactions between synthetic systems and biomacromolecules we 
deepend our understanding of the fundamental principles of self-assembly. This is important 
as it not only allows us to better understand evolution of non-living systems to living, but also 
to make use of this knowledge in the design of future custom made biomimics that could serve 
very specific applications. Finally – the work highlights the importance of a multidisciplinary 
approach and teamwork.  As demonstrated by the diverse backgrounds of scientists, that have 
helped to design the biomimetic nanoarchitectures presented in this thesis, upcoming 
biomimetically engineered nanoarchitectures will without doubt require the combined 
knowledge of fields such as syntetic chemistry, biology, pharmaceutical sciences, biophysics, 
nanotechnology and many others.  
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5.3 AUTHORS COMMENT 
 
Despite the tremendous technological, biomedical, and environmental applications of 
nanoscale biomimetical engineering, the real importance of working in natural sciences is the 
realization that, in our day and age, science is just incredibly addictive. I suppose that 
discovering new things has always been fulfilling, even centuries ago, hence the human 
progress. New discoveries spark a craving for more and more knowledge. However, what 
makes our time so special is that we are able to rationally understand how little we actually 
know about the world that surrounds us, which opens unlimited possibilities for new 
discoveries and innovation. Nowadays, scientific knowledge progresses with astonishing speed 
and discoveries on the nanoscale level are just beginning to scratch the surface of how the 
world that surrounds us functions. Not only does that help us understand what is happening 
around us, it also enables us to design new materials by modifying what nature already created. 
Richard Feynman’s quote “There is plenty of room at the bottom” has never been more relevant 
as it is today. Moreover, the space is there for us to be filled with new materials and molecular 
systems. In the end, I guess this is what makes me so happy about being a scientist. 
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Chapter 6.  
MATERIALS AND METHODS 
 
6.1 MATERIALS 
 
All chemicals and solvents were purchased from Sigma-Aldrich or Fluka (Sigma Chemical 
Co., US) and used as received, unless otherwise stated.  
 
6.2 METHODS: CHAPTER 2 
 
SYNTHESIS OF PEG-b-PMCL-b-PDMAEMA TRIBLOCK COPOLYMERS 
 
PEG-b-PMCL-PDMAEMA triblock copolymers were synthesized according to the procedure 
described by Matter et al. 194, by using poly (ethyleneglycol) monomethylether (mPEG) with a 
molar mass of 2000 Da (Aldrich), copper (I) chloride (Reagent plus > 99 %, Sigma Aldrich), 
N, N, Nʹ, Nʺ, Nʺ-pentamethyldiethylenetriamine (PMDETA) (> 99%, Aldrich), THF (Fluka), 
methanol, 2-bromoisobutyrylbromide (BIBB > 98%, Sigma Aldrich), triethylamine (> 99.5%, 
Fluka) and dichloromethane (Baker, HPLC grade).  
 
SELF-ASSEMBLY OF PEG-B-PMCL-B-PDMAEMA TRIBLOCK COPOLYMERS 
 
Supramolecular assemblies of PEG-b-PMCL-b-PDMAEMA triblock copolymers were 
prepared by the co-solvent method194. Block copolymer was dissolved in ethanol, and then a 
phosphate buffer saline solution (PBS) was added drop-wise to produce a copolymer 
concentration of 5 mg mL-1. The average size of the self-assembled nanoparticles was reduced 
by repeated extrusions (9 times) through filters (0.4 μm pore diameter) using a mini extruder 
from Avanti-Polar Lipidics Inc. Biomolecule-copolymer assemblies were prepared in a similar 
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manner. The block copolymer was dissolved in ethanol, and then a solution of the biomolecule 
(BSA or ASM) in PBS at physiological pH was added drop-wise to the copolymer solution to 
reach a copolymer concentration of 5 mg mL-1, and a biomolecule concentration of 0.058 mg 
mL-1. The final mixture was stirred overnight at room temperature and then dialyzed for 48 h 
in buffer, changing the buffer (pH = 7.2) 6 times in order to remove protein excess. 
 
LIGHT SCATTERING 
 
Dynamic light scattering (DLS) and static light scattering (SLS) were measured using an ALV 
laser goniometer with a linearly-polarized He-Ne laser operating at a wavelength of 632.8 nm 
(JDS Uniphase). Copolymer solutions were maintained at a constant temperature of 20 ± 0.1 
°C. Measurements were carried out by varying the scattering angle (θ) from 30 to 150° in 10° 
steps. The viscosity of the solutions was assumed equal to that of pure water at 20 °C (η = 1.0 
cP). The time correlation function G(t) was determined with an ALV/LSE-5004 correlator. 
Diffusion coefficients at zero deviation (D0) were evaluated from G(t) using both nonlinear 
decay-time analysis and the Laplace inversion method (CONTIN).  
TEM 
 
TEM micrographs were obtained with a Phillips EM400 electron microscope operating at 100 
kV. Nanoparticles were negatively stained by adding 5 µL of 2 % uranyl acetate solution and 
deposited on a carbon-coated copper grid. Excess uranyl acetate was removed under vacuum. 
CRYOGENIC-TEM 
 
Nanoparticle suspensions in buffer (10 mM PBS, pH 7.2, 50 mM NaCl) (1 mg mL-1) were 
deposited on glow-discharged carbon grids (Quantifoil, Germany) and blotted before quick-
freezing in liquid ethane using a Vitribot plunge-freezing device (FEI Co.). The grids were 
stored in liquid nitrogen before transferring them into a cryo-holder (Gatan). Imaging was 
performed on a Philips CM200 FEG TEM at 200 kV accelerating voltage in low-dose mode 
with a defocus value of about −4 µm  
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FLUORESCENCE CORRELATION SPECTROSCOPY 
 
FCS was performed with a Zeiss LSM 510-META/Confcor2 laser-scanning microscope 
equipped with an Ar laser (488 nm) and a 40× water-immersion objective (Zeiss C/Apochromat 
40X, NA 1.2), with the pinhole adjusted to 70 µm. Solutions of copolymers (5 mg/ml) with 
entrapped protein (BSA-FITC, λexcitation 495 nm) or enzyme (o-ASM, λexcitation 496 nm) were 
measured at room temperature in special chambered quartz-glass holders (Lab-Tek; 8-well, 
NUNC A/S), which provide optimal conditions for measurement while reducing evaporation 
of the solutions. Intensity fluctuations were analyzed using an autocorrelation function with 
the LSM 510/Confocor software package (Zeiss, AG). Spectra were recorded over 10 s, and 
each measurement was repeated ten times; results are reported as the average of three 
independent experiments. Adsorption and bleaching effects were reduced by exchanging the 
sample droplet after 2 minutes of measurement. The excitation power of the Ar laser was PL = 
200 mW, and the excitation transmission at 495 nm was 25 %. To reduce the number of fitting 
parameters, the diffusion times for free labeled protein (τD BSA-FITC = 82 µs) and for free 
labeled enzyme (τDo-ASM = 126µs) were independently determined, and fixed in the fitting 
procedure. 
 
Experimental auto correlation curves were fitted using a one-component (EQ1) or two-
component model (EQ2) including triplet state:  
!"1 ∶ % & '() = 1 + (1 + -1 − - /0 11)2(3) 15 11 + &&6 11 + 78 &&6  
 
 
 
 
EQ2: % & '() = 1 + 1 + 9:09 /0 ;;<=>? :@ AB:C ;;DB ::CEF ;;DB + 1 + 9:09 /0 ;;<=>? :@ AF:C ;;DF ::CEF ;;DF  
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τD represents the diffusion time, T the fraction of fluorophores in triplet state with triplet time 
τtrip, N is the number of particles and R the structural parameter. R and τD of free dye were 
determined independently, and subsequently fixed in the fitting procedure.  
 
 
CELL TOXICITY ASSAY 
 
The [3-(4,5-dimethyl-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium 
(MTS) assay (Promega) was used to determine cell viability after treatment of cells with ABC 
nanoparticles. Hela cells were cultured at a density of 2.5x103 cells/well in a 96-well plate. 
After 24 hours, the medium was removed and 100 µl aliquots containing the corresponding 
concentration of samples [0.5; 5 and 50 μg/ml] were added to the cell medium. Cells incubated 
only in medium served as controls. After 24 hours of incubation 20µl of MTS solution was 
added to each well. The plates were incubated for 2 hours at 37 ºC, and the absorption measured 
at λ = 490 nm. The quantity of formazan product as measured by absorbance at 490 nm is 
directly proportional to the number of living cells in culture. Absorption of cells where no 
nanoparticles were added served as 100 %. 
CLSM ANALYSIS OF SPHINGOMYELINASE LOADED NANOPARTICLES IN 
HELA CELLS 
 
HeLa cells were cultured at a density of 5x104 cells per well in an 8-well Lab-Tek (NalgeNunc 
International, USA) for 24 h in Dulbelcco’s Modified Eagle’s Medium (DMEM) containing 
10% fetal calf serum (FCS) growth medium to allow attachment to the surface. After 
attachment, the medium was removed and nanoparticles containing fluorescent labeled 
Sphingomyelinase (o-ASM) at a final polymer concentration of 0.05 mg/ml were incubated for 
an additional 24 h in DMEM growth medium. The pre-treated HeLa cells containing the o-
ASM-nanoparticles were further incubated at 37 °C for 10 min with freshly prepared Deep Red 
(Cellmask) plasma membrane stain (5 mg ml-1), and Hoechst 3342 (5 mg ml-1) DNA stain. 
Cells washed three times with PBS were visualized with a CLSM (Carl Zeiss LSM510, 
Germany) equipped with a 63x water emulsion objective (Olympus, Japan). The measurements 
were performed in multitrack mode and the intensity of each fluorescent dye was adjusted 
individually: Hoechst 3342 was excited at 405 nm in channel 1, Deep Red at 633 nm in channel 
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2 and Alexa-488 at 488 nm in channel 3. The micrographs were recorded using Carl Zeiss LSM 
software (version 4.2 SP1). 
FLOW CYTOMETRY ANALYSIS OF THE UPTAKE OF LABELED-
SPHINGOMYELINASE LOADED NANOPARTICLES 
 
8x104 HeLa cells were cultured in a well of a 24-well plate and cultured in DMEM containing 
10% FCS for 24 h at 37 °C in a humidified CO2 incubator. Then the medium was exchanged 
and polymer solution with entrapped biomolecule was added and incubated for another 24 h. 
Cells were washed with PBS, trypsinized, centrifuged, washed, centrifuged, suspended in PBS 
and put on ice. Flow cytometry was measured with a BD FACSCanto II flow cytometer (BD 
Bioscience, USA) using FSC and SSC detectors as well as a fluorescence channel o-ASM. A 
total of 10,000 events for each sample were analyzed, and data processed using Flow Jo VX 
software (TreeStar, Ashland, OR).  
SPHINGOMYELINASE ENZYME ACTIVITY ASSAY 
 
ASM release kinetics from PEG-b-PMCL-b-PDMAEMA nanoparticles incubated at 
physiological pH and acidic pH 5.5 (corresponding to lysosomal pH) were studied at room 
temperature. Nanoparticles containing no enzyme were served as a control for the background 
signal of the enzymatic assay. The enzyme kinetics of ASM was followed immediately after 
mixing the sample with the Sphingomyelinase Assay Kit (Abcam®) in Microtiter® 96-Well 
FluorescenceMicroplates (Thermo Scientific) as described by the manufacturer. 20µl of ABC 
ASM-nanoparticle solution incubated at pH 5.5 or 7.4 was tansferred to 200µl of the reaction 
mixture provided by the manufacturer. ASMase hydrolysed sphingomyelin to yield ceramide 
and phosphorylcholine, followed by hydrolysis of phosphorylcholine by alkaline phosphatase 
to form choline. In the next step choline is oxidized by choline oxidase to yield betaine and 
oxygen peroxide. In the final step horseradish peroxidase reacts H2O2 with 10-acetyl-3,7-
dihydroxyphenoxazine (ADHP) in a 1:1 stoichiometry to generate the highly fluorescent 
product resorufin. The fluorescence intensity of resorurfin (λex =530 nm, λem =580 nm), as the 
final reaction product was recorded using the Spectramax M5e microplate reader (Molecular 
Devices) 
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TITRATION OF NANOPARTICLES 
 
Nanoparticles for titration were prepared by the same method used for self-assembly at pH 7.2. 
A Zetasizer NANO with a multi-purpose titrator MPT-2 from Malvern was used, and NaOH 
(0.5 M), HCl (0.5 M) and HCl (0.05 M) solutions were used to adjust the pH between 3 and 
10. 
DETERMINATION OF ENTRAPMENT EFFICIENCY (E.E) INSIDE 
NANOPARTICLES 
 
In order to determine the entrapment efficiency by FCS, it is necessary first to calculate the 
average number of molecules in the confocal volume, which is obtained from the amplitude of 
the FCS curve. The lower the number of molecules in the confocal volume, the higher is the 
correlation amplitude. Therefore, the number of molecules contributing to a certain detected 
signal can be extracted by fitting a diffusion model to the FCS curve. Having obtained the 
correct number of molecules (N), the molecular brightness (mB) can be calculated as:  
GH = IJKL)	2N)/5	O	/OI()N)(JL	3JP/2					 
 
Using the count rate per molecule of a two component model, we determine the population of 
free dye or protein and the population of dye or protein containing in nanoparticles (NP): 5 GJQ/I/5S = 			T(5S)×V×5N	 
Where V(NP) = 4/3πRH3, C is the concentration (mol/L) and Na is Avogadro’s number. 
N(molec/NP) represents the maximum number of molecules that can be entrapped in a 
nanoparticle. 
In order to determine E.E, it is necessary to calculate the count rate per molecule of NP 
(CPMNP): VSWXYZ = 	'[\XVSW[\X + 	'@]VSW@] 
Entrapment efficiency is determined according to: 
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! = 5 GJQ/I/5S /O35 GJQ/I/5S O	100	 
Here, the term N (molec/NP)exp = CPMNP/CPMdye represents the number of molecules 
calculated by using the count rate per molecule of dye divided by the count rate per molecule 
of NP by FCS.  
 
SPHINGOMYELINASE LABELING 
 
A 2 mg mL-1 solution of Sphingomyelinase from Bacilus cerus (Sigma Aldrich) was prepared 
with 0.1M Na2CO3 buffer. 4µL of 15mM Oregon Green 488 succinimidyl ester (Life 
TechnologiesTm) in DMSO solution was added to 175µL of the enzyme solution and mixed for 
1h at room temperature. The free dye was removed by size exclusion chromatography (SEC) 
on a Sephadex G25 (300 mm) desalting column, equilibrated with PBS.  
 
6.3 METHODS: CHAPTER 3 
 
OMPF EXPRESSION, EXTRACTION 
 
The outer membrane protein F (OmpF) was expressed in BL21 (DE3) Omp8 Escherichia coli 
cells following a protocol described previously Ref103 with the following modifications: During 
the purification OmpF was solubilized in a 3% Octyl-glucopiranoside solution (OG, Anatrace) 
to remove residual lipids, as described below in detail. The extracted fraction was analyzed by 
12% SDS-PAGE (CBB stained) to confirm the protein purity, and the protein concentration 
was determined using a BCA kit (Pierce Chemical Co, Rock- ford, USA). OmpF was stored at 
4ºC in 3% OG at a concentration of 1.2mg/ml for several weeks.  
 
Under aseptic conditions, a loopful of cells from an Ampicillin resistant E. Coli strain BL21 
stock culture that overexpressed OmpF-WT was smeared onto the surface of LB, ampicillin 
agar plate. After overnight incubation at 37 °C, a single colony was transferred from the plate 
to 10 mL of TB liquid medium with 100 mg mL-1ampicillin (total 3 flasks). 3 Liters of TB 
medium with 100 mg mL-1 ampicillin was inoculated with 10 mL of the overnight culture. The 
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optical density of the growing culture was followed by measuring the absorbance at 600 nm. 
When the absorbance reached an OD of 0.5, IPTG was added to a final concentration of 1 mM 
into each flask in order to start the expression of the OmpF gene. The bacteria were grown for 
3 more hours at 37 ºC, then the E. Coli cells were pelleted at 7.000 x g for 8 min at 4 ºC.  Pellets 
were stored at -25 ºC, and on the following day were re-suspended in 50 mL of 25 mM Tris-
HCl pH 7.4.  Then 10 mg DNase and 10 mg RNase were added, and the cell suspension French 
pressed three times at 1,000 bar. 1 mL of 20% SDS was added per 10 mL of cell suspension 
and incubated for 1 h at 60 ºC. The suspension was then centrifuged at 50.000 x g at 4 ºC. The 
supernatant was removed and the cell pellet incubated in 0.125% OG for 1 h. The suspension 
was centrifuged at 50.000 x g at 4 ºC. Finally, the cell pellet was re-suspended in 3% OG in 10 
mM phosphate buffer and homogenized. The suspension was centrifuged at 50.000 x g and the 
protein concentration in the supernatant was determined by UV-Vis at 280 nm.  
 
 
OMPF MODIFICATION BY LEVOLUNIC ACID AND CYANINE5-HYDRAZIDE 
 
Levolunic acid was activated by sulfo/NHS and EDC (Sigma Aldrich) at pH 5.5 and then 75µL 
of 9.4mM activated levolunic acid was added to 600µL 1 mg mL-1 OmpF solution. OmpF was 
incubated with activated levolunic acid for 3h at pH 7.2. The OmpF-CA was immediately 
washed 10 times by 3% OG in PBS pH 7.2 in Amicon Ultra-0.5 mL centrifugal filters for 
protein purification and concentration, molecular cutoff: 30kDA (Millipore). The volume was 
adjusted to 475µL PBS pH 7.2 and 75µL of 877µM DMSO solution of Cyanine5-hydrazide 
(Cy5-hydrazide) (Lumiprobe) was added. The mixture was incubated in the dark for 24h at 
RT. The volume was adjusted to 1ml and the reaction mixture washed 25 times in Amicon 
Ultra-0.5 ml centrifugal filters with 3% OG to remove excess dye. The volume was adjusted 
to 500µL and the protein dialysed overnight against 1L of 0.05 % OG using Membra-CelTM 
dialysis membranes. The protein was dialysed for additional 4 hours against PBS pH 7.4 to 
further reduce the OG concentration. The protein concentration was determined by UV-Vis 
spectroscopy and adjusted to 0.5 mg mL-1 with PBS 7.4. 
 
 
 
 
MATERIALS AND METHODS 
 105 
CARBONYLATION ASSAY OF OMPF 
 
A commercially available protein carbonyl content assay kit (Sigma Aldrich) was used to 
determine the carbonyl content of OmpF subsets.  
 
100 µL of DNPH solution provided by the manufacturer (Sigma Aldrich) was mixed with 100 
µL of a subset of OmpF and incubated at room temperature for 10 min. 30 µL of 100% TCA 
solution was added to each sample, vortexed and incubated on ice for 5 min. The samples were 
centrifuged at 13,000 x g for 2 min and the supernatant was carefully removed. 500 µL of ice-
cold acetone mixture was added to each protein pellet and incubated for 5 min on ice. The 
samples were then centrifuged at 13,000 x g for 2 min and the acetone was carefully removed 
together with any free DNPH. 200 µL of 6 M guanidine solution was added to the pellet to re-
solubilize the protein. 100 µL of the sample was transferred to a 96-well plate and the 
absorbance measured at 370 nm with a Spectramax M5e microplate reader (Molecular 
Devices). The protein concentration was determined using a BCA protein assay kit (0.1 mg 
mL-1). The theoretical calculation is based on the starting protein concentration of the assay 
(0.1 mg mL-1), assuming that each monomoer has 2 accessible lysine residues. 
 
CHARACTERISATION OF OMPF  
 
A 20% SDS polyacrylamide gel was cast. OmpF-CA-Cy5 and OmpF-CA were mixed with 
BN-PAGE loading buffer and 15µL of the final OmpF solution was added to the gel. The gels 
were run at 300V for 6 hours.  
The Native-Page image was evaluated by using the image analysis module from OriginPro 9.1 
(OriginLab) to show an expected difference in band migration. The intensity per pixel was 
recorded along the migration lane and normalized. A Gaussian function was fitted to the data 
and their x-axis peak positions compared. R2 was 0.98 for OmpF-CA-Cy5 and 0.91 for OmpF-
CA, and the peak positions were 35.9 ± 0.015 and 37.7 ± 0.031. 
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FLUORESCENCE CORRELATION SPECTROSCOPY 
 
All FCS measurements were carried out using the ConfoCor2 instrument (Carl Zeiss, 
Germany) with a HeNe laser (633nm) using a 40x, 1.2 N.A. water immersion C-Apochromat 
objective lens. The measurements were carried out at room temperature using a sample volume 
of 20µl on a covered eight-well Lab-Tek chambered borosilicate cover glass (Nalage Nunc 
International). Measurements were recorded over 10sec and each measurement was repeated 
30 times. The structural parameter and diffusion time of the free dye (100nM Cy5-hydrazide) 
and measured probes were determined independently. The autocorrelation function was 
calculated using a software correlator and fitted with a one component fit (LSM 510 META-
ConfoCor 2 System). 
 
PREPARATION OF PH TRIGGERED CATALYTIC NANOCOMPARTMENTS  
 
pH-responsive catalytic nanocompartments were prepared at 23 ºC from the ABA triblock 
copolymer, PMOXA6-PDMS44-PMOXA6, A6B44A6 and a subset of modified or native OmpF. 
The synthetic procedure and the polymer characterization are presented in 53. pH-responsive 
catalytic nanocompartments were generated using the film rehydration technique in the 
presence of native or modified OmpF (OmpF-WT-Cy5, OmpF-WT, OmpF-CA-Cy5, OmpF-
CA) in 0.05% OG. Films were rehydrated to a final polymer concentration of 5 mg mL-1, HRP 
concentration of 0.2 mg mL-1, and OmpF concentration of 80 µg mL-1, respectively. 
Unpearmebilised polymersomes were also prepared in the absence of OmpF. Rehydrated films 
were stirred overnight at 23 ºC. All samples were extruded through an Avanti mini-extruder 
(Avanti Polar Lipids, Alabama, USA) using a 100 nm diameter pore-size polycarbonate 
membrane (11 times) in order to obtain size homogeneity. Non-encapsulated enzyme was 
removed from the catalytic nanocompartments by dialysis against PBS at pH 7.4 at RT for 5 
days, exchanging the buffer every 8 hours during the day and leaving the buffer unchanged 
overnhight, using Spectrapore dialysis tubes, MWCO 300 kDa from Spectrum Laboratories 
Inc. The dialysis buffer was kept at pH 7.4 in order to maintain the hydrazine bond stability 
during enzyme removal. All incubation experiments and activity measurements were 
performed on the following day. 
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LIGHT SCATTERING  
 
Dynamic and static light scattering (DLS and SLS) experiments were performed at 20 °C using 
an ALV/CGS–8F goniometer (Langen/Hessen, Germany) equipped with a frequency-doubled 
He-Ne laser (JDS Uniphase, λ = 632.8 nm). pH-responsive catalytic nanocompartments were 
serially diluted to polymer concentrations ranging from 0.05 mg mL-1 down to 0.025 mg mL-1, 
and measured at scattering angles between 30° and 150°, with an angular step of 10°, in 10 mm 
diameter cylindrical quartz cells mounted in a thermostatted optical matching bath (toluene 
bath). The photon intensity auto-correlation function, g2(t), was determined with an ALV/LSE–
5004 digital correlator.  A nonlinear decay-time analysis supported by regularized inverse 
Laplace transform of g2(t) (CONTIN algorithm) was used to analyze the DLS data. The angle-
dependent apparent diffusion coefficient was extrapolated to zero momentum transfer (q²) 
using the ALV/Static and dynamic FIT and PLOT 4.31 software. Angle and concentration-
dependent SLS data are presented as Guinier plots254.  
 
 
TRANSMISSION ELECTRON MICROSCOPY  
 
Vesicle- and cell-samples containing catalytic nanocompartments for TEM imaging studies 
were negatively stained with 1.5% uranyl acetate solution and deposited on carbon-coated 
copper grids. A transmission electron microscope (Philips Morgagni 268D) at 293 K was used. 
 
CRYOGENIC-TEM 
 
Catalytic nanocompartment suspensions in buffer (10 mM PBS, pH 7.4, 50 mM NaCl) at high 
concentrations (1 mg mL-1) were deposited on glow-discharged carbon grids (Quantifoil, 
Germany) and blotted before quick-freezing in liquid ethane using a Vitribot plunge-freezing 
device (FEI Co.). The grids were stored in liquid nitrogen before transferring them into a cryo-
holder (Gatan). Imaging was performed on a Philips CM200 FEG TEM at 200 kV accelerating 
voltage in low-dose mode with a defocus value of about −4 µm. 
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FLUORESCENCE CORRELATION SPECTROSCOPY 
 
All FCS measurements were carried out using a ConfoCor2 instrument (Carl Zeiss, Germany) 
with a 40x, 1.2. water immersion C-Apochromat objective lens. Measurements were carried 
out at room temperature using a sample volume of 20 µL on a covered eight-well Lab-Tek 
chambered borosilicate cover glass (Nalage Nunc International).  A HeNe laser was used for 
excitation of the Cy-5 fluorophore the 633 nm.  The fluorescence signal was measured in real 
time and the autocorrelation function was calculated by a software correlator (LSM 510 
META-ConfoCor 2 System). Measurements were recorded over 10 s and each measurement 
was repeated 30 times. Experimental auto correlation curves were fitted using a one-component 
model including triplet state: 
% & '() = 1 + (1 + -1 − - /0 11_`aZ) 15 11 + &&6 11 + 78 &&6  
 
τD represents the diffusion time, T the fraction of fluorophores in triplet state with triplet time 
τtrip, N is the number of particles and R the structural parameter. R and τD of free dye (Cy5 – 
hydrazine) were determined independently, and subsequently fixed in the fitting procedure for 
Cy5-bound OmpF and vesicles with reconstituted OmpF.  
 
 
ENZYMATIC ASSAY TMB 
 
The final catalytic nanocompartment solutions incubated at pH 7.4 or 5.5 were added to a 
preprepared TMB/H2O2 PBS solution at pH 7.4 and measured in 96-well plates. The 
absorbance of each well mixture was measured with a Spectromax M5e microplate reader 
(Molecular Devices) at 370 nm.  
 
The enzymatic reaction speeds of catalytic nanocompartments were determined by comparing 
TMB slopes of linear regions of the TMB kinetic graphs of catalytic nanocompartments as a 
direct measure for the relative reaction speed. The time dependence of the conversion of TMB 
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into its first oxidation product, which absorbs at 370nm was measured at pH 7.4. Linear 
regression was performed using Graphpad Prism software, in order to determine the best linear 
section. Slopes determined from the linear regression are a direct measure of the relative 
reaction speed, as the difference in absorbance over time is directly liked to the difference in 
concentration of the first TMB oxidation product. The actual conversion rate of TMB 
(nmol/sec) could not be determined, as b of the first TMB oxidation product measured at 
370nm is unknown. For % of activity, slopes were compared to those for TMB conversion of 
OmpF-WT catalytic nanocompartments incubated at pH 5.5.   
 
 
ENZYMATIC ASSAY AMPLEX RED 
 
The emission fluorescence intensity was determined using a LS 55 Flourescence Spectrometer 
(Perkin Elmer). Samples containing the catalytic nanocompartments were excited at 535 nm 
and the emission intensity was monitored at 590 nm (15nm slits). Final catalytic 
nanocompartment solutions equipped with different OmpFs were adjusted to pH 5.5. 
Immediately and after 1 hour of incubation time, the samples were injected into a freshly 
prepared Amplex Red/H2O2 PBS solution and measured in PBS at pH 7.4. 20µl of the samples 
were transferred to 440µl of the reaction mixture (4.5 µM H202 and 3.4 µM Amplex Red) PBS 
pH 7.4. Fluorescence was expressed as arbitrary fluorescence units (AU) and was measured at 
the same instrument setting in all experiments. The detailed procedure and calculation of 
enzyme kinetics are described below  
 
HRP kinetic assays carried out with Amplex Red concentrations ranging from 0.011 to 0.41 
mM provided apparent Michaelis-Menten parameters, Km, by fitting the Michaelis-Menten 
equation to plots of the initial reaction rate vs. Amplex Red concentration. HRP used in our 
study exhibited Km of 0.11and 0.12 mM at pH 7.4 and 5.5, respectively. These values are higher 
than reported for Amplex Red 0.36, and indicate a better affinity for the substrate at 7.4255.  
 
Conversion of Amplex red into its fluorescent product resorufin was determined by observing 
fluorescence intensity at pH 7.4 as a function of time. Linear regression was performed using 
Graphpad Prism software, in order to identify the best linear section. Similarly to the TMB 
assaay, slopes determined from the linear regression of Amplex red conversion are a direct 
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measure for the relative reaction speed, as the difference in fluorescence over time is directly 
liked to the difference in concentration of the fluorescent resurfin. For % of activity, slopes 
were compared to Amplex red conversion of OmpF-WT catalytic nanocompartments. 
 
6.4 METHODS: CHAPTER 4 
 
OMPF EXPRESSION, EXTRACTION 
 
The outer membrane protein F (OmpF) K89 R270 cysteine mutant and the outer membrane 
protein F wild type were expressed in BL21 (DE3) Omp8 Escherichia coli cells following a 
protocol described previously 234. The detailed procedure is described in below. The extracted 
fraction was analysed by a 4-15% Mini-PROTEAN® TGX™ Precast SDS (Bio-Rad 
Laboratories, USA) gel to confirm the protein purity and the protein concentration was 
determined using a BCA assay kit (Pierce Chemical Co, Rock- ford, USA). OmpF was stored 
at 4ºC in 3% OG at a concentration of 1.2mg/ml for several weeks. 
 
Under aseptic conditions, cells from an ampicillin resistant Escherichia Coli strain BL21 stock 
culture overexpressing the cysteine OmpF K89 R270 mutant were smeared onto the surface of 
LB, ampicillin agar plate. After 16h incubation at 37 °C, a single bacterial colony was 
transferred from the plate to 15 mL of TB liquid medium with 100 mg mL-1 ampicillin (total 5 
flasks). 5 times 1 L of TB medium with 100 mg mL-1 ampicillin was inoculated with 15 mL of 
the overnight culture. The optical density of the growing culture was followed by measuring 
the absorbance at 600 nm. Once the absorbance reached an optical density (OD) of 0.6, IPTG 
was added to a final concentration of 1 mM into each flask in order to start the over-expression 
of the OmpF K89 R270 gene. Bacteria were grown for 16 more hours at 25 ºC with vigorous 
shaking. Then the E. Coli cells were pelleted at 7.000 x g for 8 min at 4 ºC.  Pellets were stored 
at -25 ºC, and on the day following the harvesting re-suspended in 50 mL of 25 mM Tris-HCl 
at pH 7.4. 10 mg DNase and 10 mg RNase were added, and the cell suspension was french 
pressed five times at 1,000 bar. 1 mL of 20% SDS was added per 10 mL of cell lysate and 
incubated for 1 h at 60 ºC. The suspension was centrifuged at 50.000 x g at RT. The supernatant 
was removed and the cell pellet incubated in 0.125% OG for 1 h at 37ºC. The suspension was 
centrifuged at 50.000 x g at RT. Finally, the cell pellet was re-suspended in 3% n-octyl-β-D-
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glucopyranoside (OG) (Anatrace, USA) in 10 mM phosphate buffer and homogenized. The 
suspension was centrifuged at 50.000 x g and the protein concentration in the supernatant was 
determined by UV-Visible absorption spectroscpy at 280 nm.  
 
 
OMPF MODIFICATION WITH SAMSA FLUORESCEIN; OMPF-S-S-CF 
 
The OmpF K89 R270 double cysteine mutant was modified by disulphide binding of SAMSA 
fluorescein to the free cysteine residues. The same reaction was also performed in presence of 
OmpF wild type in 3% Octyl-glucopyranoside (OG) (Anatrace, USA) and 3% OG in order to 
serve as controls. 20µl of 959µM SAMSA-CF (5-((2-(and-3)-S-(acetylmercapto) succinoyl) 
amino) Fluorescein) (Thermofischer Scientific) dissolved in 5% DMSO, 1% OG in PBS buffer 
was added to 400µl of 0.5mg/ml OmpF and mixed. The mixture was shaken in dark conditions 
for 30min. After 30min, the deprotection of SAMSA-CF was initiated by adjusting the pH of 
the solution to pH 8.5 with 0.5M NaOH. The reaction was incubated and shaken protected from 
light for 24 hours at RT. After 24 hours another 5µl of 959µM SAMA fluorescein was added. 
24 hours after the second addition of SAMSA fluorescein the protein was purified from the 
reaction mixture by washing it 25 times with 1% OG in PBS pH 7.2 in Amicon Ultra-0.5 mL 
centrifugal filters for protein purification and concentration, molecular cutoff: 30kDA 
(Millipore) (10min at 13 000 RPM). Volume was adjusted to 475µL PBS pH 7.2 and protein 
concentration was determined by UV-Vis spectroscopy. 40µl of the purified protein fraction 
was taken for FCS analysis and SDS gel electrophoresis. The volume was adjusted to 500µL 
and the protein was dialysed against 1L of 0.05 % OG in PBS for 16 hours and twice against 
PBS for 2 hours using 14kDa Membra-CelTM (Carl Roth, Germany) dialysis membranes. The 
protein concentration was verified by UV-VIS (A280) (Thermofischer Scientific, Switzerland). 
 
 
 
OMPF MODIFICATION WITH (BIS-(2,2,5,5-TETRAMETHYL- 3-IMIDAZOLINE-
1-OXYL-4-YL)DISULFIDE); OMPF-S-S-NO* 
 
The OmpF K89 R270 double cysteine mutant was modified by disulphide binding of (bis-
(2,2,5,5-Tetramethyl- 3-imidazoline-1-oxyl-4-yl)disulfide) (Noxygen, Germany) to the free 
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cysteine residues. The same reaction was also done in presence of OmpF wild type in 3% OG 
PBS and 3% OG PBS in order to serve as controls for unspecific binding of (bis-(2,2,5,5-
Tetramethyl- 3-imidazoline-1-oxyl-4-yl)disulfide) to wild type OmpF and unspecific 
interactions with OG micelles. 20µl of dissolved (bis-(2,2,5,5-Tetramethyl- 3-imidazoline-1-
oxyl-4-yl)disulfide) (1.4 mM) in 4% DMSO, 1% OG in PBS Buffer was added to 400µl of 
0.5mg/ml OmpF and mixed. The reaction was shaken protected from light for 24 hours at RT. 
24 hours after the second addition of (bis-(2,2,5,5-Tetramethyl- 3-imidazoline-1-oxyl-4-
yl)disulfide) the conjugated protein was purified from the reaction mixture by washing it 25 
times with 1% OG in PBS pH 7.2 in Amicon Ultra-0.5 mL centrifugal filters for protein 
purification and concentration, molecular cutoff: 30kDA (Millipore). Volume was adjusted to 
475µL PBS pH 7.2 and protein concentration was determined by UV-Vis spectroscopy. 40µl 
of the purified protein fraction was taken for EPR analysis. The volume was adjusted to 500µL 
and the protein dialysed against 1L of 0.05 % OG in PBS for 16 hours and twice against PBS 
for 2 hours using 14kDa Membra-CelTM (Carl Roth, Germany) dialysis membranes. The protein 
concentration was verified by UV-VIS (A280) (Thermofischer Scientific, Switzerland). 
 
CHARACTERISATION OF SAMSA FLUORESCEIN CONJUGATED OMPF  
 
A 4-12% SDS polyacrylamide gel was cast. Samples were mixed with BN-PAGE loading 
buffer and 15µL of the final OmpF solution was added to the gel. To show the effect of GSH, 
separate probes were incubated with the loading buffer supplemented with 30mM GSH. The 
gels were run at 200V for 45min. Gels were scanned unstained and stained with Brilliant blue.  
 
PREPARATION OF OMPF EQUIPPED POLYMERSOMES 
 
OmpF equipped polymersomes were prepared at RT from the ABA triblock copolymer, 
PMOXA6-PDMS44-PMOXA6, (A6B44A6) and a subset of modified or unmodified OmpF 
(OmpF-SH, OmpF-S-S-NO. and OmpF-S-S-CF). The synthetic procedure and the polymer 
characterization are presented in 53. Polymersomes were generated using the film rehydration 
technique where the polymer was dried in the presence of native or modified OmpF K89 R270 
cysteine mutant (OmpF-SH, OmpF-S-S-CF or OmpF-S-S-NO.). Horseradish peroxidase 
(HRP), Atto-488 conjugated HRP (Atto488-HRP) or Atto-647 conjugated HRP (Atto647-
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HRP) in PBS buffer pH=7.4 at RT were used as rehydration solutions. Films were rehydrated 
to a final polymer concentration of 2.5 mg mL-1, HRP concentration of 0.2 mg mL-1, and OmpF 
concentration of 50 µg mL-1, respectively. Control polymersomes were also prepared in the 
absence of OmpF. Rehydrated films were stirred overnight at RT, protected from light. All 
samples were extruded through an Avanti mini-extruder (Avanti Polar Lipids, USA) using a 
100 nm diameter pore-size polycarbonate membrane (11 times) at RT in order to obtain size 
homogeneity. Non-encapsulated enzyme was removed from the polymersomes by dialysis 
against PBS at pH 7.4 at RT for 5 days, exchanging the buffer every 3 hours during the day 
and leaving the buffer unchanged overnight, using Spectrapore dialysis tubes, MWCO 300 kDa 
(Spectrum Laboratories Inc., USA) Steps involving the generation of catalytic 
nanocompartments were preformed protected from light in order to avoid photodegradation of 
fluorophores. Incubation experiments and activity measurements were performed on the day 
following the last dialysis step.  
 
LC-MS-MS 
 
Mass spectrometry was applied in order to determine the degree of labelling of the OmpF 
conjugates 234. The spectrometer consisted of a LC-MS column ReproSil-Pur C18–AQ, 1.9 μm 
resin Dr. Maisch GmbH, Ammerbuch-Entringen, Germany combined with a dual pressure 
LTQ-Orbitrap Elite mass spectrometer connected to an electrospray ion source (Thermo Fisher 
Scientific). The in gel digestion was based on256. Briefly, the band of interest was cut out of the 
SDS-gel and the sample was cut to tiny cubes. The coomassie blue staining was rinsed out and 
the protein was alkylated with iodoacetamide and digested using Trypsine. The peptides were 
then washed out and desalted with C18 reversed phase spin columns Microspin, Harvard 
Apparatus. After drying, the samples were dissolved and subjected to LC–MS analysis using a 
linear gradient from 95% solvent A (0.15% formic acid, 2% acetonitrile) and 5% solvent B 
(98% acetonitrile, 0.15% formic acid) to 28% solvent B over 40 min at a flow rate of 0.2 μl/min. 
The 20 most intense ions were released from the linear ion trap and subjected to a MS-MS 
analysis. The intensity of the mutation carrying fragment was put into relation with another 
fragment of the same sample to eliminate the dependence on the concentration and the ratio 
was then compared to the same ratio of OmpF with free thiol groups (EQ1).  
 
Eq. 1: cdefg=hijkl<cm<nk=fg=hijkl< opqrstu_X cdefg=hijkl<cm<nk=fg=hijkl< vs_uq_ 
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For three separately measured samples a labeling degree of 96+/-4% (100%, 95%, 100%) 
degree of labelling of OmpF was determined for NO. labelling and 81+/-31% (100%, 100%, 
46%) for labelling with SAMSA-CF. 
 
FLUORESCENCE CORRELATION SPECTROSCOPY 
 
 
All FCS measurements were carried out using a ConfoCor2 instrument (Carl Zeiss, Germany) 
with a 40x, 1.2. water immersion C-Apochromat objective lens. Measurements were carried 
out at room temperature using a sample volume of 20 µL on a covered eight-well Lab-Tek 
chambered borosilicate cover glass (Nalage Nunc International, USA). An Argon 488 laser 
was used for excitation of the SAMSA-CF fluorophore at 488 nm (Laser power output 20%, 
8mW) with the appropriate filter sets.  The fluorescence signal was measured in real time and 
the autocorrelation function was calculated by a software correlator (LSM 510 META-
ConfoCor 2 System). Measurements were recorded over 3s and each measurement was 
repeated 60 times. Correlation curves that could not be fitted were excluded (<10%). 
 
For determining the binding of SAMSA-CF to OmpF-SH and the successful reconstitution of 
OmpF-S-S-CF into HRP loaded PMOXA-PDMS-PMOXA polymersomes, experimental auto 
correlation curves were fitted using a one component model including triplet state (Eq1): 
 
% & '() = 1 + (1 + -1 − - /0 11)2(3) 15 11 + &&6 11 + 78 &&  
 
 
τD represents the diffusion time, T the fraction of fluorophores in triplet state with triplet time 
τtrip, N is the number of particles and R the structural parameter. R and τD of free dye SAMSA-
CF were determined independently. Number of SAMSA-CF molecules per OmpF was 
determined based on the molecular brightness (CPM) of SAMSA-CF (2.2 ± 0.7 kHz) in 
comparison with SAMSA-CF covalently attached to OmpF K89 R270 (4.8 ± 0.6 kHz). The 
number of OmpF-S-S-CF monomers per vesicle was determined by comparing the molecular 
MATERIALS AND METHODS 
 115 
brightness of SAMSA-CF (2.2 ± 0.7 kHz) to the molecular brightness of OmpF-S-S-CF in 1% 
OG (18.9 ± 11.1 kHz), taking into consideration that every OmpF monomer is modified by two 
SAMSA-CF molecules.  
 
For determining the release kinetics of SAMSA-fluorescein from OmpF-S-S-CF experimental 
auto correlation curves were fitted using a two-component model including triplet state (Eq. 
2.): 
 
 
% & '() = 1 + 1 + -1 − - /0 11_`aZ 15 ':1 + &&61 11 + 78 &&61
+ 1 + -1 − - /0 11_`aZ 15 '81 + &&62 11 + 78 &&62  
 
 
τD represents the diffusion time, T the fraction of fluorophores in triplet state with triplet time 
τtrip, N is the number of particles and R the structural parameter.  
 
R and τD of free dye (SAMSA-CF) were determined independently in 30mM GSH, PBS pH 
7.4, and subsequently fixed in the fitting procedure in order to determine the % of free dye 
fraction, which represented SAMSA-CF released from OmpF-S-S-CF in 1% OG 30mM GSH, 
PBS pH 7.4. 
 
EPR MEASUREMENTS OF OMPF-S-S-NO. 
 
 
EPR measurements were performed on a Bruker CW EPR Elexsys-500 spectrometer 
equipped with a variable temperature unit. The spectra were recorded at 298 K with the 
following parameters: 100 KHz magnetic field modulation, microwave power 2 mW, 
conversion time 61.12 ms, number of scans up to 200, resolution 2048 points, modulation 
amplitude 0.5 G for the samples containing the free nitroxide and 1 G for the samples 
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containing spin labeled OmpF (OmpF-S-S-NO.), sweep width 150 G. Note: the EPR spectra 
presented in the figures were zoomed to a maximum of 80G sweep width for better resolution 
of the peaks. Isotropic EPR spectra were simulated using the WINSIM (NIEHS/NIH) 
simulation package, while the anisotropic spectra were simulated with Bruker WinEpr 
SimFonia package.  
For the free nitroxide spin probe (bis-(2,2,5,5-tetramethyl- 3-imidazoline-1-oxyl-4-yl) 
disulfide), aN values correspond to half the distance (in Gauss) between the low-field and high-
field lines of the isotropic spectra (triplets).  
 
CRYOGENIC-TEM 
 
Polymersome suspensions in buffer (10 mM PBS, pH 7.4, 50 mM NaCl) at high concentrations 
(2.5 mg mL-1) were deposited on glow-discharged carbon grids (Quantifoil, Germany) and 
blotted before quick-freezing in liquid ethane using a Vitribot plunge-freezing device (FEI 
Co.). The grids were stored in liquid nitrogen before transferring them into a cryo-holder 
(Gatan). Imaging was performed on a Philips CM200 FEG TEM at 200 kV accelerating voltage 
in low-dose mode with a defocus value of about -4 µm. 
 
LIGHT SCATTERING  
 
Dynamic and static light scattering (DLS and SLS) experiments were performed at 20 °C using 
an ALV/CGS–8F goniometer (Langen/Hessen, Germany) equipped with a frequency-doubled 
He-Ne laser (JDS Uniphase, λ = 632.8 nm). Reduction-responsive polymer nanocompartments 
were serially diluted to polymer concentrations ranging from 0.05 mg mL-1 down to 0.025 mg 
mL-1, and measured at scattering angles between 30° and 150°, with an angular step of 10°, in 
10 mm diameter cylindrical quartz cells mounted in a thermostatted optical matching bath 
(toluene bath). The photon intensity auto-correlation function, g2(t), was determined with an 
ALV/LSE–5004 digital correlator.  A nonlinear decay-time analysis supported by regularized 
inverse Laplace transform of g2(t) (CONTIN algorithm) was used to analyze the DLS data. The 
angle-dependent apparent diffusion coefficient was extrapolated to zero momentum transfer 
(q²) using the ALV/Static and dynamic FIT and PLOT 4.31 software. Angle and concentration-
dependent SLS data are presented as Guinier plots 93. 
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AMPLEX ULTRA RED ENZYMATIC ASSAY 
 
The emission fluorescence intensity was determined using a a Spectromax M5e microplate 
reader. Samples were incubated with a final concentration of 30mM GSH in PBS pH 7.4. The 
pH was kept at pH 7.4. For the measurement 10µl of the samples mixed with GSH were 
transferred to 220µl of the reaction mixture (4.5 µM H202 and 3.4 µM Amplex Ultra Red) PBS 
pH 7.4. The reaction mixture was excited at 530 nm and the emission intensity was monitored 
at 590 nm. Fluorescence was expressed as relative fluorescence units (RFU) and was measured 
at the same instrument setting in all experiments.  
 
The reacting rate at which catalytic HRP-loaded polymersomes, equipped with different 
OmpFs, perform in solution was studied by employing the Amplex Ultra Red enzymatic assay. 
Conversion of Amplex Ultra Red into its fluorescent product was determined by observing 
fluorescence intensity in PBS pH 7.4 as a function of time in the presence of GSH. Linear 
regression was performed using Origin software, in order to identify the best linear section. 
Substrate turnover of OmpF-S-S-CF equipped, HRP-loaded polymersomes, OmpF-SH 
equipped HRP-loaded polymersomes and unpermeabelized HRP-loaded polymersomes was 
averaged between three separately prepared samples. Slopes determined from the linear 
regression of Amplex Ultra red conversion are a direct measure for the relative reaction speed, 
as the difference in fluorescence over time is directly linked to the difference in concentration 
of the fluorescent product 257. For % of relative activity, slopes were compared to Amplex Ultra 
red conversion of OmpF-SH catalytic nanocompartments in presence and absence of GSH. The 
minor decrease in total HRP substrate turnover in the presence of GSH is expected due to 
noncompetitive inhibiton of the enzyme and previously reported by Ref258. The significant 
difference between the slopes of OmpF-S-S-CF equipped HRP loaded polymersomes and 
OmpF-SH equipped polymersomes immediately after addition of 30mM GSH was verified by 
two sample t-test (p < 0.02, n=3). 
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HRP CONJUGATION WITH ATTO-488 AND ATTO-647  
 
Atto-488 carboxylic acid succinimidyl ester (Atto-488 NHS ester) (Atto-TEC, Germany). A 
0.2 mg ml-1 HRP solution was prepared in 0.2 M sodium bicarbonate buffer pH = 8.1. 10µL of 
10mM Atto-488 NHS ester was added per 1 mL of enzyme solution. The final solution was 
mixed protected from light for 24h. Upon labelling the Atto-488 HRP conjugate was purified 
by dialysis against PBS pH 7.4 for 72 hours, exchanging the buffer 3 times daily (MWCO: 10-
14 kDa). Samples were further purified using Amicon Ultra-15mL Centrifugal Filters for DNA 
and protein concentration (MWCO: 10kDa) (EMD Millipore, USA). Labeling was confirmed 
by SDS-PAGE.   
 
Atto-647 carboxylic acid succinimidyl ester (Atto 647 NHS ester) (Atto-TEC, Germany). A 
0.2mg ml-1 HRP solution was prepared in 0.2 M sodium bicarbonate buffer pH = 8.1. 10µL of 
10mM Atto-647 NHS ester was added per 1 mL of enzyme solution. The final solution was 
mixed protected from light for 24h. Upon labelling the Atto-647 HRP conjugate was purified 
by dialysis against PBS pH 7.4 for 72 hours, exchanging the buffer 3 times daily (MWCO: 14 
kDa). Samples were further purified using Amicon Ultra-15mL Centrifugal Filters for DNA 
and protein concentration (MWCO: 10kDa) (EMD Milipore, USA). Labeling was confirmed 
by SDS-PAGE.  
 
CELL TOXICITY ASSAY OF CATALYTIC NANOCOMPARTMETNS 
 
The [3-(4,5-dimethyl-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium 
(MTS) assay (Promega) was used to determine cell viability. Hela cells were seeded at a density 
of 2.5x103 cells/well in a 96-well plate. Cells were cultured for 24 h in DMEM growth medium 
(supplemented with 10% fetal calf serum, penicillin (100 units ml-1) and streptomycin (100 µg 
ml-1)). After 24 hours, the medium 100 µl aliquots containing the corresponding concentration 
of catalytic nanocompartments [0.25, 0.5 and 0.75 mg ml-1] were added to the cell medium in 
triplicate. Cells incubated only in medium served as control (100%). After 24 hours of 
incubation 20µl of MTS solution was added to each well. The plates were incubated for 1 hour 
at 37ºC, and the absorption was measured at λ = 490nm. The quantity of formazan product as 
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measured by absorbance at 490nm is directly proportional to the number of living cells in 
culture. Absorption of cells where no formulation was added served as 100%. 
 
 
 
FLOW CYTOMETRY ANALYSIS OF ARTIFICIAL ORGANELLE IN CELLULO 
ACTIVITY  
 
HeLa cells were seeded in a well of a 24-well plate (8x104 cells / well) and cultured in 
Dulbelcco’s Modified Eagle’s Medium (DMEM) containing 10% fetal calf serum, penicillin 
(100 units ml-1) and streptomycin (100 µg ml-1)) for 24 h at 37°C in a humidified CO2 incubator. 
Then the medium was exchanged and polymersome solution was added to a final concentration 
of 0.5 mg ml-1 for another 24 h. Cells were washed 3 times with PBS, trypsinized, centrifuged, 
washed, centrifuged, suspended in 1ml PBS. AR/H202 was added to a final concentration of 
10µM. After 2 hours, flow cytometry analysis was performed using a BD FACSCanto II flow 
cytometer (BD Bioscience, USA). Doublets were excluded using FSC and SSC detectors, 
single cells were excited at 561 nm and the emission was detected in FL5 (586/15; Resorufin 
Channel). A total of 10’000 single cells for each sample were analyzed, and data processed 
using Flow Jo VX software (TreeStar, Ashland, OR). 
 
INTRACELLULAR STABILITY OF AO 
 
HeLa cells were seeded at a density of 3x104 cells ml-1 onto poly-D-lysine-coated glass 
coverslips. Cells were cultured for 24 h in DMEM growth medium (supplemented with 10% 
fetal calf serum, penicillin (100 units ml-1) and streptomycin (100 µg ml-1)). After attachment 
to the surface, the medium was removed and catalytic nanocompartments were added to a final 
polymer concentration of 0.5 mg ml-1. Cells were incubated for an additional 24 h in medium. 
Then cells were washed trice with PBS and fixed with 4% PFA for 15min. After a 
neutralization step using 50mM NH4Cl, cells were either treated with PBS (control) or 0.1% 
Saponin for 10 min at room temperature. After additional washing steps, cell nuclei were 
counterstained for 10 min using Hoechst 33342 (0.5 µg mL-1). Finally cells were embedded in 
Vectashield antifade mounting media. Confocal laser scanning microscopy was performed 
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using an Olympus FV1000 inverted microscope (Olympus Ltd., Tokyo, Japan) equipped with 
a 60x UPlanFL N oilimmersion objective (numerical aperture 1.40). Cells were excited at 
405 nm (Hoechst 33342) and 488 nm (Atto488-HRP), and the fluorescence signal was 
collected using Kalman modus between 425-475 nm and 500-600 nm, respectively. To 
minimize spectral cross talk the samples were scanned using sequential mode. The laser 
settings were adjusted depending on the treatment. Images were processed using Fiji open 
source image processing package of ImageJ. 
 
INTRACELLULAR LOCALIZATION OF ARTIFICIAL ORGANELLES 
 
HeLa cells were seeded at a density of 3x104 cells/well onto poly-D-lysine-coated glass 
coverslips. Cells were cultured for 24 h in DMEM growth medium (supplemented with 10% 
fetal calf serum, penicillin (100 units ml-1) and streptomycin (100 µg ml-1)) to allow attachment 
to the surface. After attachment, the medium was removed and catalytic nanocompartments 
were added to a final polymer concentration of 0.5 mg ml-1. For images taken of non fixated 
cells after 24h, the cells were washed trice with PBS and imaged directly. For fixated cells, 
after 24 h cells were washed trice with PBS and then fixed for 15 min using 4% PFA. After a 
neutralization step using 50 mM NH4Cl cells, cells were incubated with either rabbit polyclonal 
anti-EEA1 (ab2900, Abcam) or anti-LAMP1 (ab24170, Abcam) antibody (1:1000) for early 
endosome or lysosome staining, respectively7. The cells were washed with PBS, followed by 
staining with the secondary goat anti-rabbit polyclonal Dylight633-labelled antibody (1:1000; 
#35562, ThermoFisher Scientific). Cell nuclei were counterstained for 10 min using Hoechst 
33342 (0.5 µg ml-1). Finally, cells were embedded in Vectashield antifade mounting media. 
Confocal laser scanning microscopy was performed using an Olympus FV1000 inverted 
microscope (Olympus Ltd., Tokyo, Japan) equipped with a 60x UPlanFL N oilimmersion 
objective (numerical aperture 1.40). Z-stacks were taken using Kalman modus and a step size 
of 450 nm. Cells were excited at 405 nm (Hoechst 33342), 488 nm (Atto488-HRP), and 633 
nm (Early Endosome/Lysosome). The fluorescence signal was collected between 425-475 nm, 
500-600 nm and 655-755 nm, respectively. To minimize spectral cross talk the samples were 
scanned using sequential mode. Images were processed using Fiji open source image 
processing package of ImageJ and Imaris image analysis software. 
Colocalization of polymersomes with markers of early endosome (EEA1) or lysosome 
(LAMP1) were carried out using JaCoP plug-in in Fiji. Pearson’s correlation coefficient (PCC), 
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Mander’s coefficients (M1/M2, using thresholds of A=200 and B=180) and Costes’ 
randomization based colocalization (200 randomization rounds) were used to assess extend of 
colocalization 259. 
 
 
 
CELLULAR ACTIVITY OF ARTIFICIAL ORGANELLES BY CLSM 
 
HeLa cells were cultured at a density of 3x104 cells per well in an 8-well Lab-Tek (NalgeNunc 
International, USA) for 24 h in DMEM growth medium (supplemented with 10% fetal calf 
serum, penicillin (100 units ml-1) and streptomycin (100 µg ml-1) to allow attachment to the 
surface. After attachment, the medium was removed and catalytic nanocompartments were 
added to a final polymer concentration of 0.25mg ml-1. Cells were incubated for an additional 
24 h in medium. After 24 h cells were washed twice with PBS, and AR/H2O2 were added in 
the ratio of 1:1 to a final concentration of 10µM. After 30min, cells washed three times with 
PBS. Cell nuclei were counterstained for 10 min using Hoechst 33342 (0.5 µg ml-1). Cells were 
washed twice with D-PBS and cultured in DMEM. CellMask Deep Red Plasma membrane 
stain (0.5 µl ml-1) was added and cells were analyzed after 5 min. Confocal laser scanning 
microscopy was performed using an Olympus FV-1000 inverted microscope (Olympus Ltd., 
Tokyo, Japan) equipped with a 60x UPlanFL N oil-immersion objective (numerical aperture 
1.40). Cells were excited at 405 nm (Hoechst 33342), 559 nm (RLP), and 635 nm (CellMask 
Deep Red Plasma membrane stain) and the fluorescence signal was collected between 425-
475 nm, 575-620 nm, and 655-755 nm, respectively. To minimize spectral cross talk the 
samples were scanned using sequential mode. The laser settings for RLP, the photomultiplier 
tube gain, and the pinhole settings were kept constant during the analysis. Images were 
processed using Olympus FluoView software (v3.1, Olympus). 
 
IN VIVO ACTIVITY OF ARTIFICIAL ORGANELLES 
 
Standard zebrafish embryo (ZFE) culture medium at pH 7.4 was prepared at final 
concentrations of 5 mM sodium chloride, 0.25 mM potassium chloride, 0.5 mM magnesium 
sulfate, 0.15 mM potassium dihydrogen phosphate, 0.05 mM sodium phosphate dibasic, 0.5 
mM calcium chloride, 0.71 mM sodium bicarbonate, and 0.001 % (w/v) methylene blue. 
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Collected eggs from adult ABC/TU ZFE (Wildtype) and EGFPs843 ZFE (GFP-macrophage 
line) were kept in ZFE culture medium at 28°C. PTU (0.03 mg ml-1) was added 1-day post 
fertilization (dpf) in order to avoid pigment cell formation. Three different enzyme loaded 
polymersomes were injected into 2 dpf ZFE according to an adapted protocol originally 
designed for microangiography. ZFE were anesthetized using 0.01% tricaine (w/v) and casted 
into 0.3% (w/v) agarose containing the same amount of tricaine. Immobilized ZFE were 
injected with either with 3 nL of 0.2 mg ml-1 free HRP or 3 nL AO solution (5mg ml-1), removed 
from the agarose and kept in ZFE culture medium containing PTU for 24 hours. Then, a second 
injection of 1 nL AR (78µM) was performed following the same procedure. As control 
experiments, ZFE were injected with the enzymatic substrate AR and AR mixed with H2O2 
without previous AO injection. Fluorescence imaging of injected ZFE was performed using an 
Olympus FV1000 confocal microscope (Olympus Schweiz AG, Volketswil, Switzerland). ZFE 
were excited at 488 nm (Atto 488 HRP), 559 nm (Melanocytes), and 635 nm (Resazurin like 
product) and the fluorescence signal was collected between 500-530 nm, 575-620 nm, and 655-
755 nm, respectively. 
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Chapter 7. 
APENDIX – SUPPLEMENTARY INFORMATION 
7.1 Chapter 2 
 
 
 
Figure S1. 1H NMR spectra of ABC tri-block copolymers. Blue line A44B110C37, Black line: 
A45B101C27 
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Figure S2. Particle size distribution of A45B110C37 tri-block copolymers. Panel a.) Mass 
weighted distribution. Panel b.) Number weighted distribution. 
 
A
B
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Figure S3. Transmision Electron Microscopy of A45B110C37 copolymer Panel A.) sample 
prepared at first day Panel B.) sample after 60 days. Scale bar: 500 nm 
 
 
 
Figure S4. Influence of pH on molecular weigth (Mw) of A45B110C37 copolymers 
The decrease of Mw with pH increase is supposed to be related to the aggregation process 
(supported by Rh increase). Big aggregates can interact with the cuvette walls or sediment in 
the SLS experiment, which influences the measurement (only small particles that do not 
sediment remain suspended in the solution). 
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Figure S5. Effect of temperature on particle size of ABC copolymers. (squares) A45B110C37; 
(circles) A45B101C27. 
 
 
Table S1. Attachment efficiency for sodium fluorescein to ABC nanoparticles. 
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Figure S6. Zeta-potential titration measurements of ABC copolymers. Panels A.) and B.) 
A45B110C37 Circles: Hydrodynamic diameter (DH) Triangles: ζ-potential. Panels C.) and D.) 
A45B101C27 Circles: Hydrodynamic diameter (DH) Triangles: ζ-potential. Dash lines: Isoelectric 
point. 
 
Figure S7. Fluorescence correlation spectroscopy of BSA-FTIC modified nanoaprticles 
Panel A.) FCS autocorrelation curves (continuous lines) and their fit (dashed lines) of: Free 
BSA-FITC (a) and BSA-FITC-A45B110C37 (b). Panel B.) BSA-FITC (a) and BSA-FITC 
A45B101C27 (b). Curves normalized to 1 to facilitate comparison.  
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Figure S8. BSA-FITC release from ABC nanoparticles as a function of time at pH = 5.8. 
(diamonds) A45B31C44; (triangles) A45B84C85; (circles) A45B101C27; (squares) A45B101C20 followed 
by FCS. 
 
 
Figure S9. TEM micrographs after attachment of o-ASM to ABC nanoparticles. Panel 
A.) o-ASM/A45B101C27; Panel B.) o-ASM/A45B110C37. Scale bar: 200 µm.  
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Figure S10. Zeta potential measurements of ABC nanoparticles at pH 7.4. (empty squares) 
A45B110C37 without protein; (empty circles) A45B101C27 without protein; (filled squares) 
A45B110C37 with protein; (filled circles) A45B101C27 with protein. 
 
 
Figure S11. Fluorescence correlation spectroscopy of o-ASM modified ABC 
nanoaprticles.  FCS autocorrelation curves (continuous lines) and their fit (dash lines). Panel 
A.) Free o-ASM protein (a), and  A45B110C37 nanoparticles attached with non-labelled ASM 50 
min after mixing with a solution of free o-ASM (b). Panel B.) free o-ASM (a), and A45B101C27 
nanoparticles attached with non labelled ASM 50 min after mixing with a solution of o-ASM 
(b). Curves normalized to 1 to facilitate comparison. 
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7.2 Chapter 3 - SI 
 
 
Figure S12. 20% SDS Native gel of OmpF. Lane 1. Benchmark Protein Ladder. Lane 2-3 
OmpF-CA-Cy5, Lane 4-5 OmpF-CA.  
 
 
 
 
Figure S13. Analysis of 20% native page electrophoresis. Electrophoretic mobility of 
carbonylated OmpF (OmpF-CA) and OmpF modified with Cy5 (OmpF-CA-Cy5). 
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Table S2. Molecular brightness and diffusion times for OmpF-CA+Cy5, OmpF-WT+Cy5, and 
Cy5 in 3% OG measured at pH 7.4 and 5.5 respectively.  
 
OmpF subset CPM (kHz) τ[µs] 
   OmpF-CA+Cy5, 3% OG pH 7.2 17±1 350±27 
OmpF-WT+Cy5, 3% OG pH 7.2 4±1 266±51 
Cy5 , 3% OG pH 7.2 7±1 249±34 
OmpF-CA+Cy5, 3% OG pH 5.5 12±1 445±40 
OmpF-WT+Cy5, 3% OG pH 5.5 4±1 324±30 
Cy5 in 3% OG pH 5.5 7±1 297±29 
   
Cy5 in PBS  3±1 67±1 
   
 
 
 
Figure S14. FCS autocorrelation curves of Cy5. 100 nM Cy5-hydrazine in PBS solution 
(Blue), OmpF-CA-Cy5 at pH 7.4 (Cyan), OmpF-WT-Cy5 at pH 7.4 (Green), OmpF-WT+Cy5 
pH 5.5 (Yellow), 3% OG + Cy5 pH 7.2 (Orange), 3% OG + Cy5 pH 5 (Violet), OmpF-CA+Cy5 
pH 5.5 (Red).  
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Table S3. Size of nano-assemblies based on PMOXA6–PDMS44–PMOXA6 without and with 
reconstituted OmpF, pH 5.5. 
 
Size and stability of nano-assemblies 
DLS/SLS 
Rg 
[nm] 
Rh 
[nm] 
ρ = Rg/Rh 
Non-permeabelised Polymersomes 89 86 1.04 
OmpF-CA-Cy5 Polymersomes 85 81 1.05 
OmpF-WT Polymersomes 84 88 0.96 
 
 
 
 
 
 
Figure S15. TEM and Cryo-TEM micrographs of OmpF-WT catalytic 
nanocompartments. Panel a.) Overview TEM picture of a 0.5mg/ml OmpF-WT catalytic 
nanocompartment solution.  Scale bar 50nm. Panel b.) Overview Cryo-TEM picture of a 
2.5mg/ml OmpF WT catalytic nanocompartment solution. Scale bar: 100nm. 
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Figure S16.  TMB conversion kinetics of free HRP. HRP incubated at pH 7.4 (Blue) and 
5.5 (Red) and measured at pH 7.4.  
 
 
Figure S17. Amplex red conversion kinetics of Free HRP measured at pH 5.5 and 7.4. 
Amplex red conversion at pH 7.4 (Blue), Amplex red Conversion at pH 5.5 (Red). 
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Figure S18. TMB conversion kinetics at pH 7.4 of HRP loaded polymersomes modified 
with different OmpF subsets. TMB conversion kinetics measured at pH 7.4 of catalytic 
nanocompartments prepared with different OmpF subsets.  Red: OmpF-WT catalytic 
nanocompartments incubated at pH 7.4, Blue: OmpF-CA-Cy5 catalytic nanocompartments 
incubated at 7.4, Grey: OmpF-CA catalytic nanocompartments incubated at pH 5.5, Black: 
OmpF-CA-Cy5 catalytic nanocompartments incubated at 5.5, Yellow: OmpF-CA-Cy5 
catalytic nanocompartments incubated at 5.5.  
 
 
 
Figure S19. Amplex red conversion kinetics of catalytic nanocompartments equipped 
with different OmpFs. Incubaton time at pH 5.5 0h Panel A.) and after 1 hour Panel B.). Red: 
OmpF-CA-Cy5 catalytic nanocompartments, Grey: OmpF-CA catalytic nanocompartments, 
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Black: OmpF-WT catalytic nanocompartments, Orange: Unpermeabelised HRP loaded 
polymersomes. 
 
7.3 Chapter 4  
 
 
 
Figure S20. EPR measurement of free bis-(2,2,5,5-Tetramethyl- 3-imidazoline-1-oxyl-4-
yl)disulfide Panel A.) EPR signal of bis-(2,2,5,5-Tetramethyl- 3-imidazoline-1-oxyl-4-
yl)disulfide in PBS, experimental (black) and simulated (blue) Panel B.) EPR signal of bis-
(2,2,5,5-Tetramethyl- 3-imidazoline-1-oxyl-4-yl)disulfide in presence of 10mM  DTT 
experimental (black) and simulated (blue). 
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Figure S21: 4-15% SDS-PAGE of modified and unmodified OmpF. Left: Coomassie blue 
stained gel. Right: Fluorescent image. Lane 1. OmpF Wild type exposed to 30mM GSH, Lane 
2. OmpF Wild Type exposed to SAMSA- CF and 30mM GSH, Lane 3. OmpF K89 R270 
exposed to 30mM GSH, Lane 4. OmpF K89 R270 exposed to SAMSA- fluorescein and 30mM 
GSH Lane 5. OmpF Wild type, Lane 6. OmpF Wild Type exposed to SAMSA- fluorescein, 
Lane 7. OmpF K89 R270, Lane 8. OmpF K89 R270 exposed to SAMSA-fluorescein 
 
 
 
 
 
Figure S22: FCS analysis of OmpF-S-S-CF stimuli responsiveness. FCS autocorrelation 
curves of SAMSA-CF in 1% OG 30mM GSH (red), OmpF-S-S-CF mixed with 30mM GSH 
in 1% OG Time 1h (green) and OmpF-S-S-CF in 1% OG Time 0h, PBS (blue). Dotted line – 
experimental auto correlation curves, Full line – fit. Curves normalized to 1 to facilitate 
comparison.     
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Figure S23: Cryo-TEM overview micrographs of Panel a.) Polymersomes loaded with HRP 
and equipped with OmpF-S-S-CF. Panel b.) polymersomes loaded with HRP and equipped 
OmpF-SH. Panel c.) polymersomes loaded with HRP. Scale bar:100 nm   
 
Figure S24: Guinier plot representation of SLS data. HRP-loaded polymersomes equipped 
with OmpF-S-S-CF in PBS pH 7.4 (A), in presence 30mM GSH in PBS 7.4 (B). 
 
Figure S25: Guinier plot representation of SLS data. HRP-loaded polymersomes equipped 
with OmpF-SH in PBS pH 7.4 (A), in presence 30mM GSH in PBS pH 7.4 (B).  
 
(q²+kc)(×(µm² ×(104
0.0 1.5 3.0 4.5 6.0
ln
(K
c/
R)
,(K
c/
R(
in
(m
ol
/g
<18.00
<17.70
<17.40
<17.10
<16.80
<16.50
Mw(c):'4.178e+07'g/mol Mw(q²):'4.351e+07'g/mol
A2:';1.513e;09'mol'dm³/g² Rg:'7.134e+01'nm
(q²+kc)(×(µm² ×(104
0.0 1.5 3.0 4.5 6.0
ln
(K
c/
R)
,(K
c/
R(
in
(m
ol
/g
<18.00
<17.70
<17.40
<17.10
<16.80
Mw(c):'5.407e+07'g/mol Mw(q²):'4.378e+07'g/mol
A2:'2.835e:11'mol'dm³/g² Rg:'5.758e+01'nm
A B
(q²+kc)(×(µm² ×(104
0.0 1.5 3.0 4.5 6.0
ln
(K
c/
R)
,(K
c/
R(
in
(m
ol
/g
<19.00
<18.40
<17.80
<17.20
<16.60
Mw(c):'1.597e+08'g/mol Mw(q²):'1.546e+08'g/mol
A2:'1.472e<09'mol'dm³/g² Rg:'1.256e+02'nm
(q²+kc)(×(µm² ×(103
0.00 8.00 16.00 24.00 32.00
ln
(K
c/
R)
,(K
c/
R(
in
(m
ol
/g
=19.00
=18.50
=18.00
=17.50
=17.00
Mw(c):'1.780e+08'g/mol Mw(q²):'1.255e+08'g/mol
A2:'3.151e:09'mol'dm³/g² Rg:'9.596e+01'nm
A B
APENDIX – SUPPLEMENTARY INFORMATION 
 
 138 
 
Figure S26: Guinier plot representation of SLS data. HRP-loaded polymersomes in PBS 
(A), in presence 30mM GSH in PBS (B). 
 
 
 
 
 
Nanocompartments ρ = Rg/Rh 
HRP-loaded polymersomes 0.97 ± 0.01 
HRP-loaded polymersomes equipped with OmpF-S-S-CF 0.93 ± 0.02 
HRP loaded polymersomes equipped with OmpF-SH 0.98 ± 0.04 
  
 
Tale S2: Molecular Characteristics of PMOXA6−PDMS44-PMOXA6 assemblies in PBS pH 7.4. 
Mw = 4500 g/mol, PDI = 1.8, fhydrophylic = 25% 
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Nanocompartments ρ = Rg/Rh 
HRP-loaded polymersomes 0.95 ± 0.01 
HRP-loaded polymersomes equipped with OmpF-S-S-CF 0.96 ± 0.02 
HRP loaded polymersomes equipped with OmpF-SH 0.95 ± 0.04 
 
Table S3: Molecular Characteristics of PMOXA6−PDMS44-PMOXA6 assemblies in PBS pH 
7.4 + 30mM GSH. Mw = 4500 g/mol, PDI = 1.8, fhydrophylic = 25% 
 
 
 
 
 
 
Figure S27. Enzymatic Amplex Ultra red conversion by catalytic nanocompartments.  
OmpF-SH permeabilised catalytic nanocompartments (red), OmpF-S-S-CF permeabelized 
catalytic nanocompartments (green), unpermeabilised HRP-loaded polymersomes (black) in 
the presence of 30mM GSH in PBS pH 7.4. Panel a.) t=0, Panel b.) t=1h.   
 
a b
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Figure S28: Amplex Ultra Red conversion of free HRP in presence of 30mM GSH. 
Immediately after mixing with 30mM GSH (blue) and 1 hour after mixing with 30mM GSH 
in PBS pH 7.4 (black). 
 
 
 
  
 
Figure S29. Cytototxicity of catalytic nanocompartments. 24h (left) and 48h (right) cell 
viability of HeLa cells incubated with HRP-loaded polymersomes, HRP-loaded 
polymersomes equipped with OmpF-SH and HRP-loaded polymersomes equipped with 
OmpF-S-S-CF. 
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Figure S30: 4-20% SDS-PAGE of Atto-488 conjugated HRP and Atto-647 conjugated 
HRP. Panel A.) Left: Coomassie blue stained gel. Right: Fluorescent image. Lane 1: Protein 
ladder. Lane 2. Atto-488 Conjugated HRP. Panel B.) 4-20% SDS-PAGE. Left: Coomassie blue 
stained gel. Right: Fluorescent image. Lane 1: Protein ladder. Lane 2: Atto-647 conjugated 
HRP.  
 
 
 
 
 
Figure S31. Time dependent cellular uptake of Atto-488 conjugated HRP-loaded 
polymersomes equipped with OmpF-S-S-CF over 24 hours. CLSM micrographs of HeLa 
cells treated with PBS (Control) or 0.25 mg/ml Atto-488 HRP-loaded polymersomes equipped 
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with OmpF-S-S-CF. Blue: Hoechst 33342 nucleus stain, Gray: CellMask Deep Red Plasma 
membrane stain, Green: Atto-488. Scale bars: 20 µm   
 
 
Figure S32. Cellular uptake of different HRP-loaded polymersomes after 24 hours. CLSM 
micrograph of HeLa cells treated with PBS (Control), HRP-Atto488 loaded polymersomes, 
HRP-Atto488loaded polymersomes equipped with OmpF-SH and HRP-Atto488 loaded 
polymersomes equipped with OmpF-S-S-CF. Blue: Hoechst 33342 nucleus stain, Gray: 
CellMask Deep Red Plasma membrane stain, Green: Atto-488. Scale bar: 20µm   
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Figure S33. Intracellular localization of HRP-loaded polymersomes. Maximum intensity 
projections including lateral view of HeLa cells treated with HRP-Atto488 loaded 
polymersomes equipped with OmpF-S-S-CF for 24 hours. Endosomes were visualized with 
EEA1 staining, and lysosomes with LAMP1 staining. Blue: Hoechst 33342 nucleus stain, 
Green: Atto-488, Red: Early Endosome. Magenta: Lysosome. Scale bar: 10µm  
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Figure S34. Effect of saponin treatment on localization of polymersome encapsulated 
HRP-Atto488. CLSM maximum intensity projection micrograph of uptake experiments in 
HeLa cells with HRP-Atto488 loaded polymersomes equipped with OmpF-S-S-CF. After 24 
hours cells were treated with PBS (control) or 0.1% saponin. Blue: Hoechst 33342 nucleus 
stain, Green: Atto-488. Scale bar: 10µm  
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Figure S35. Intracellular conversion of Amplex Ultra Red by HRP loaded polymersomes. 
CLSM micrograph of HeLa cells treated with PBS (Control), Unpermeabilised HRP loaded 
polymersomes, OmpF-SH permeabelised HRP loaded polymersomes and HRP loaded 
polymersomes equipped with OmpF-S-S-CF.  Blue: Hoechst 33342 nucleus stain, Cyan: 
CellMask Deep Red Plasma membrane stain, Red: converted Amplex Red product. Scale bar: 
20µm   
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Figure S36. Flow cytometry analysis of Amplex Ultra Red Conversion in HeLa cells. Panel 
a.) Dot plots of FSC area against SSC area are shown. Inserts show the doublet exclusion for 
the SSC Panel b.) Analysis of Hela cells incubated with: PBS (Blue), Unequipped HRP loaded 
polymersomes (Gray), OmpF-SH equipped polymersomes (Red), OmpF-S-S-CF equipped 
polymersome (Green). Panel c.) Shematic representation of artificial organelle activity. 
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Figure S37. Lateral view of the ZFE cross-section used for fluorescent imaging.  
 
 
 
Figure S38. Biodistribution of HRP loaded catalytic nanocompartments in ZFE. Lateral 
view of the ZFE embryo cross-section. Panel a.) ZFE injected with HRP loaded 
polymersomes. Panel b.) ZFE injected with HRP-Atto488 loaded polymersomes equipped with 
OmpF-S-S-CF, Panel c.) ZFE injected with HRP loaded polymersomes equipped with OmpF-
SH. 
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Figure S39. Localisation of AO in ZFE. Lateral view of the ZFE cross-section. Panel A: ZF 
injected with  HRP-Atto647 Panel B: ZF injected with HRP-Atto488 loaded polymersomes 
equipped with equipped with OmpF-S-S-CF. Arrowheads: Localization of AO. 
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Figure S40. Injection of Amplex Ultra Red in ZFE Lateral view of the ZFE cross-
section. Panel A.) ZFE control. B.) ZFE injected with only Amplex Red, C.) ZFE injected 
with Amplex Red and H2O2.  
 
No Resorufin like product (RLP) or Resazurin like product (RZLP) was observed in ZFE 
control or in ZFE injected with only AR. Injection of AR and H2O2 resulted in a staining 
pattern of the erythrocytes. 
A B CZF MelanocytesHRP-Atto488
RLP
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ABBERVATIONS 
  
% Percent 
AO Artificial organelle 
AqpZ Aquaporin Z 
AR Amplex Red or  Amplex Ultra Red in Chapter 4 
Ar Argon 
ASM Acid sphingomyelinase 
ATRP Atom transfer radical polymerization 
BCA Bicinchoninic acid assay 
BSA Bovine serum albumine 
CMC Critical micellar concentration 
CMT Critical micellar temperature 
CPM Counts per molecule 
CRP Controlled radical polymerization 
Cu/ZnSOD Copper-zinc superoxide dismutase 
DLS Dynamic light scattering 
DMSO Dimethyl sulphoxide 
DNPH 2,4-Dinitrophenylhydrazine 
EEv Encapsulation efficiency based on vesicles 
EGFP Enhanced green fluorescent protein 
FACS Fluorescence-activated cell sorting 
FCS Fluorescence correlation spectroscopy 
FhuA Ferrichrome outer membrane transporter 
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FITC Fluorescein IsoThioCynanate 
G Autocorrelation amplitude 
gA Gramicidin 
GFP Green fluorescent protein 
GSH Glutathione 
GUV Giant unilammelar vesicle 
h Hour 
HCl Hydrochloric Acid 
He-Ne Helium-Neon 
HRP Horseradish peroxidase 
IPTG β-D-thiogalactopyranoside 
kDa kilo Dalton 
kHz kilo Hertz 
LamB Maltoporin membrane protein 
LB Lysogen Broth  
LBL Layer by layer 
LSM Laser scanning microscopy 
min Minute 
ms Millisecond 
MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) 
Mw Molecular weighted polymer molecular eight 
mW Milliwat 
MWCO Molecular weight cutoff  
NHS N-hydroxysuccinimide 
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nm Nanometre 
nM Nanomolar 
NMP Nitroxide-mediated radical polymerization 
NMR Nuclear magnetic resonance 
NP Nanoparticle 
ºC Degree Celsius 
OG n-Octyl-β-D-Glucoside 
OmpF Outer Membrane protein F 
PAA Polyarylamide 
PAGE Polyacrylamide gel electrophoresis 
PBS Phosphate buffer saline 
PCL Polycaprolactone 
PDI Polydyspersity 
PDMAEMA poly((dimethylamino)ethyl methacrylate) 
PEG Poly (Ethylene Glycol) 
PLA Poly Lactic Acid 
PMCL Poly(4-methyl-ε-caprolactone 
PMOXA-b-PDMS-b-
PMOXA 
poly(2-methyloxazoline)-block-poly(dimethylsiloxane)-block-
poly(2-methyloxazoline) 
RAFT Reversible Addition–Fragmentation chain Transfer 
RFP Red fluorescent protein 
RNS Reactive nitrogen species 
ROP ring-opening polymerization 
ROS Reactive oxygen species 
s Second 
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SAMSA-CF 5-((2-(and-3)-S-(acetylmercapto) succinoyl) amino) Fluorescein 
SANS Small angle neutron scattering 
SDS Sodium dodecyl sulfate  
SEM Scanning electron microscopy 
SLS Static light scattering 
SPT Single particle tracking 
TB Terrific broth 
TCA Trichloroacetic acid 
td Diffusion time 
TEM Transmission electron microscopy 
TEM Transmission Electron Microscopy 
TMB 3,3’,5,5’-Tetramethylbenzidine 
ttrip Triplet time 
ZFE Zebrafish Embryo 
λem Emission wavelength 
λem Emission wavelength 
λex Excitation wavelength 
λex Excitation wavelength 
µL Microliter 
µM Micromolar 
µs Microsecond 
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